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ABSTRACT 
 
The Effects of Resistance Exercise on In Vivo Cumulative Skeletal Muscle Protein 
Synthesis. (May 2009) 
Heath G. Gasier, B.S., Youngstown State University; 
M.S., Case Western Reserve University 
Co-Chairs of Advisory Committee: Dr. Steven E. Riechman 
                                                      Dr. James D. Fluckey 
  
An acute bout of resistance exercise (RE) and dietary protein consumption 
stimulate muscle protein synthesis (MPS). This anabolic effect is believed to be 
attenuated with resistance exercise training (RET), however, the mechanism for this 
„plateau‟ is unknown. In addition, the ideal timing for protein consumption to optimize 
MPS is not well characterized. The central hypothesis of this research is that RE 
stimulates cumulative (measured over 24-36 h) MPS in rats and humans.  
Study one determined whether an acute bout of RE in rats enhances MPS when 
assessed with the traditional flooding dose (~ 25 min) and 2H2O (4 and 24 h 
measurements); thus a comparison of the two methodologies was made. An acute 
session of RE did not result in an elevation in MPS when quantified by either the 
flooding dose or 2H2O over 4 and 24 h (methods compared qualitatively). Therefore, an 
acute bout of RE in rats does not appear to be anabolic and adaptation resulting from 
multiple bouts is likely necessary.  
Study two determined if RET in rats results in attenuation in MPS (plateau  
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effect) 16 h following the final RE session (peak anabolic window) and if it is due to an  
increase in 4E-BP1 (a key regulator of mRNA translation initiation) activity; or if the 
timing in anabolism changes, which could be detected with a cumulative assessment 
(2H2O). MPS at 16 h was unchanged following RE training. Consistent with this finding, 
there were no differences in 4E-BP1 activity. Conversely, cumulative MPS was 
significantly increased with RET, suggesting a temporal shift in anabolism. 
 Study three determined if dietary protein consumed immediately following RE 
augments cumulative (24 h) MPS in young adult human males when energy and 
macronutrients are controlled. RE and post-RE protein had no effect on mixed MPS; 
however, myofibrillar MPS was significantly increased with RE suggesting specific 
changes within a heterogeneous protein pool. 
 Collectively, these are the first studies to assess changes in cumulative MPS with 
RE in rats and humans. The long term goals of this research are to understand muscle 
protein anabolism in „free-living‟ mammals and the mechanisms that regulate this 
process. 
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NOMENCLATURE 
 
Ala (A)  Alanine 
ALT   Alanine aminotransferase 
AMP   Adenosine monophosphate 
AMPK   5‟ AMP activated protein kinase 
A site   Aminoacylated-tRNA site  
ATP   Adenosine triphosphate 
CRT   Chronic resistance exercise training 
DNA   Deoxyribonucleic acid 
eEF   Eukaryotic elongation factors 
eIF   Eukaryotic initiation factors 
eRF   Eukaryotic release factors 
ERK   Extracellular-signal regulated kinase 
E site   Ejection site 
FSR   Fractional rates of protein synthesis 
Gly (G)  Glycine 
Glu (Q)  Glutamine 
GTP   Guanosine triphosphate 
2H2O Deuterium oxide 
2H Deuterated  
Met (M) Methionine 
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mRNA Messenger RNA 
MPS Muscle protein synthesis 
OA Oxaloacetate 
PEP-CK Phosphoenolpyruvate carboxykinase 
Phe (F)  Phenylalanine 
PI3K Phosphatidylinositol 3-kinase 
P site Peptidyl-tRNA site 
Pyr Pyruvate 
Ras   GTPase 
RRF Ribosomal recycling factor 
rRNA Ribosomal RNA 
RNA Ribonucleic acid 
RPS  Rates of protein synthesis 
RE Resistance exercise 
Ser (S) Serine 
Thr (T) Threonine 
tRNA Transfer RNA 
1RM One repetition maximum  
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CHAPTER I 
INTRODUCTION 
 
 The field of skeletal muscle biology has evolved over the past 50 years, from 
defining structure and function to identifying a central role in the pathogenesis of many 
debilitating and chronic diseases (AIDS, cancer, sarcopenia, starvation, trauma and 
sepsis and several metabolic disorders). Much of the interest in skeletal muscle research 
can be attributed to its overall contribution to structure (40-45% of body mass with ~ 
60% being protein) and function (primary reservoir for amino acids and glycogen, and 
thus energy transduction) (27, 134, 135). As a result of its structure and function, 
skeletal muscle accounts for ~ 30% of whole-body protein metabolism under fasting 
conditions, 35% with feeding and up to 45% following resistance exercise (RE) with the 
ingestion of mixed meals (135). Due to the increases with feeding and resistance 
exercise, designing experiments to include these perturbations can further our 
understanding of non-steady state protein anabolism which may ultimately result in 
identification of the defect(s) that regulate skeletal muscle metabolism and growth. 
 There is little known of the effects of a single bout of RE on stimulating muscle 
protein synthesis (MPS) in rats as the majority of the investigations define „acute‟ as 2-4 
bouts of RE (23, 50-52, 54-57, 84, 85). Conversely, it is well documented that a single 
bout of RE in humans increases MPS from 1-48 h (15, 35, 37, 41, 108). The accepted 
theory behind muscle hypertrophy resulting from resistance exercise training is that the  
____________ 
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anabolic effects are cumulative; however, when making direct comparisons to acute 
resistance exercise, chronic resistance exercise training appears to result in an attenuated 
MPS response (50, 77, 107, 109). Therefore, it would seem likely that a rate limiting 
control step(s) within the myocyte signal transduction pathway exists, which ultimately 
serves as a regulator of muscle growth. Of the most likely candidates is an inhibitory 
protein, eukaryotic initiation factor (eIF) 4E-BP1, which functions downstream of a key 
muscle growth regulator, the mammalian target of rapamycin (mTOR) protein kinase (5, 
21-23, 112, 115). Upon activation by mechanical strain, growth factors and nutrients, 
mTOR phosphorylates 4E-BP1 allowing liberation of eIF4E to bind the 5‟ cap structure 
of a transcript to promote the initiation of mRNA translation (22, 28, 65, 95, 112, 123). 
Therefore, increased expression and/or hypophosphorylation of 4E-BP1 may occur with 
chronic resistance exercise training, serving as a break on protein synthesis, thus 
resulting in a plateau in skeletal muscle growth.    
As mentioned, the provision of macronutrients stimulates MPS. Of the three 
macronutrients (carbohydrates, protein, fat) protein (amino acids) appears to be the most 
potent stimulator of protein synthesis. The combination of resistance exercise and 
nutrients yield an interactive benefit in stimulating anabolism with a concomitant 
decrease in skeletal muscle breakdown (40, 80, 114, 127, 128). Thus, providing adequate 
nutrition, protein specifically, with resistance exercise would appear to maximize one‟s 
growth potential. Although the amount of protein to be consumed with resistance 
exercise has been suggested to be 1.3 to 1.8 g  kg body mass-1  d-1 (1, 68, 103, 106, 
107), the precise timing of protein ingestion with resistance exercise is unknown when 
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controlling for energy and macronutrient composition. Therefore, more research in the 
area of protein consumption (variable time of ingestion) with resistance exercise is 
warranted to determine the optimal dietary intervention for optimizing MPS and thus, 
muscle growth.   
Labeled amino acids (tracer) have traditionally been used to measure tissue 
specific (direct incorporation approach) protein synthesis (146, 152); however, the 
results can often times vary based on the type of tracer employed in the study. In 
addition, the necessity for controlling experimental conditions (post-absorptive and 
stress free) limits the ability to investigate mammals in free-living environments. 
Moreover, it is known that a wide variety of conditions can alter muscle protein 
anabolism (e.g. feeding, fasting, sleep, stress and activity). To circumvent these issues, 
an alternative tracer (deuterium oxide - 2H2O) has been purported to provide accurate 
measurements of tissue specific protein synthesis over short and prolonged periods of 
time non-invasively (8, 30, 44, 111, 151). To date, no investigation has examined in vivo 
cumulative skeletal MPS with 2H2O to include known perturbations (food ingestion and 
resistance exercise) in the assessment.  
  The overall objectives of this research were to determine if acute resistance 
exercise in rats is anabolic, if chronic resistance exercise in rats leads to an inhibition in 
MPS which is explainable by over-expression of 4E-BP1, and to establish whether the 
manipulation of the diet (timing of protein ingestion) following resistance exercise in 
humans influences muscle protein synthesis. Moreover, the central hypothesis of this 
research is that RE stimulates cumulative (over 24-36 h) MPS in rats and humans. In 
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order to conduct these experiments, a validation study between 2H2O (alternative, allows 
long-term measurements) and flooding dose (traditional, limited to short-term 
measurements) was necessary.  
The findings from this research may change our current understanding of what 
occurs with resistance exercise and muscle protein synthesis. Furthermore, these data 
will assist muscle biologists in experimental design to encompass every day normal 
physiology/biochemistry which provides an overall picture of muscle anabolism. In 
addition, these results will be foundational for which comparisons can be made to with 
investigations in debilitating and metabolic disease states.   
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CHAPTER II 
BACKGROUND 
 
Protein Synthesis Overview 
Protein synthesis (translation) is the process by which genetic information 
contained in transcripts (messenger ribonucleic acid, mRNA) is used to produce 
sequences of amino acids, or proteins (136). An adult male (~ 70 kg) contains roughly 
12 kg of protein (7 kg in skeletal muscle) and 220 g of free amino acids (120 g within 
skeletal muscle cytoplasm and 5 g in the circulation) (134). The synthesis of proteins is 
among the most energetically costly biological processes as 4 mol of adenosine 
triphosphate (ATP) or equivalent (1 mol ATP releases 20 kcal) are required per mole of 
amino acid incorporated into protein (145). The process by which translation occurs is a 
coordinated series of events that, similar to deoxyribonucleic acid (DNA) replication and 
transcription, can be divided into three sequential stages; initiation, elongation and 
termination (136). In order to carry out each of these steps, there are four key 
components required: mRNA (80% of RNA), transfer RNA (tRNA,15% of RNA), 
ribosomal RNA (rRNA, 5% of RNA) and aminoacyl tRNA synthetases (136). The 
remainder of this section will focus on each of the three translational steps. 
 Translation initiation is the primary rate–limiting step in mRNA translation (116) 
and is controlled by many proteins that are activated and/or inhibited by extracellular 
signals. The process can be divided into three stages: i) the binding of initiator 
methionyl-tRNA (met-tRNAi) to the 40S ribosomal subunit to form the 43S preinitiation 
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complex, ii) the formation of the 48S preinitiation complex by binding of the mRNA to 
the 43S preinitiation complex and iii) the binding of the 60S ribosomal subunit to the 
48S preinitiation complex to yield the functional 80S initiation complex (78) (Fig. 1, 
page 7). The first stage occurs by the formation of a ternary complex which consists of 
eIF2 (GTPase), GTP (guanosine triphosphate) and met-tRNAi and attachment on the P 
site (binding site for the peptidyl-tRNA) of the 40S subunit with the assistance of eIF5B-
GTP (GTPase) (22, 78, 91, 136). In addition, eIF1A (inhibits early hydrolysis of the 
ternary complex) and eIF3 (inhibits reassociation with the 60S subunit) bind to the 
aminoacylated-tRNA site (A site) and the ejection site (E site) respectively (91, 136). 
Prior to the formation of the 48S preinitiation complex, a three-subunit protein, eIF4F 
(comprised of eIF4E, eIF4G and eIF4A) must recognize and bind to the 5‟ cap (7-
methylguanosine-triphosphate, m7pppN, where N is any nucleotide) of the mRNA (91, 
95, 123, 136). More descriptively, eIF4E binds directly to the 5‟ cap structure, eIF4G is 
a scaffold and eIF4A is an ATP-dependent RNA helicase that unwinds secondary 
structures (hairpins) once activated by eIF4B (an RNA binding protein) (91, 95, 123). 
Next, eIF4F, eIF4B and the transcript can bind to the 43S preinitiation complex via an 
eIF4G and eIF3 interaction (91). Prior to the final stage (80S initiation complex 
formation) the 48S preinitiation complex scans the mRNA (5‟  3‟) in an ATP-
dependent manner for the start codon (AUG) (136). Correct base-pairing (codon on 
mRNA and anti-codon on tRNA) triggers the release of eIF2 (GTP hydrolysis), eIF3 and 
eIF4B allowing the 60S subunit to associate with the 48S complex. (136). The formation  
of the 80S complex stimulates eIF5B-GTP hydrolysis resulting in the release of eI5B,  
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Fig. 1. Translation initiation. The figure illustrates the three stages (see text for detailed 
description) of translation initiation. Stage 1, the formation of the 43 preinitiation 
complex (initiator methionyl-tRNA binds to 40S); stage 2, the formation of the 48 
preinitiation complex (mRNA with eIF4F binds to 43S) and stage 3, the formation of 
functional 80S ribosome (60S binds to 48S). 
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eIF1A and the correct placement of met-tRNAi, triggering translation initiation (136). In 
order for another round of initiation to occur, the GDP (guanosine diphosphate) bound to 
eIF2 must be exchanged with GTP, which occurs via eIF2B (guanine nucleotide 
exchanger) (78).  
Translation elongation occurs once the met-tRNAi is placed into the P site of the 
assembled 80S ribosome and can be explained by three sequential steps. Prior to step 
one and the addition of amino acids to the peptide chain, the tRNA is charged via 
adenylylation with the correct amino acid and the transfer of the adenylylated amino acid 
to the tRNA (136). Step one consists of the aminoacyl-tRNA moving into the A site of 
the ribosome with the assistance of eukaryotic elongation factor (eEF) 1A-GTP (112). 
Upon GTP hydrolysis, eEF1A-GDP is released and the aminoacyl-tRNA is moved into 
position of the peptide in the P site (136) with the resulting eIF1A-GDP getting 
recharged by the guanine nucleotide exchange factor, eEF1B (112). The second step is 
the formation of the peptide bond between the existing peptidyl-tRNA in the P site and 
the aminoacyl-tRNA in the A site (where the growing peptide is shifted to) and is 
catalyzed by peptidyl transferase (136). Thirdly, the peptidyl-tRNA is translocated from 
the A site to the P site with the assistance of eEF2-GTP (GTP hydrolysis) (112). In 
addition, the ribosome moves by one codon relative to the mRNA with the previous 
peptidyl-tRNA moving into the E site.  
  The final stage of translation, termination, can be explained by two sequential  
steps, followed by the dissociation of the 80S ribosome. First, eukaryotic release factor 
(eRF) 1 recognizes one of three stop codons on the mRNA (UAG, UGA or UAA) by a 
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peptide anticodon (136). Additionally, eRF1 possesses a glycine, glycine and glutamine 
(GGQ) motif that is located in close proximity to the 3‟ end of the peptidyl-tRNA, which 
results in peptide hydrolysis (136). Step two involves the binding of eRF3-GDP to the 
eRF1 within the intact ribosome that still has two deacylated tRNAs bound to the P and 
E sites. The interaction between eRF3-GDP and eRF1 results in GTP exchange with 
eRF3-GDP and subsequent hydrolysis resulting in the dissociation of eRF1 and eRF3 
from the ribosome (136). Now that the peptide has been synthesized, the ribosome must 
release from the mRNA so that another round of translation can occur. Although not 
completely understood, it is believed that this is accomplished by a ribosomal recycling 
factor (RRF), eEF2-GTP and eIF3. More specifically, the RRF binds to the A site 
(mimicking a tRNA) and recruits eEF2-GTP to the ribosome, followed by hydrolysis 
which stimulates the release of the uncharged tRNAs from the P and E sites (136). 
Finally, eIF3 is recruited into the E site of the 40S subunit causing release of eEF2-GDP, 
RRF the 60S subunit and mRNA (136). The machinery is now readily available to 
undergo another cycle of mRNA translation. 
The process of protein synthesis occurs with near flawless precision (no more 
than 1 in 1000 amino acids are erroneously incorporated to the growing peptide (136)) 
upon initiation. The process may be regulated in each phase of translation; however, 
since translation initiation is the rate limiting phase of protein synthesis, studies focusing 
on control and regulation of protein metabolism at this phase are of interest. In order for 
translation to occur, stimuli such as dietary factors, hormones and mechanical strain 
must transduce signals from the external milieu to the site of initiation. The following 
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sections will describe the effects of nutrition, resistance exercise and their interactive 
role in modulating muscle protein synthesis, followed by the regulation (signal 
transduction) of protein synthesis with special emphasize placed on the control of cap 
dependent translation initiation (primary process by which eukaryotes translate mRNA) 
by 4E-BP1. 
 
Response of Muscle Protein Synthesis to Feeding  
As previously mentioned, skeletal muscle is the major reservoir for free amino 
acids and therefore, ingestion of protein or amino acids serve to maintain the preexisting 
muscle protein pool. The process by which this occurs can be explained from the point 
of mastication. More specifically, upon ingestion of protein, the stomach pH (HCl 
release) stimulates the release of pepsin from parietal cells which cleaves the proteins 
into smaller peptides that then pass into the small intestine (73). The peptides become 
further hydrolyzed into amino acids and di-and tri-peptides by pancreatic enzymes 
(trypsin, chymotrypsins, elastase and carboxypeptidases), followed by uptake into 
mucosal cells (active transport) where the small peptides undergo final hydrolysis into 
amino acids (73). Next, the absorbed amino acids are either metabolized within the 
enterocyte or enter the portal circulation and carried to the liver where a portion are used 
and the remainder pass through the systemic circulation to be utilized by the periphery 
(73). Upon entering a tissue bed (skeletal muscle) the amino acids can either pass 
directly into the venous circulation, or be transported into the muscle via amino acid 
transporters where they can charge tRNA and be incorporated into protein and/or 
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undergo metabolism (Fig. 2, page 11) (14, 135). If the availability of amino acids  from 
the extracellular pool become limited (20), muscle protein degradation may ensue, as 
well as de novo synthesis. The fate of the latter is either recycling for muscle 
preservation and/or release into the venous circulation to be transported to the kidney 
and liver (gluconeogenesis) or other tissues in need of amino acids for protein 
production. Therefore, the maintenance of skeletal muscle is a balance between synthesis 
and breakdown and feeding stimulates synthesis and depresses breakdown (129). 
 
 
Fig. 2. General model of muscle protein metabolism. Systemic amino acids (AA) can 
enter skeletal muscle (SM) via amino acid transporters and charge tRNA for protein 
synthesis and/or undergo metabolism (disappearance). Intracellular amino acids from 
protein breakdown and de novo synthesis can enter the venous circulation along with 
amino acids that continue directly from artery to vein without intracellular uptake 
(appearance), or can be recycled for protein synthesis. 
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Much of the research over the past 25 + years has focused on the provision of  
amino acids to stimulate muscle protein synthesis in rats (61, 76), pigs (137) and  
humans (11, 12, 20, 58, 64, 96, 97, 99, 100). The reasoning for this experimental 
rationale is threefold. First off, although glucose and fat are the primary energy 
substrates under resting and exercising conditions, they do not appear to directly 
stimulate protein synthesis in the absence of amino acids (122). However, they may 
become instrumental when the energy status becomes low (increased AMP:ATP and 
5‟AMP-activated protein kinase, AMPK), which occurs during starvation and exercise; 
or through the actions of hormones, such as an increase in insulin secretion resulting 
from increased glucose (129). Secondly, even though mixed meals stimulate muscle 
protein synthesis (60, 151), amino acids (essential/indispensible) alone do not require 
digestion and are rapidly absorbed, creating hyperaminoacidemia in the systemic 
circulation which appears to modulate muscle protein synthesis (20). The mechanism by 
which this occurs has been suggested to be via mass action (increased intracellular 
availability of amino acids charge available tRNA), signal transduction of translation 
initiation or the presence of a membrane-bound sensor that transmits a signal to initiate 
translation and is independent of amino acid transporters (20, 129). To date, the evidence 
is mounting in support of signal transduction control, primarily through leucine in 
stimulating mTOR; however, it is premature to discount mass action and the presence of 
a membrane bound sensor due to the necessity for amino acid transport. Thirdly, the 
measurement of muscle protein synthesis is difficult to accurately assess under 
postprandial conditions due to the perturbed state of the precursor pool (plasma or 
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intracellular), which results in dilution of the tracer and the potential for false 
quantification of fractional synthesis rates of protein synthesis (FSR). Therefore, the 
experimental conditions generally require fasting conditions (overnight fast) and if meals 
are to be provided during the tracer infusion, caution is warranted, as liquid-only meals 
or parenteral nutrition with a precise amount of tracer must be added. Thus, at least in 
the post-absorptive state, nutrient ingestion (primarily indispensible amino acids) 
stimulates muscle protein synthesis. 
 
Response of Muscle Protein Synthesis to Resistance Exercise 
 Studies examining the effects of an acute bout of resistance exercise in the post-
absorptive state have reported increases in mixed (15, 41, 50, 52, 57, 77, 84, 108, 109), 
myofibrillar (77, 94) and sarcoplasmic (94) muscle protein synthesis in animals and 
humans from 1-72 h following the session; as well as a concomitant increase in 
breakdown (41). The increases may be attributable to the accelerated amino acid 
transport that occurs in coordination with increased blood flow (15, 16, 153). However, 
it is worth mentioning that Roy et al. (117) (resistance exercise in humans) and Fluckey 
et al. (54) (electrical stimulation in rats) did not observe a stimulatory effect following a 
single bout. The discrepancies have been proposed to be a result of the training status in 
humans (129) and either an excess in the stimulus provided and/or the necessity for 
adaptation to occur in rats. In support of this, Roy et al. (117) recruited subjects who had 
been participating in a regular resistance exercise training program and Farrell et al. (50, 
52), Fluckey et al. (57) and Kubica et al. (84) described “acute” as being 4 progressive 
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bouts of resistance exercise (weighted Velcro vest protocol). One could argue that 4 
sessions of resistance exercise provides more than just a “brief” stimulus to the muscle 
and an adaptation is actually occurring. To further strengthen this argument, Fluckey et 
al. (57) reported increases in total RNA content (translational capacity), which would 
only be expected to be observed after successive bouts of muscle overload versus acute 
tension (generally explainable by enhanced translational efficiency, rate of synthesis 
relative to RNA) (69). Thus, as a whole, the data support the notion that acute resistance 
exercise in the post-absorptive state increases muscle protein synthesis in humans 
(unknown in rats) and what has traditionally been referred to as „acute‟ in rats may 
actually be an early trained state. Finally, although muscle protein synthesis is increased, 
muscle protein degradation is also increased and the overall balance remains negative 
(15, 108). 
 Less is known of chronic resistance exercise training and protein balance (post-
absorption); likely due to the degree of complexity and cost that a regular, supervised 
training program adds to the design. The belief is that the anabolic effects that occur 
with acute resistance exercise become cumulative over time and are responsible for 
muscle hypertrophy. However, if this were the case than the growth potential for 
mammals would essentially be unlimited. Thus, it could be that there is a plateau effect 
with skeletal muscle growth resulting from resistance exercise training. 
The results of the studies that have been reported are mixed, which can likely be 
explained by methodological differences. For instance, Yarasheski et al. (150) reported a 
57% and 155% increase in FSR in young and aged subjects respectively, following two 
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weeks of daily resistance exercise training; however, the researchers compared a basal 
sample (prior to training) to the post-training sample (3 h following the final exercise 
bout). Therefore, question arises as to whether it was truly the training or the acute effect 
of exercise. To answer this question, Phillips et al. (109) compared resistance exercise 
trained (≥ 5 yr) to untrained young adults following an acute bout of unilateral leg 
exercise. They (109) observed an exercise effect in stimulating muscle protein synthesis 
(within 4 h following the session) above resting values; however, no differences between 
the trained (~ 0.067% ∙ h-1) and untrained (~ 0.080% ∙ h-1) subjects. Additionally, 
breakdown was increased by ~ 37% in the untrained following exercise, but did not 
change in the trained group, thus the net balance of protein accretion was in favor of the 
trained individuals. However, the subjects did not actually participate in a supervised 
resistance training program and were, instead, recruited by self reporting their training 
history. To alleviate this methodological limitation that may exist with a self-reported 
training history, others have conducted supervised resistance exercise training from 8-12 
weeks in rats (50) and humans (77, 138). The findings are suggestive that the acute 
elevations in muscle protein synthesis no longer persist following a resistance exercise 
training program in the mixed muscle homogenate at a time when an acute increase is 
observed (50, 77); however, the myofibrillar fraction is either increased (77) or 
decreased (138). The discrepancy in the myofibrillar FSR can be attributed to the 
methodological differences (i.e. tracer used, time of measurement, length and type of 
training program implemented). Therefore, more research examining the effects of 
chronic resistance exercise and muscle protein synthesis is needed to further elucidate  
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whether or not a plateau does in fact exist, or if there is just a shift in the timing by  
which the process of translation is carried out. 
 
Interactive Effects of Nutrition and Resistance Exercise 
 Since feeding stimulates muscle protein synthesis and undergoing an acute bout  
of resistance exercise increases synthesis and breakdown (14, 93, 129, 144), consuming 
nutrients with resistance exercise would seem to yield a synergistic benefit (effect 
greater than the sum) on skeletal muscle anabolism. Although the research in this area 
supports the notion that nutrient ingestion (amino acids specifically) in conjunction with 
resistance training are required for an optimal anabolic response, the data are not 
conclusive. Three questions have yet to be convincingly answered: First, what should the 
composition of the meal be and what time should the nutrients be ingested; second, does 
resistance exercise training alter the response in the fed state and third, should the 
measurements be made following an overnight fast with only the addition of the selected 
nutrients during isotopic infusions? This section will describe the research that has been 
conducted in this area (in the context of protein kinetic assessment) and illuminate some 
of the potential limitations of these studies.  
 Studies examining the effect of feeding prior to resistance exercise are scarce, 
which may be due to the need for a post-absorptive state with traditional tracer infusion 
protocols. The studies that have been conducted are conflicting, as Tipton et al. (128) 
observed increased amino acid uptake, phenylalanine disappearance (indirect indicator 
of MPS) and protein balance when an essential amino acid (6 g) + carbohydrate (35 g 
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sucrose) beverage was provided just prior to versus following resistance exercise (2 h) 
following an over-night fast. However, when the same group compared pre and post-
resistance exercise (immediately before and 1 h after) whey protein (20 g) consumption 
on the same parameters, no differences were observed (126). The authors (126) 
concluded that the differences were because amino acids require little time for 
absorption as compared to whey protein; however, they did not make direct comparisons 
between amino acids and whey protein rendering this conclusion speculative. Moreover, 
the subjects were assessed following an over-night fast over ~ 5 h, thus providing any 
nutrients either before or after would serve to augment the increase in protein synthesis 
from resistance exercise (no control was used). To further clarify whether pre-resistance 
exercise nutrient ingestion is anabolic, Fujita et al. (59) compared an essential amino 
acid (20 g) + carbohydrate (27 g) supplement to an over-night fasted group, followed by 
an acute bout of resistance exercise. Unlike the previous investigations, Fujita et al. (59) 
directly measured muscle protein synthesis and observed no differences 2 h following 
exercise when providing amino acids + carbohydrate prior to resistance exercise. As a 
consequence of the above mentioned studies, it remains inconclusive whether providing 
nutrients prior to resistance exercise following an over-night fast is synergistically 
anabolic, at least in the short time-frame following the exercise session (1-5 h).  
 Similar to the concerns with maintenance of steady state isotopic  
enrichments in pre-resistance exercise feeding, little work has been reported with 
feeding during resistance exercise on muscle metabolism. Of the three published reports, 
Chesley et al. (35) was the first to address this question by assessing protein synthesis in 
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the biceps brachii 4 and 24 h following resistance in humans with mixed meal 
supplements (Ensure Supplement, ~ 50% of the subjects reported mean daily intake) 
during the tracer infusion. They (35) observed a 50% increase in FSR 4 h and 109% 
increase 24 h following exercise when comparing the exercised to the non-exercised arm 
in the subjects. However, it is not clear whether the subjects were assessed in a fed or 
fasted state and whether tracer was added to the supplements to prevent isotopic dilution, 
limiting the study‟s interpretative value.  
Miller et al. (94), using a unilateral leg protocol, assessed myofibrillar and 
sarcoplasmic protein synthesis with mixed meal supplements (1.4 x basal metabolic rate) 
provided during the exercise and tracer infusion protocol. The investigators (94) reported 
significant elevations in both muscle fractions from 6-72 h following an acute bout of 
resistance exercise. Although this group suggested that this occurred in a fed state, the 
protocol was initiated following an overnight fast, thus one could argue that this truly 
wasn‟t a postprandial assessment. More recently, Beelen et al. (9) examined the response 
of protein (casein, 21 g) + carbohydrate (glucose + maltodextrin, 0.15 g ∙ kg-1 ∙ h-1) 
supplemented during 2 h of whole body resistance exercise under postprandial 
conditions. Thus, that may represent the first study (11) to assess protein balance and 
muscle protein synthesis in the fed state (early evening) versus following an overnight 
fast, enhancing the practicality of the design. However, since no tracer was added to the 
supplements, the precursor enrichment (plasma) likely became diluted and yielded a 
false elevation in FSR. If, in fact, the investigators (9) used the protein-free enrichment 
as the precursor, no differences between carbohydrate and protein + carbohydrate would 
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have been observed. Therefore, although this design is promising for future studies in the 
area of nutrition and resistance exercise, the question as to whether providing nutrients 
during resistance exercise enhances anabolism remains inconclusive. 
 In contrast to „pre‟ and „during‟ resistance exercise designs, a substantial amount  
of experiments have been conducted following resistance exercise with nutrient 
manipulation. In regards to carbohydrate alone, providing 1 g ∙ kg-1 of glucose (117) or 
100 g of maltodextrin (25) following resistance exercise (assessment made following an 
over-night fast) did not result in stimulation of tracer disappearance (glucose) or muscle 
protein synthesis (maltodextrin). However, 3-Methylhistidine excretion and urinary urea 
nitrogen (indicators of protein breakdown) were decreased with glucose administration 
(117). Moreover, there was a decrease in tracer appearance and thus, an improvement in 
overall net protein balance (25) with carbohydrate administration. In both of these 
studies (25, 117), insulin was increased significantly with carbohydrate, which has been 
suggested to play a permissive role in stimulating muscle protein synthesis, as well as an 
instrumental role in inhibition of muscle protein breakdown (36, 66, 104). When 
examining the role of either a complete (16) or essential (127) amino acid mixture under 
fasting condition, increases in muscle protein synthesis were reported (~ 150% over non-
hyperaminoacidemia) in the former and net protein balance significantly improved in the 
latter, suggesting that only indispensible amino acids are required. Furthermore, when 
combining carbohydrate with indispensible amino acids (6–45 g), mixed muscle protein 
synthesis increased from 1-6 h (40, 42, 114) and myofibrillar and sarcoplasmic FSR 
increased from 6-24 h (37) post-resistance exercise. Additionally, net protein balance 
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significantly improved with the combination of the amino acid + carbohydrate 
supplement (40, 114). However, it is worth mentioning that this nutrient augmented 
response was delayed in the aged (70 y) 6 h versus immediately following exercise (42). 
Taken together, these results suggest that hyperaminoacidemia with a concomitant 
increase in muscle blood flow, as well as the inhibitory action of insulin on breakdown, 
augment muscle anabolism following resistance exercise. 
 Although the post-resistance exercise increase in muscle protein synthesis and/or 
muscle protein balance reported with either carbohydrate and/or amino acids 
(indispensible) is an appealing approach to optimize muscle anabolism, one must 
consider that humans consume mixed meals on a daily basis and not single 
macronutrients. Koopman et al. (83) compared the effects of post-resistance exercise 
consumption of either carbohydrate (glucose + maltodextrin, ~ 122 g), carbohydrate + 
whey protein hydrolysate (~ 82 g whey) or carbohydrate + whey protein + leucine (+ 41 
g leucine) on muscle and whole body protein balance (fasted assessment). Their findings 
were suggestive of a stimulatory effect on muscle protein synthesis (6 h following 
exercise) with both carbohydrate + whey and carbohydrate + whey + leucine; and an 
overall improvement in whole body protein balance, although the differences in the latter 
finding were minimal. In addition, Koopman et al. (82) (using a similar protocol as 
above (83) with the exception that there was no carbohydrate + protein group) reported 
elevations in both young and aged subjects, supporting the notion that there is not an 
impairment in protein synthesis stimulation in the elderly. More recently, the same group 
(80) (using a similar design) observed no added benefit on muscle protein synthesis and 
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whole body protein balance with either low (0.15 g ∙ kg-1 ∙ h-1) or high (0.6 g ∙ kg-1 ∙ h-1) 
carbohydrate supplemented with casein protein (hydrolysate) in the 6 h following 
resistance exercise. The discrepancy between the two studies can likely be attributed to 
the sufficient rise in insulin (~ 17 µU/ml) with casein protein in the latter study (80). To 
determine the effects of food on muscle protein synthesis following resistance exercise, 
Wilkinson et al. (141) and Elliot et al. (46) examined whether milk consumption (fasted 
conditions) following resistance exercise stimulates muscle anabolism. Both observed an 
anabolic effect, such that the Wilkinson et al. (141) reported a significant increase in 
synthesis rates and muscle protein balance and Elliot et al. (46) observed an increase in 
muscle protein balance. These results suggest, at least under post-absorptive conditions, 
that intact proteins with carbohydrate, which can be found in an inexpensive food item 
similar to milk, may be advantageous in augmenting muscle protein synthesis following 
resistance exercise. In addition, the optimal amount of indispensible amino acids and 
intact protein that have been used appears to be between 6-15 g and ~ 20 g respectively. 
There are limited data on the response of chronic resistance exercise to feeding. 
The results that have been reported vary due to the differences in methodological 
approaches, making it difficult to draw solid conclusions. In addition, during training, 
typical approaches to these studies are that subjects consume their own meals daily and 
the researchers gain insight by periodic diet records, which can fail in precision as 
subjects may underreport by as much as 10-40% (73). The first study to examine the 
effects of 12 weeks of whole body resistance exercise training (5 days per week) with 
ingestion of meals during the tracer infusion (no tracer added) was performed by 
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Yarasheski et al. (149). They (149) found a 38% increase in muscle protein synthesis ~ 
20 h following the last training session compared to pre-training resting values, as well 
as an increase in strength and muscle mass. To overcome the limitation of this 
comparison, Phillips et al. (107) assessed muscle protein synthesis in the 6 h following 
an acute bout of unilateral resistance exercise (contralateral leg served as control) prior 
to and following 8 weeks (6 days per week) of whole body resistance exercise training. 
In addition, a casein (10 g) + glucose (75 g) supplement was provided following each 
session and a mixed supplement was provided during tracer infusion (no tracer was 
added). The findings were an increase in resting muscle protein synthesis, but an 
attenuation in the post-resistance exercise values (no change from basal levels) (107). 
This may be explained by the training protocol (whole body) versus acute bout of 
unilateral resistance exercise used prior to and after training for protein turnover 
measurement. Thus the same group (124) performed a similar study, however, only 
trained one leg for 8 weeks to maintain consistency with the unilateral leg protocol for 
protein turnover assessment. In addition, they (124) made the measurements with mixed 
meals (tracer added) 4 h and 28 h following an acute bout of resistance exercise. The 
data revealed that exercise training increased muscle protein synthesis by ~ 162% 
following acute exercise in the trained leg compared to acute exercise prior to training; 
however, at 28 h the values returned to normal in the trained leg. In addition, acute 
resistance exercise in the untrained leg following exercise training increased muscle 
protein synthesis by 108% (4 h) and 70% (28 h) post-exercise. Although humans 
typically undergo whole body resistance exercise training programs, the unilateral leg 
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protocol is likely ideal for determining the response of chronic exercise to nutrients as a 
consequence of the protein kinetic assessment protocol being similar. Recently, 
Wilkinson et al. (140), using a similar unilateral leg protocol, observed an increase in 
resting and post-acute resistance exercise myofibrillar protein synthesis following 10 
weeks of unilateral leg exercise training; however, mitochondrial FSR was decreased 
following the acute bout of resistance exercise with training. Therefore, the fraction of 
muscle protein being synthesized may be masked when mixed muscle homogenates are 
assessed (common), although one must wonder if 4 h is sufficient to assess a detectable 
amount of enrichment in the myofibrillar fraction due to the slower turnover properties. 
Finally, although nutrients were provided during all of the tracer infusion protocols, all 
measurements were initiated following an over-night fast. 
 Should the assessment of muscle protein turnover be made under post-absorptive 
conditions? Recently (as mentioned above) Beelen et al. (9) examined  
protein kinetics with resistance exercise at the end of the day that included regular 
feeding, thus measurements were made in the postprandial state. In addition, they added 
nutrients during the tracer infusion protocol to determine whether additional protein 
(above what humans consume during daily feeding) augments acute exercised induced 
muscle protein synthesis. The authors made the following statement to justify their 
design: “Studies that have reported on the benefits of protein ingestion on postexercise 
recovery generally investigate subjects in the overnight fasted state. Under these 
conditions, it might be speculated that endogenous amino acid availability from the gut 
and/or the intramuscular free amino acid pool might be limiting. Such postabsorptive 
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conditions differ substantially from normal everyday practice in which recreational 
sports activities are generally performed in the evening in a fed state. Thus far, no data 
are available on the effect of protein and carbohydrate coingestion on muscle protein 
synthesis during resistance-type exercise under normal, fed conditions (9).” More than a 
decade has past with differing study designs, but a common theme in all is assessments 
are made in a post-absorptive state. Thus, the improvement in muscle protein balance 
with nutrient supplementation may really only represent a return to baseline following 
10 h of fasting with an acute bout of exercise. If we are to ultimately determine whether 
nutrients (protein specifically) augments the anabolic process, then muscle biologists 
should assess muscle protein anabolism over extended periods of time to include 
activities of daily living, feeding, exercise, stress and sleep. The major limitation in 
doing so is the influence feeding has on steady state tracer enrichments and amino acid 
recycling when using labeled amino acids; however, the use of an alternative stable 
isotope (2H2O) eliminates these concerns (will be discussed in the 2H2O section below). 
 In summary, providing protein or amino acids with carbohydrate in combination 
with resistance exercise may serve to optimize anabolism, although the optimal time to 
ingest these nutrients has yet to be elucidated. The degree of anabolism varies with 
reports in fasted-state human muscle FSR ranging from ~ 0.02-0.06% ∙ h-1 under resting 
conditions, ~ 0.04% ∙ h-1  during exercise and  between ~ 0.04-0.12% ∙ h-1  in the hours 
following resistance exercise. In the fed state, muscle FSR range from ~ 0.04-0.07% ∙ h-1 
under resting conditions, ~ 0.04-0.07% ∙ h-1 during and ~ 0.05-0.14% in the hours 
following resistance exercise. The variability in the values can be attributed to the 
         
25 
different designs employed to investigate resistance exercise under fed and fasted 
conditions; such as the isotope used, the precursor surrogate used (plasma, intracellular 
protein-free or aminoacyl tRNA), the feeding regimen (amino acids, protein, with or  
without carbohydrate and lipid), the training state  and the fraction of muscle protein  
assessed (mixed, myofibrillar, sarcoplasmic and mitochondrial).  
As opposed to human studies, muscle protein synthesis assessed in animals is 
commonly determined by the amount of  amino acid (nmol) incorporated into a known 
amount of tissue per unit of time, accounting for the protein pool versus just the 
enrichments of labeling. The values in the mixed gastrocnemius (commonly assessed) 
range from ~40-100 nmol in non-exercised animals to ~ 40-200+ nmol in those that have 
undergone resistance exercise. Similar to humans, these values can vary depending upon 
the muscle type and the different training protocols. Thus, when making comparisons 
between investigations, one must use caution and base results qualitatively versus 
quantitatively and in the context by which the study was conducted. Finally, prior to 
making conclusive statements in regards to the influence that feeding has in augmenting 
exercised induced elevations in muscle protein synthesis; more research is warranted 
with designs that allow for the inclusion of normal daily routines.  
 
Control of Protein Synthesis by 4E-BP1 
 The independent and interactive anabolic effects of nutrients and exercise are 
mediated through changes in signal transduction. The signaling networks connect the 
external environment to that of the intracellular milieu leading to the initiation of mRNA 
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translation, which is the rate limiting step in mRNA translation (116). The process is 
highly complex and coordinated, involving several proteins that serve to activate and/or 
inactivate one another based on the presented stimuli. The end result is activation and 
acceleration in the rates of protein synthesis, and thus, hypertrophy. Although a great 
deal of research in the area of skeletal muscle signal transduction control with nutrition 
and mechanical strain has been conducted, the comprehensive picture remains to be fully 
elucidated. One of the primary reasons for this is the number of pathways and cross-talk 
that are involved in initiating or inhibiting translation. To date, there appears to be three 
distinct signaling cascades that directly or indirectly mediate the rate limiting step in 
mRNA translation initiation, the binding of eukaryotic initiation factor (eIF) eIF4E to the 
mRNA 5‟-cap structure and eIF4G (Fig. 3, page 27) (67, 86, 91, 95, 123, 136). The three 
include i) the phosphatidylinositol 3-kinase (PI3K)-mTOR, which is activated through 
growth factors (insulin and insulin like growth factor-1, IGF-1); ii) the Ras (GTPase)-
extracellular signal-regulated kinase (ERK), which is activated by growth factors 
(insulin and insulin like growth factor-1, IGF-1) and mechanical strain; and iii) the direct 
activation of protein kinase B (PKB)-mTOR via nutrients (amino acids) and mechanical 
strain (21, 30, 32, 38, 42, 55, 69-71, 92, 112, 118, 142). Figure 3 (page 27) provides a 
general depiction and brief overview of these signal transduction pathways and how they 
may act in regulating mRNA translation initiation via activation of the mammalian target 
of rapamycin (mTOR) with subsequent phosphorylation of eIF4E- binding proteins (4E-
BP1, a repressor of eIF4E). Thus, 4E-BP1 may regulate muscle protein synthesis and 
ultimately growth with resistance exercise training. This section will describe the control 
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Fig. 3. Regulation of mRNA translation initiation through 4E-BP1. Signaling pathways 
that have been shown to be activated by hormones via tyrosine receptor kinase, 
mechanical strain from resistance exercise or by amino acids. Hormonal receptor 
binding and mechanical strain can activate both the phosphatidylinositol 3-kinase (PI3-
K) and protein kinase B, and the Ras (GTPase) and extracellular signal-regulated kinase 
(ERK) pathways. The former acts by either direct phosphorylation of the mammalian 
target of rapamycin complex 1 (mTORC1) or by phosphorylation of the tuberous 
sclerosis complex (TSC1/2, GTPase-activating protein). The latter may serve to activate 
mTORC1 by ERK and/or p90RSK (90 kDa ribosomal protein S6 kinase) phosphorylation 
of TSC1/2. Phosphorylation of TSC1/2 inhibits its activity and allows mTORC1 to 
become activated. In addition, amino acids and possibly mechanical strain can directly 
stimulate mTORC1 activity. The consequences of mTORC1 phosphorylation and 
activation is the phosphorylation of 4E-BP1 (Thr37, Thr46, Ser65 and Thr70), thus allowing 
eIF4E to form the eIF4F (eIF4E, eIF4G and eIF4A) complex with the mRNA and bind 
the remainder of the translational apparatus so that mRNA translation can ensue. Green 
arrows, activating steps; Blocked lines, inhibitory steps in the pathway. Dotted lines, 
incompletely defined mechanism. mTOR, mammalian target of rapamycin; raptor, 
regulatory associated protein of rapamycin; GβL, G-protein β-subunit like protein; 
PABP, poly A binding protein.  
         
28 
of protein synthesis by 4E-BP1 with special emphasis placed on the effects of RE.  
As previously mentioned, eukaryotic mRNA are modified at their 5‟-ends with a 
7-methylguanosine-containing cap (m7GpppN) that facilitates the binding of the 
ribosomal 40S to the mRNA through the interaction with eIF4F (composed of three 
subunits; eIF4E, eIF4G and eIF4A) (13, 67, 86, 91, 95, 123, 136) (Fig 1, page 7). The 
binding of eIF4E to the cap and to eIF4G is necessary for translation of transcripts that 
contain a significant quantity of secondary structures in their 5‟-untranslated regions 
(86). Only when the eIF4F complex is formed can the helicase activity of eIF4A (in 
coordination with eIF4B) unwind secondary structures (86). Thus, the availability of 
eIF4E (25 kDa) allows for efficient translation of highly structured messages. Although 
not fully understood, it is believed that there is more eIF4A and eIF4G relative to eIF4E 
suggesting that eIF4E limits the amount of eIF4F present within a cell, serving as a 
master switch for translation initiation (86, 130). This master switch is, however, 
regulated by a family of small translational repressor proteins, PHAS (phosphorylated 
heat- and acid-stable) or more commonly, 4E-BPs (86, 101, 123). The binding of eIF4E 
by 4E-BPs inhibits the formation of the eIF4F complex as both 4E-BPs and eIF4G 
interact with eIF4E through a similar binding motif (YXXXXLΦ, where X is any amino 
acid and Φ is a hydrophobic residue) (65). More simplistically, eIF4E can continue to 
bind the 5‟ cap structure of the mRNA when bound to 4E-BP1, it just cannot bind to 
eIF4G (translation initiation cannot start) until released from 4E-BP1 control.  
 In 1981, Denton et al. (39) reported insulin-stimulated phosphorylation of  a ~ 22  
kDa protein (4E-BP1). In 1994, Hu et al. (72) determined, through purification  
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techniques, that the protein was ~ 12 kDa. Additionally, this group and others (90, 101) 
obtained the amino acid sequence for 4E-BP (1 and 2) in the rat, mouse and human. 
Later, 4E-BP3 was identified (110); thus in mammals, the 4E-BP family consists of 4E-
BP1, 4E-BP2 and 4E-BP3; however, 4E-BP1 and 4E-BP2 are the predominant forms 
expressed in tissues involved in glucose and lipid homeostasis, including skeletal 
muscle, adipose tissue, the pancreas and liver (87). Furthermore, it was determined that 
4E-BP1 was the form that controls cell growth (mTOR mediated) as rapamycin 
administration has been reported to reduce 4E-BP1 phosphorylation, thus preventing 
eIF4E to bind with eIF4G inhibiting cap-dependent translation and ultimately cell size 
(4, 13, 28, 53, 67). mTOR control was confirmed by Azpiazu et al. (4) who, in addition 
to incubating muscles in rapamycin, also incubated with the mitogen activated protein 
kinase kinase (MEK; ERK pathway, see Fig. 3 on page 27 for description) inhibitor, PD 
098059 and insulin. They (4) observed an increase in phosphorylation of 4E-BP1 with 
insulin; however, this was abolished with rapamycin, but not PD 098059, suggesting 
mTOR as being the primary regulator of 4E-BP1. As a result of these findings, it would 
seem plausible that the anabolic effects of resistance exercise are mediated through 4E-
BP1 control. 
 Due to 4E-BP1 being a relatively newly discovered protein involved in the 
control of protein synthesis, it was not until 2000 that Farrell et al. (52) were the first to 
examine the effects of acute resistance exercise on 4E-BP1 in rats. They (52) found that 
16 h following resistance exercise (point at which muscle protein synthesis is 
significantly increased) there were no changes in total 4E-BP1 or phosphorylated (γ 
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form), or in the association of 4E-BP1 with eIF4E or eIF4E with eIF4G, suggesting that 
the timing of assessment may be of concern. To determine if timing was a concern, the 
same group (23) extracted muscle from 5-60 min following acute resistance exercise 
(same paradigm) and reported significant increases in 4E-BP1 phosphorylation (γ form) 
and an association of eIF4E with eIF4G at 5 and 10 min following exercise, suggesting 
that the control of translation initiation is an immediate response following acute 
resistance exercise. In further support of this was a recent investigation conducted by 
Thomson et al. (125) who observed a significant increase in 4E-BP1 phosphorylation (γ 
form) immediately, 20 min and 40 min following an acute bout of high intensity 
electrical simulation in rats. Therefore, translational control appears to occur within 
minutes following resistance exercise, increasing protein synthesis; however, the time by 
which this becomes significant in terms of measurement (synthesis rates) may take 
hours.  
One limitation in the above mentioned investigations is the means by which 
phosphorylation state of 4E-BP1 was determined. 4E-BP1 resolves into distinct 
electrophoretic forms (α, β and γ, Fig. 4, page 31) (23, 86). However, there are 4 key 
phosphorylation sites (Thr-37, Thr-46, Ser-65 and Thr-70) on 4E-BP1 (48, 49) and 
although it is assumed that they are within the γ form (at least some) (86), it is not 
completely descriptive of whether 4E-BP1 is fully phosphorylated and thus, inhibited or 
not. 4E-BP1 can remain bound to eIF4E with mTOR phosphorylation on Thr-37 and 
Thr-46 (65). In addition, Tomoo et al. (130) reported that single Ser-65 phosphorylation 
was inadequate for releasing 4E-BP1 from eIF4E. Taken together, phosphorylation of 
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4E-BP1 on Thr-37 and Thr-46 serves as a priming event for subsequent phosphorylation 
on carboxy terminal sties (Ser-65 and Thr-70), which appear to be required for full 
release of eIF4E from 4E-BP1 (65, 112). In support of this, Kubica et al. (84) examined 
the effects of acute resistance exercise in rats on muscle protein synthesis and translation 
initiation factors with specific phosphorylation sites on 4E-BP1 measured. This group‟s 
(84) findings were an increase in the γ form, increased phosphorylation on Thr-37 and 
Thr-46, but not Thr-70 16 h following resistance exercise (protein synthesis was 
significantly increased). In addition, although the data appeared to support a reduction in 
the association of 4E-BP1 with eIF4E in the resistance exercise animals, they were not 
statistically different from the control. Thus, examination of Thr-70 phosphorylation 
within 4E-BP1 (in addition to associations) may be more descriptive of its activity.  
 
 
 
 
 
 
Fig. 4. Expression of 4E-BP1 proteins in the soleus muscle from ~ 7 mo Sprague 
Dawley rats. The electrophoretic separation of the α, β and γ forms from a 10% 
discontinuous polyacrylamide gel. The γ form represents the hyperphosphorylated form; 
however, specific phosphorylated sites (Thr-37, Thr-46, Ser-65 and Thr-70) cannot be 
determined and thus, whether or not there was complete separation from eIF4E.  
Therefore, mobility shift assays may not be completely useful without measurement with 
anti-antibodies specific to the phosphorylated residue of interest.  
 
 
Although there are data on the effects of acute resistance exercise on 4E-BP1  
control of mRNA translation, there is only one study examining the effects of chronic  
γ  
β 
α 
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resistance exercise training on 4E-BP1 (88). That group (88) observed no changes in 4E-
BP1 phosphorylation (Thr-37 and Thr-46) 48-72 h following 8 weeks of resistance 
exercise training in humans, which significantly increased strength and thigh cross-
sectional area. Muscle protein synthesis was not measured so it is difficult to determine 
if 4E-BP1 activity correlated with changes in synthesis rates. 
Based on the reported research from rats (23, 52, 84, 125)  and humans (38, 40-
42, 143), there is an increase in 4E-BP1 within minutes (23, 125), a decrease in 4E-BP1 
phosphorylation (Thr-37 and Thr-46) during or immediately after (23, 38, 40, 41, 125, 
143) and an increase in 4E-BP1 phosphorylation (Thr-37 and Thr-46) hours (38, 42, 84, 
143) following acute resistance exercise. However, due to the paucity of data that exists 
on 4E-BP1 activity and chronic resistance exercise training, little can be concluded. 
More research in this area is warranted due to the changes in muscle protein synthesis 
that occur with acute (increased) and chronic (attenuated response) resistance exercise. It 
may be that the changes in phosphorylation of 4E-BP1 that are observed with acute 
resistance exercise support the elevations in protein synthesis and that the attenuated 
responses that occur with chronic resistance exercise training are associated with an 
increase in 4E-BP1 expression and decreased phosphorylation.  
 
Approaches for Assessing Muscle Protein Synthesis 
There have been four approaches developed over the years to assess protein  
metabolism: i) nitrogen balance (intake – loss) (89), ii) arteriovenous differences to  
determine amino acid balance (6), iii) turnover of proteins by labeling and monitoring its  
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decay (75) and  iv) direct incorporation using precursor-product labeling (152); however, 
the direct incorporation method is preferred for determining muscle protein synthesis 
due to its precision in measurement. One drawback of the precursor-product labeling 
method is that it only provides data on the changes in synthesis and is not descriptive of 
breakdown (protein balance is the difference in synthesis and breakdown). As a result of 
this, the addition of the arteriovenous balance technique across the area that the muscle 
is sampled from can yield a breakdown rate by determining the enrichments in the 
artery, vein and muscle (14, 15, 146). However, this approach has gained a great deal of 
criticism over the years due to the potential for amino acid recycling (i.e. if a protein is 
broken down and the amino acid is reincorporated back into a protein, less will be 
released into the venous circulation and a falsely low breakdown rate will be 
determined) and the contribution of turnover from other muscles in the vicinity of 
sampling. Thus, few studies exist which have attempted to assess muscle protein 
breakdown. Overwhelmingly, studies examining protein metabolism report changes in 
muscle fractional synthesis rates (FSR, the fraction of the total protein-bound pool that is 
being synthesized), which is often expressed per unit of time and assumes that FSR and 
the pool size are constant (146). 
In order to measure protein synthesis using direct incorporation  
(precursor-product labeling), a tracer (labeled amino acid) and tracee (same amino acid 
but unlabeled) are administered. The tracers that are commonly used to measure muscle 
protein synthesis include radionuclides (atoms with an unstable nucleus that emit 
radiation), such as [14C]leucine and [3H]phenylalanine; and stable isotopes (atoms with 
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an additional neutron, thus altered mass), such as [13C] leucine, or [13C], [15N], or 
[2H]phenylalanine (146). Although both leucine and phenylalanine have recently been 
shown to yield similar results (119), phenylalanine is generally preferred since it is not 
oxidized in skeletal muscle (134). The tracer and tracee can be delivered to the organism 
as either a continuous infusion (constant infusion over time of measurement), a primed-
continuous infusion (bolus, followed by constant infusion over time of measurement) or 
as a flooding dose (supraphysiological bolus over a few seconds-minutes) (146); 
although, due to the time necessary to reach a plateau in isotopic enrichment of the 
precursor (plasma, intracellular or aminoacyl-tRNA) and thus, product (protein-bound), 
researchers commonly use the primed-continuous or flooding dose protocols.  
 
Flooding Dose 
 One of the major limitations that has plagued researchers who study tissue 
protein synthesis is assessment of the true precursor pool, the aminoacyl-tRNA (137). 
However, due to the rapid turnover and difficulty in measuring aminoacyl-tRNA, a 
surrogate marker (plasma or intracellular) is normally used (146). Several studies (7, 33, 
36, 137) have compared the plasma, intracellular (protein-free) and aminoacyl-tRNA 
when using the primed-continuous infusion protocol and have reported different results. 
For instance, Watt et al. (137) reported higher plasma leucine and leucyl-tRNA then 
protein-free leucine values in rat gastrocnemius muscle. However, Baumann et al. (7) 
observed higher protein free leucine then leucyl-tRNA, but very similar values when 
using phenylalanine as the tracer in swine semimembranosus and semitendinosus 
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muscle. Caso et al. (33) also reported similar protein-free phenylalanine and phenyl-
tRNA in the bicep femoris muscle of dogs. More recently, however, Chow et al. (36) 
reported similar plasma and protein-free leucine with leucyl-tRNA in human vastus 
lateralis muscle; thus there are apparent discrepancies as to what precursor surrogate 
should be used. Although, it should be noted that the three investigations that used 
[13C]leucine (7, 36, 137) as the tracer, the venous α-ketoisocaproic acid (KIC) values 
corresponded most closely with the leucyl-tRNA (leucine undergoes transamination, and 
thus, oxidation (134)) and should be used as the precursor surrogate when [13C]leucine is 
used as the tracer. Taken together, variable synthesis rates can be determined when using 
different tracers and different surrogates (plasma vs. protein-free) as the precursor pool.  
To circumvent this concern/issue, the flooding dose was developed and presented 
by Garlick et al. (63) in 1980. The flooding dose consists of injecting a large bolus of 
tracer (typically [3H]phenylalanine in animals and [2H]phenylalanine in humans) along 
with the same unlabeled amino acid used over seconds in rats (63) to ~ 10 minutes in 
dogs (33) and humans (34). The amount of the labeled and unlabeled amino acid are 
several-fold higher than the endogenous free pool of the amino acid used (e.g. 
phenylalanine); thus, the tissue uptake becomes saturated in a shorter period of time (~ 
10, 45 and 90 min in rats, dogs and humans respectively) (33, 34, 63). Furthermore, due 
to short assessment times, there is little concern for dilution of the specific activity as a 
consequence of muscle protein breakdown. In addition, the short time of measurement 
only warrants one biopsy vs. two or more, which are generally needed with the primed-
continuous infusion protocols to insure that the protein-bound label incorporation 
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exceeds background. The result is that there is no question as to the precursor 
enrichment as the plasma, protein-free and aminoacyl-tRNA are very similar due to 
saturation (33, 63).  
 Although the flooding methodology eliminates some of the major issues that  
exist with primed-continuous protocol; there is one concern that the supraphysiological 
bolus of amino acid that is given could influence the rate of protein synthesis. Garlick et 
al. (63), in conjunction with the flooding dose experiment, provided two different tracers 
([3H]lysine and [14C]threonine) with either 0.9% NaCl or 150 mM of unlabelled 
phenylalanine (amount provided with flooding dose experiments in rats) and reported no 
differences with either tracer between the saline and phenylalanine bolus. Furthermore, 
Garlick et al. (62) did a follow up study in 1989 in humans using [13C]leucine as the 
tracer and observed similar plasma leucine, plasma α-KIC and protein-free leucine in the 
vastus lateralis with  synthesis values ~ 2.0% per day (within range that has been 
reported). However, Jahoor et al. (74) reported that the flooding dose resulted in 
significantly higher rates in protein synthesis than the primed-constant infusion in the 
hindlimb muscle of dogs and that providing a bolus of leucine renders the method 
invalid as a result of increasing the precursor specific activity and decreasing tracer 
incorporation into protein if a tracer other than leucine is used. Thus it would appear 
leucine, a potent stimulator of protein synthesis, may not be the best choice of tracer 
when using the flooding dose protocol.  
To determine if other indispensable amino acids stimulate human muscle protein  
synthesis with the flooding dose, Smith et al. (120) provided a primed-continuous  
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infusion of [13C]leucine for 6 h, at which time, a flooding dose of either phenylalanine,  
threonine (both indispensible), arginine, [13C]serine or [13C]glycine were provided. Their 
findings (120) were that both phenylalanine and threonine stimulated protein synthesis, 
whereas, the others did not. However, these individuals were measured in the fasted state 
and the provision of indispensible amino acids would likely serve to be anabolic. 
Therefore, Caso et al. (34) measured fed state muscle protein synthesis with both 
flooding dose and primed-continuous infusion with [2H5]phenylalanine in humans and 
observed no differences between either of them when the protein-free compartment 
(vastus lateralis) was used for calculation of FSR with the primed-continuous infusion. 
Thus, the potential for the flooding dose to stimulate muscle protein synthesis does exist; 
however, this concern can be minimized by avoiding prolonged fasting conditions. 
 The concerns that generally exist with the primed-continuous infusion (length of 
time for precursor and product enrichments, time of infusions and risk of amino acid 
recycling, to name a few) can be eliminated with the flooding dose. Although there have 
been discrepant findings from flooding dose experiments in dogs and humans, rat 
experiments have been consistent and this may be associated to the time needed to flood 
all compartments (~ 10 min in rats vs. ~ 20-90 min in dogs and humans respectively), as 
well as the tracer used and the fed/fasted state. Therefore, it can be concluded that 
flooding with phenylalanine in rats does not stimulate muscle protein synthesis and is a 
reliable and valid method for determining synthesis rates. In addition, when using the 
flooding dose in humans, phenylalanine should be used as the tracer and the infusion  
should be started in an early post-absorptive state or with the provision of nutrients  
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during the experiment. 
 
2
H2O 
 One of the major limitations with using labeled amino acids as tracers is the time  
by which assessment of muscle protein synthesis can be made. Primed-continuous 
infusion protocols typically run for ~ 360 minutes and flooding dose infusions run from 
seconds to ~ 10 minutes in larger mammals. Although these provide reliable and valid 
results under those specific conditions of measurement, they do not yield data over long 
periods of time (days and even weeks). Muscle FSR (expressed as a % per day) values 
are believed to be ~ 2.0% in humans (145) and anywhere from 3-20+ % in rats (64) 
(variability is likely due to rapid growth patterns and short life span). However, these 
values come from extrapolating values that were obtained with short isotopic infusions 
over a 24 h day and rarely account for feeding. Thus, the data that exist today on skeletal 
muscle protein synthesis rates are specific to the precise methods and exclusive to the 
conditions of measure. In addition, although feeding in close proximity to the start of a 
flooding dose or shortly thereafter is recommended when using an essential amino acid 
as the tracer, large quantities of nutrient provision are likely inappropriate as this may 
decrease the likelihood that label will accumulate into the protein. With primed-
continuous infusions, feeding prior to the infusion of the tracer is generally not 
recommended due to the potential for dilution of the precursor pool (more unlabeled 
amino acid will be present from exogenous sources and decrease the specific activity). 
Additionally, when nutrients are provided during the tracer protocol, additional tracer 
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should be added to the nutrients to avoid the dilution. However, even if care is taken by 
adding more tracer, selecting the correct precursor surrogate becomes questionable (both 
plasma and protein-free should be measured). Another limitation to tracer experiments is 
the invasiveness of the procedures and cost, both of which limit the number of 
investigations that are conducted on muscle protein synthesis. 
An alternative approach by which these limitations can be avoided for the study  
of protein synthesis is the use of 2H2O; first presented by Hans Ussing (Copenhagen  
University) in 1941 (131). Dr. Ussing determined that by providing 2H2O to mice and 
rats, one could determine protein renewal by the incorporation of 2H into protein; 
including liver, kidney , skeletal muscle and specific proteins such as myosin (131). He 
believed that if 2H2O was provided to an animal and the concentration was maintained 
then the 2H would accumulate into protein over time approaching a constant value that 
could be determined by their synthesis rates (131). More specifically, Dr. Ussing thought 
that this occurred by the transfer of 2H with the H of amino acids through transamination 
reactions and similar processes, which would then be incorporated into protein (131). 
Additionally, he suggested that measurement of this process would be easiest if the 
exchange in 2H with amino acids occurred very rapidly so that their 2H content would 
not change throughout the incorporation process as long as a consistent 2H2O 
concentration was maintained (131). Due to the difficulty in obtaining 2H2O during that 
time, follow up investigations were not possible (131). However, in 1961 Oshima and 
Tamiya (98) were able to confirm Ussing‟s hypothesis that 2H exchange with the H of 
amino acids (alanine) occurs through transamination (Fig. 5, page 40). Furthermore, 
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alanine labeling occurs rapidly through transamination, and although other amino acids 
(leucine, glycine and glutamate) undergo this process as well, it is the number of  
hydrogen‟s and the simplicity in the structure of alanine that makes it easily quantifiable.  
 
 
Fig. 5. 2H labeling of alanine using 2H2O. Administration of 2H2O results in rapid 
equilibration with body H2O (~ 20 min), which can then label Ala (alanine) through 
intermediary metabolism and become incorporated into a protein. Dissimilar to labeled 
amino acids which must gain entry into the cell via transporters, the 2H labeling of Ala 
occurs intracellularly. OA, oxaloacetate; PEP-CK, phosphoenolpyruvate carboxykinase; 
Pyr, Pyruvate; ALT, alanine aminotransferase. 
 
 
Although it was determined that 2H2O could be used for measuring muscle  
protein synthesis (131) and the process by which this occurred was understood (98), it  
still wasn‟t clear whether feeding (potential disruption of the alanine pool) influenced 
the labeling, and thus the ability to assess synthesis rates. If this were the case, then the 
use of 2H2O would be limited to post-absorptive experiments. In 2004, however, Dufner 
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et al. (44) provided rats with 2H2O (bolus intraperitoneal injection) and determined that 
the percent of 2H2O in body water was identical with the percent of 2H-labeled alanine 
and the time by which this was achieved was ~ 20 minutes. Additionally, the same group 
(44) provided a large bolus of unlabeled alanine after 90 minutes and observed similar 
2H-labeled alanine and 2H2O in body water within ~ 30 minutes, supporting the notion 
that feeding will not alter the precursor pool (i.e. 2H2O). However, this experiment was 
conducted on plasma and not within a specific protein, site of transamination of alanine; 
thus it could not be concluded at this time if the plasma labeling was equal to the 
labeling of the protein-free compartment. Thus, additional experiments  (44, 111) by the 
same group compared protein-free 2H labeling of alanine in rat liver tissue (44) and 
human albumin (111) with that of plasma 2H labeling of alanine and 2H2O and observed 
very similar values. In addition to the benefits of intracellular 2H labeling of alanine and 
the lack of an alteration in labeling gradients with feeding, 2H2O can also be used safely 
(102) for prolonged periods of time (111) at a relatively low cost and noninvasively to 
assess protein synthesis. However, to date, no studies have been published the area of 
exercise and muscle protein synthesis using 2H2O as a tracer. The benefit of conducting 
these experiments would be that cumulative differences in muscle protein synthesis are 
assessed in real-time environments (no laboratory or controlled environment required). 
In addition, the measurements could be made over extended periods of time to provide 
an actual daily rate vs. an extrapolated one.  
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CHAPTER III 
A COMPARISON OF 2H2O AND PHENYLALANINE FLOODING DOSE TO 
INVESTIGATE MUSCLE PROTEIN SYNTHESIS WITH ACUTE EXERCISE IN 
RATS 
 
Introduction 
 Tracers have been used to study whole-body and tissue-specific protein synthesis 
under various conditions (i.e. post-absorptive, post-prandial, disease and exercise) for 
more than 35 years. Questions are addressed using either “stochastic methods” (which 
measure the dilution/excretion of a carbon- or a nitrogen-labeled amino acid) or using 
“direct incorporation methods” (which compare the labeling of a protein-bound amino 
acid against the labeling of the amino acid precursor). Direct incorporation methods (i.e. 
precursor:product labeling ratios) are generally accepted as yielding reliable 
measurements of protein synthesis in specific proteins. Since skeletal muscle accounts 
for ~ 60% of total body protein (134) and plays a pivotal role in health and the pathology 
of many chronic diseases, direct examination of this protein pool is of great interest to 
researchers. 
 The use of continuous infusion with either  [13C]leucine, or [13C], [15N], or [2H] 
phenylalanine is common, but requires adequate time to achieve a steady state in 
precursor enrichment (146) and substantial incorporation into newly made protein. In 
addition, uncertainty regarding the measurement of the true precursor pool (which is 
assumed to be the tRNA-bound amino acid) exists. However, since the tRNA-bound 
         
43 
pool of amino acids is relatively small and is expected to have a high turnover, 
investigators have proposed various surrogates (intracellular or plasma), e.g. α-
ketoisocaproate (KIC) labeling as a marker of intracellular leucine labeling. 
 An alternative to the continuous infusion is the flooding dose. The principle is 
that by providing a large bolus that contains a mixture of labeled and unlabeled amino 
acids over a short period of time (seconds to minutes), there will be a saturation of the 
uptake of the amino acid by a tissue(s) and therein minimize labeling gradients between 
plasma and tRNA-bound amino acids, thus making amino acid labeling in the plasma 
pool appropriate to use as the precursor (33, 63). An advantage of the flooding dose 
method is that it allows measurements over short periods of time (10 min in animals and 
90 min in humans). However, the primary concern regarding the flooding dose centers 
on the physiological perturbation that occurs; therefore, one must consider whether the 
increase in the pool size of the tracee alters the metabolism under investigation. In 
support of this, Jahoor et al. (74) and Smith et al. (120) have observed increases in 
muscle protein synthesis when using the flooding dose (with essential amino acids) in 
dogs and humans, respectively; however, Garlick et al. (63) did not find a stimulatory 
effect when flooding with phenylalanine in rats. Although the differences may be 
explained by the species used, the possibility that supraphysiological concentrations of 
essential amino acids stimulate muscle protein synthesis warrants consideration. 
 These methods are faced with major challenges when the aim is to study protein 
synthesis under perturbed conditions. For example, nutrient ingestion can dilute the 
tracer and therein influence assumptions regarding precursor labeling. The use of 2H2O 
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(a “primed-infusion method”) minimizes precursor labeling gradients since cells are 
labeled from the inside via transaminase reactions (8, 30, 43, 98, 111) (Fig. 6, page 45). 
Since cells readily produce alanine, its labeling should reflect that of body water under 
many conditions, especially since alanine undergoes rapid turnover, even in the fed state. 
Thus, one can compare the precursor labeling (body water) with either the 2H labeling of 
the α-hydrogen or total 2H labeling of protein-bound alanine divided by “n”, the number 
of incorporated deuteriums, which we have found to be 3.7 (a factor that is consistent 
with isotope effects on enzyme catalyzed reactions and is supported by other recent data) 
(8, 44, 111). The use of 2H2O has practical advantages in that studies do not require a 
post-absorptive state and can assess protein synthesis over short and long periods of 
time. 
 Belloto et al. (10) recently demonstrated similar apoB100-VLDL protein 
synthetic rates with 2H2O and a primed-infusion of leucine, further validating the 
reliability of using labeled water. However, to our knowledge, no studies exist 
comparing the flooding dose and 2H2O methodologies on muscle protein synthesis. We 
aimed to determine if 2H2O and flooding with L-[2,3,4,5,6-3H]phenylalanine would yield 
comparable results. The experiments examined two physiological scenarios (i.e. basal vs. 
an acute bout of resistance exercise) and considered measurements over different periods 
of time.  
 
 
         
45 
 
Fig. 6. Depiction of mRNA translation elongation with two different isotopes (2H2O and 
L-[2,3,4,5,6-3H]F). The flooding dose works on the assumption that providing a large 
bolus of labeled (3H-F) and unlabeled (F) over seconds-minutes will result in similar 
specific activities (SA) between the plasma, intracellular and ultimately the aminoacyl-
tRNA. The 2H2O method works on the assumption that 2H rapidly equilibrates with the 
body water which leads to the intracellular 2H labeling of alanine via transamination 
reactions; therein bypassing the requirement for rapid transmembrane amino acid 
transport. 
 
 
Materials and Methods 
Chemicals and Supplies 
Unless specified, all chemicals and reagents were purchased from Fisher 
Scientific (Pittsburgh, PA). 2H2O (99.9 atom percent excess) and L-[ring-
13C6]phenylalanine (F) (99% enriched) were purchased from Cambridge Isotopes 
(Andover, MA). MTBSTFA + 1% TBDMCS was purchased from Pierce (Rockford, IL). 
L-[2,3,4,5,6-3H]F was purchased from GE Healthcare Life Science-Amersham 
(Buckinghamshire, England). Gas chromatography-mass spectrometry supplies were 
purchased from Agilent Technologies (Wilmington, DE) and Alltech (Deerfield, IL).  
Kinase buffer (10X) was purchased from Cell Signaling Technologies (Danvers, MA). 
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Animals and Operant Conditioning 
Twenty-four male Sprague-Dawley rats (5 mo old) were individually housed in a  
climate controlled small animal facility with a 12 hour light (start at 10:00 pm) and dark 
cycle (start at 10:00 am). Rats were fed a standard feed ad libitum and had free access to 
water. The rats were assigned by body mass into one of four groups: 4 h control (CON 
4h, n = 6), 4 h resistance exercise (RE 4h, n = 6), 24 h control (CON 24h, n = 6) or 24 h 
resistance exercise (RE 24h, n = 6). All experimental procedures were approved by the 
Institutional Animal Care and Use Committee of Texas A&M University. 
The RE animals were operantly conditioned to depress an illuminated  
bar located high on a Plexiglas exercise cage (56). Negative reinforcement via an  
electrical foot shock (<3 mA, 60Hz) was used to train the rats to perform the desired 
movements. After the animals were conditioned (4 sessions), a non-weighted Velcro vest 
was strapped over the scapulae and the rats were required to touch the illuminating bar 
50 times for an additional two sessions. The CON animals were free from physical 
activity and remained single-housed over the course of the study. 
Experimental Protocol 
On the day of the study, half of the animals (24 h CON and 24 h RE) received 20 
µl per g of body mass, via an intraperitoneal injection (IP), of 99.9% 2H2O and allowed 
free access to drinking water enriched to 4.0% 2H2O (Fig. 7, page 47). In addition, half 
of the animals (24 h RE and 4 h RE) performed a progressive bout of RE. The protocol 
consisted of the RE animals performing 0 g (10 repetitions), 80 g (15 repetitions), 110 g 
(12 repetitions), 180 g (10 repetitions), 230 g (8 repetitions) and 80 g (15 repetitions). 
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        Ten out of the 12 RE animals completed this protocol, however, two failed to complete 
the 8 repetitions with 230 g, and therefore, we increased the repetitions of the final set at 
80 g to equal the total volume that the other rats completed. Twelve hours following the 
RE session, the remaining animals (4 h CON and 4 h RE) received the same quantity of 
2H2O and allowed free access to drinking water enriched to 4.0% 2H2O. In addition, the 
food was withdrawn at this time. 
 
Fig. 7. Schematic display of study design used to measure muscle protein synthesis 
with 2H2O and flooding dose of phenylalanine. At time 0, an intraperitoneal bolus of  
2H2O was provided to the rats (n = 12) and 4% 2H2O drinking water was provided ad 
libitum. The acute bout of resistance exercise (n = 12) was completed at time + 8 h. At  
time + 20 h, the other group of rats (n = 12) were provided an intraperitoneal bolus of  
99.9% 2H2O and 4% 2H2O ad libitum drinking water. At + 24 h, all animals (n = 24)  
were anesthetized, cannulated and administered a F flooding dose, as well as muscle 
harvest to assess fractional rates of protein synthesis (FSR). 
 
 
Four hours later, all rats were anesthetized with Ketamine (40-55 mg/kg) and  
Medetomidine (0.4 mg/kg) via an IP injection. The left carotid artery and right jugular 
vein were cannulated with sterile, heparinized polythene tubing (PE-50). While sedated a 
flooding dose of L-[2,3,4,5,6-3H]F (0.5 mCi/rat) in unlabeled F (150 mM, 1ml · 100 g 
body mass-1) was injected into the venous catheter over a 10- to 15-s period (63). Three 
arterial blood samples (1 ml) were taken from the carotid cannula during a 12 min period 
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(2, 6 and 12 min) for the determination of F specific radioactivity. After arterial 
sampling, the mixed gastrocnemius (M. Gastroc), plantaris (Plant) and soleus (Sol) 
muscles were excised, immediately frozen to the temperature of liquid nitrogen between 
aluminum blocks, and stored at -80ºC until analyzed. 
Flooding Dose Sample Preparation and Analyses 
Tissue and plasma specific radioactivity were determined using a modified 
version of the protocols outlined by Garlick et al. (63) and Vary et al. (133) (see 
Appendix A for detailed description). A known amount of muscle (~ 0.150-0.200 g) was 
pulverized under liquid nitrogen followed by homogenization in 2.0 ml of 10% 
trichloroacetic acid (TCA) and centrifuged at 3,800 rpm for 15 min at 4ºC. The 
supernatant (SPNT) was discarded and the protein precipitate was washed four 
additional times in 2.0 ml of 10% TCA, then freed from lipid with 2.0 ml of acetone, 
washed with 2.0 ml of distilled H2O and dissolved in 2.0 ml 0.25 N NaOH. A portion of 
the protein was used to quantify protein content using the bicinchoninic acid (BCA) 
method (121). To determine tissue specific radioactivity, 0.5 ml of the protein solution 
was measured by liquid-scintillation counting with appropriate corrections made for 
quench. Protein-bound F was determined by re-precipitating the protein from the 0.25 N 
NaOH solution with 1.0 ml of 10% TCA and centrifugation at 3,800 rpm for 15 min at 
4ºC, followed by 2 additional wash steps. The precipitate was then hydrolyzed for 24 h 
at 110ºC with the addition of 0.1 ml of 10 µmol/ml of [ring-13C6]phenylalanine  to serve 
as an internal standard (14). Blood samples (2, 6 and 12 min) were centrifuged at 3,800 
rpm for 30 min at 4ºC followed by removal of 0.4 ml of plasma and the addition of 0.4 
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ml of 10% TCA and 0.4 ml of 30-60 nmol/ml [ring-13C6]phenylalanine to quantify the 
total F in the plasma samples. To determine plasma radioactivity, 0.05 ml was measured 
by liquid-scintillation counting with appropriate corrections made for quench.  
In order to quantify both plasma and tissue phenylalanine, 0.05 ml was dried 
under a stream of N2, followed by the addition of a 1:1 solution of acetonitrile:N-methyl-
N-tert-(t-butyldimethylsilyl)trifluoracetamine ± tert-butyl dimethylchlorosilane 
(MTBSTFA + 1% TBDMCS); modified from Calder et al. (31). After reacting at room 
temperature for 30 min, the samples were analyzed using an Agilent 5975C-MSD 
equipped with an Agilent 7890 GC system, and a HP-5ms capillary column (30 m × 0.25 
mm × 0.25 µm). The following temperature program was used: 160ºC initial and hold 
for 5 min, increase by 15°C/min to 270ºC and hold for 8 min. The sample was injected at 
a spit ratio of 40:1 with a helium flow of 30 mL/min. Phenylalanine eluted at ~ 12 min. 
The mass spectrometer was operated in electron impact mode (70eV). Selective ion 
monitoring of mass-to-charge ratios (m/z) 234 (M) and 240 (M + 6) was conducted using 
a dwell time of 30 ms per ion. 
2H2O Preparation and Analysis 
Labeling (2H) of body water was assessed by exchange with acetone described 
by Yang et al. (148) (see Appendix B for detailed description). The reaction occurred 
with 20 µL of a sample/standard, 2 µL of 10N NaOH and 4 µL of a 5% (vol/vol) 
solution of acetone in acetonitrile for 24 h. Acetone was removed by the addition of 0.6 
ml of chloroform and 0.5 g Na2SO4. The samples were mixed and 0.1 ml of the 
chloroform was transferred to a GC-MS vial. The samples were analyzed using an 
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Agilent 5975C-MSD equipped with an Agilent 7890 GC system, and a HP-5ms capillary 
column (30 m × 0.25 mm × 0.25 µm). The following temperature program was used: 
60ºC initial, increase by 20°C/min to 100ºC, increase by 50ºC/min to 220ºC, and hold 
for 1 min. The sample was injected at a spit ratio of 40:1 with a helium flow of 1 
mL/min. Acetone eluted at ~ 1.7 min. The mass spectrometer was operated in electron 
impact mode (70eV). Selective ion monitoring of mass-to-charge ratios (m/z) 58 (M) and 
59 (M + 1) was conducted using a dwell time of 10 ms per ion. 
  Labeling (2H) of protein-bound alanine was measured as previously described by  
Dufner et al. (44) (see Appendix B for detailed description). Briefly, ~ 0.030 g of M. 
Gastroc, Plant and Sol were homogenized on ice in 0.3 ml of a 10% (wt/vol) TCA and 
centrifuged at 3,750 rpm at 4°C for 15 min. The SPNT was discarded and the protein 
pellet was washed 3 additional times with TCA. The protein pellet was then dissolved in 
6 N HCl (0.1 mL/0.010 g tissue) and reacted at 100ºC for 18 h. In order to determine if 
there was a difference in mixed muscle versus myofibrillar, ~ 0.060 g of M. Gastroc was 
homogenized on ice in 400 µL of a 1 X  kinase buffer (25 mM Tris-HCl, 5 mM ß-
glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2) with 200 µM 
ATP and 0.01% Triton. Homogenates were centrifuged at 14,000 rpm at 4ºC for 30 min. 
After centrifugation, the SPNT containing the cytosolic and membrane portion was 
discarded and the precipitate (representative of the myofibrillar fraction) was prepared 
the same as the mixed muscle. An aliquot (0.1 ml) of the hydrolysate was dried under a 
stream of N2 for ~ 1 h. A 3:2:1 ratio (0.1 mL) of “Methyl-8” reagent (Pierce, Rockford, 
IL), methanol and acetonitrile was added to the residue to determine the 2H labeling of 
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alanine on its methyl-8 derivative. All samples were analyzed using an Agilent 5973N-
MSD equipped with an Agilent 6890 GC system, and a DB17-MS capillary column (30 
m × 0.25 mm × 0.25 µm) was used in all analyses. The following temperature program 
was used: 90ºC initial, hold for 5 min, increase by 5°C/min to 130ºC, increase by 
40ºC/min to 240ºC, and hold for 5 min. The sample was injected at a spit ratio of 20:1 
with a helium flow of 1 mL/min. Alanine eluted at ~12 min. The mass spectrometer was 
operated in electron impact mode. Selective ion monitoring of mass-to-charge ratios 
(m/z) 99 (M) and 100 (M + 1) was conducted using a dwell time of 10 ms per ion.     
Calculations (See Appendix D for detailed description) 
Rates of protein synthesis (RPS) were calculated for the F flooding dose using 
the equation described by Vary et al. (133): 
(DPM ∙ g wet wt-1) ∙ (SĀ)-1∙ (t)-1 (eq 1) 
where DPM (disintegrations per minute) ∙ g wet wt-1 is the quantity of L-[2,3,4,5,6-3H]F 
incorporated into the available pool (mg protein per g of tissue), SĀ is the mean specific 
activity in plasma (DPM · nmol F-1) over 12 minutes of flooding and t is incorporation 
time in hours. Fractional rates of protein synthesis (FSR) with F were calculated using 
the equation described by Garlick et al. (63): 
 SP ∙ (SĀ x t)-1 x 100 (eq 2) 
where SP is the specific radioactivity of protein (DPM · nmol F -1) (63). When 2H2O was  
provided, FSR was calculated using the equation: 
EA · [EBW x 3.7 x time (h)]-1 x 100 (eq 3) 
where EA represents amount of protein-bound 2H Ala (MPE, mole percent excess), EBW  
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is the quantity of 2H2O in body water (MPE) and 3.7 represents the exchange of 2H 
between body water and alanine (44, 111, 146). The assumption is that 2H-labeled body 
water equilibrates with free alanine more rapidly than 2H-labeled alanine incorporates 
into newly made protein and that protein synthesis is linear over time.  
Statistical Analysis  
Analyses were completed using SigmaStat version 3.5 and values are expressed 
as means ± SE. A one-way ANOVA was used to compare differences between the 
exercise and control groups, the different approaches (4 h 2H2O vs. 24 h 2H2O and 
flooding), F specific radioactivities, mg protein relative to tissue and plasma 2H2O 
labeling. A two-way ANOVA was used to compare differences between the myofibrillar 
and mixed muscle (activity x muscle fraction), as well for 2H-labeled alanine (activity x 
time of administration). If a test of normality or equal variance failed, a ranks test 
followed by a Dunn‟s Test was conducted. A Fisher LSD Post hoc test was used when a 
main effect was observed. We accepted an analysis as statistically significant if P < 0.05. 
 
Results 
Exercise vs. Control Assessed with F Flooding Dose 
           The specific activities (SA) of the plasma and muscle (DPM ∙ nmol F-1) are shown in 
Tables 1 and 2 (pages 53 and 54). In all cases we obtained sufficient counts to allow for 
the calculation of protein synthesis. RE did not affect protein synthesis in any muscle 
type (Fig. 8, page 55; main panel FSR and inset RPS). As a result of this finding, we 
collapsed the groups to compare muscle type differences (data not shown) and observed 
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higher RPS in the soleus (89%, slow oxidative (3)) compared to the plantaris and mixed 
gastrocnemius (P < 0.001); which is consistent with previous findings (50, 57, 132) 
regardless of whether plasma or the intracellular compartment was used as the precursor 
pool in the calculations. In addition, FSR was significantly higher in the soleus vs. the 
plantaris and mixed gastrocnemius muscles (P < 0.05). The nmol of F and DPM relative 
to the pool size (mg protein ∙ g wet weight-1) did not differ statistically between the 
mixed gastrocnemius (122 ± 6 and 36 ± 5) plantaris (131 ± 9 and 41 ± 4) and soleus (109 
± 7 and 56 ± 7); however, given that total F was similar for all muscles, but more DPM 
relative to the pool size in the soleus, it suggests that muscle composed of predominately 
slow muscle have greater RPS and FSR values. 
 
Table 1.  Plasma phenylalanine specific activity (F SA) and 2H-labeling of body water 
 
Group           n                  F SA                 2H2O at 1h                2H2O at 24h 
CON 4h 6    592.68 ± 47.55                NA                       2.47 ± 0.12   
             
RE 4h  6    575.76 ± 23.67               NA            2.80 ± 0.08   
             
CON 24h 6          NA            2.63 ± 0.02              2.71 ± 0.16 
    
RE 24h 6     NA            2.65 ± 0.13              2.69 ± 0.05 
Values are means ± S.E. F SA, specific activity of plasma (DPM ∙ nmol phenylalanine-
1); Plasma 2H2O expressed as MPE, mole percent excess.  
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Table 2. Tissue phenylalanine SA and 2H-labeling of protein-bound alanine 
 
Group  n      F SA Tissue                2H-Labeling Tissue 
Mixed Gastrocnemius 
 
CON 4h 6      0.22 ± 0.06                 0.37 ± 0.04 
RE 4h  6      0.36 ± 0.02                      0.50 ± 0.06 
CON 24h 6         -         -                 0.72 ± 0.04 ‡ 
RE 24h 6                 -         -                0.71 ± 0.05 † 
Mixed Gastrocnemius Myofibrillar 
 
CON 24h 6         -          -                 0.69 ± 0.04 
RE 24h 6         -         -                           0.65 ± 0.04 
Plantaris 
 
CON 4h 6      0.24 ± 0.05                 0.43 ± 0.10 
RE 4h  5      0.36 ± 0.02                          0.35 ± 0.04 
CON 24h 5         -          -                            0.74 ± 0.06 † 
RE 24h 6         -          -                           0.71 ± 0.06 ‡ 
Soleus 
 
CON 4h 5      0.44 ± 0.10                 0.38 ± 0.07 
RE 4h  6      0.49 ± 0.05                 0.41 ± 0.05 
CON 24h 6         -          -                 0.94 ± 0.10 ‡ 
RE 24h 6         -          -                  0.86 ± 0.04 ‡ 
Values are means ± S.E. F SA, specific activity of tissue ([DPM ∙ nmol phenylalanine-1); 
2H labeling of protein-bound alanine expressed as MPE, mole percent excess. 
†Significantly different in 24 h from 4 h in same group (P<0.01); ‡Significantly different 
in 24 h from 4 h in same group (P<0.001). 
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Fig. 8. Fractional rates of protein synthesis (FSR, main panel) and rates of protein 
synthesis (RPS, inset) assessed with L-[2,3,4,5,6-3H]F in the mixed gastrocnemius (M. 
Gastroc), plantaris (Plant) and soleus (Sol) 16 h following the resistance exercise (RE) 
session or control (CON). Data are expressed as % ∙ h-1 (nmol F incorp. ∙ g-1 ∙ h-1, inset) 
and presented as means ± SE; (n = 5-6 per group). The groups were collapsed to 
determine muscle type differences. * = significant differences between the Sol and the 
M. Gastroc and Plant for FSR (P < 0.05); ‡ = significant differences between the Sol and 
the M. Gastroc and Plant for RPS (P < 0.001); (n = 11-12 per muscle). 
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Exercise vs. Control Assessed with 2H2O 
Tables 1 and 2 (pages 53 and 54) demonstrate that the labeling of body water 
remained virtually constant over the 24 h period and show incorporation of protein-
bound 2H Ala into the various muscles. Consistent with the F flooding dose, the 2H2O 
method did not detect any effect(s) of RE on protein synthesis in the 4h 2H2O (Fig. 9A, 
page 57) or the 24h 2H2O rats (Fig. 9B, page 57). In addition, similar to the F flooding 
dose higher FSR in the soleus muscle, we observed a significant increased in the 24h 
2H2O rats soleus compared to the mixed gastrocnemius and plantaris (data not shown) 
when the CON and RE groups are collapsed (P < 0.01). It is commonly accepted that 
mixed muscle protein synthesis should be reflective of myofibrillar proteins (which 
comprise > 70% of the total protein pool (105)). However, myofibrillar proteins turnover 
at a much slower rate relative to other proteins in the mixed pool, which may limit one‟s 
ability to detect alterations in protein synthesis using methods over short periods. Thus, 
we directly examined the gastrocnemius myofibrillar fraction in the animals that 
received 2H2O over 24 h in order to determine whether or not protein synthesis in the 
myofibrillar fraction was reflective of the total mixed pool. Interestingly, FSR in the 
mixed muscle or myofibrillar proteins fractions did not differ (P > 0.05) in the 24h 2H2O 
CON (0.27±0.01 vs. 0.26±0.01 respectively), nor was it affected by RE (0.29±0.02 vs. 
0.26±0.01, respectively). 
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Fig. 9. Fractional rates of protein synthesis (FSR) assessed with 2H2O in animals over 4 
h (A) and 24 h (B) in the mixed gastrocnemius (M. Gastroc), plantaris (Plant) and soleus 
(Sol). Data are expressed as % ∙ h-1 and presented as means ± SE; (n = 5-6 per group). 
The groups were collapsed to determine muscle type differences. † = significant 
differences between the Sol and the M. Gastroc and Plant in the 24 h (B) animals (P < 
0.01); (n = 11-12 per muscle). 
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F Flooding vs. 4h 2H2O and 24h 2H2O 
In addition to making qualitative comparisons, we also wanted to make direct 
comparisons (quantitatively) between 2H2O (different time of assessment) and flooding 
dose expressed % ∙ h-1 (Fig. 10, page 59). As a result of not detecting an exercise effect, 
we collapsed the groups and observed significant differences between 4h 2H2O approach 
and F flooding and 24h 2H2O in the mixed gastrocnemius, plantaris and soleus (P < 
0.001); and between the 24h 2H2O and F flooding in the mixed gastrocnemius and 
plantaris (P < 0.05). Note that a greater percentage of protein was synthesized in the 24h 
2H2O (7.2 ± 0.3, 7.4 ± 0.5 and 9.1 ± 0.6) vs. 4h 2H2O (4.4 ± 0.4, 4.0 ± 0.5 and 4.0 ± 0.5) 
and F flooding (0.05 ± 0.01, 0.05 ± 0.01 and 0.09 ± 0.01) in the mixed gastrocnemius, 
plantaris and soleus respectively (P < 0.001). These observations underscore the 
importance of tissue heterogeneity (i.e. the complexity of the total protein pool) and its 
affect(s) when calculating synthesis rates. 
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Fig. 10. Fractional rates of protein synthesis (FSR) assessed with F (flooding dose) and 
2H2O (4 and 24 h) in the mixed gastrocnemius (M. Gastroc), plantaris (Plant) and soleus 
(Sol). Data are expressed as % ∙ h-1 and presented as means ± SE; ‡ = significant 
difference between 4h 2H2O vs. F and 24h 2H2O for M. Gastroc, Plant and Sol (P < 
0.001); * = significant difference between 24h 2H2O and F in the M. Gastroc and Plant; 
(n = 11-12 per group).  
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Discussion 
The main purpose of the present work was to determine if 2H2O provided 
comparable results as the traditional flooding dose (using L-[2,3,4,5,6-3H]F as the tracer) 
with an acute bout of high intensity resistance exercise. We chose to include an acute 
bout of high intensity resistance exercise due to its anabolic nature and role in prevention 
and treatment of many diseases. Additionally, we wanted to measure protein synthesis 
rates over different time points with 2H2O (4 h and 24 h) to ascertain whether 
extrapolating short-term synthesis rates (% · h-1) over a day provides similar values to 
the measured (% newly synthesized protein). We report three novel findings from our 
study; i) 2H2O provides comparable results to the flooding dose when studying sedentary 
and exercising conditions, ii) a single bout of high intensity resistance exercise without 
prior training does not appear to be anabolic in rats, and iii) extrapolating values that are 
measured over a short interval does not accurately reflect what might occur over an 
entire day. 
The ability to quantify protein synthesis during non steady-state metabolism has 
presented a challenge to investigators since it can be difficult to assess amino acid 
precursor labeling, particularly as temporal changes or perturbations in biochemical flux 
(such as what occurs with feeding or exercise) disrupt steady state metabolism. The 
flooding dose method offers some advantages, in that measurements of protein synthesis 
can be made with infusion periods of ~ 10 to 90 min (33, 34, 63, 74, 120) by imposing a 
saturation of the precursor pool. Furthermore, flooding dose methodologies may be 
preferred in short term intervention studies where rapid physiological responses are 
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expected. However, flooding dose can become problematic when designing experiments 
since vascular cannulation has traditionally been required and measurements of protein 
flux over longer periods is not practical. The use of 2H2O for assessing protein synthesis 
can bypass some of the traditional tracer limitations; such as measurement of the true 
precursor pool, the need for post-absorptive conditions prior to initiation of the tracer, 
the necessity of a general clinical research center and laboratory confinement (if using 
humans) and skilled personnel for cannulation. In addition, measurements can be made 
over relatively short (~ 4 h) and long intervals (days or perhaps weeks), therein 
permitting acute and cumulative studies of protein synthesis in vivo (10, 30, 44, 111, 
151). Note that 2H2O results a rapid equilibration (~ 20 min) between the hydrogen 
labeling in body water and those stably bound to free alanine (10, 44, 111), thus the 
labeling of plasma water seems to provide a reliable surrogate of the precursor labeling 
over a range of experimental conditions making the use of 2H2O a suitable tracer in the 
free living environment.  
In the current studies we were unable to detect any stimulatory effect(s) of a 
single bout of resistance exercise on protein synthesis. Particular attention was focused 
on 16 h post-resistance exercise, since we and others have demonstrated that this time 
corresponds to the peak „anabolic window‟ (time of elevated rates of protein synthesis) 
(23, 51, 52, 56, 57) after 2 or 4 bouts of exercise without prior training. Likewise, the 
cumulative measurements over a 24-hour period made using 2H2O did not reveal any 
stimulatory effect of resistance exercise on protein synthesis. These observations raise 
important questions regarding alterations of muscle protein synthesis after a single bout 
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of resistance exercise in animals that are consuming food, ad libitum. For example, 
resistance exercise exerts both anabolic and catabolic stimuli, whereas feeding 
simultaneously stimulates protein synthesis and inhibits protein breakdown (103, 106, 
115, 127, 129). One might expect that while resistance exercise may lead to elevated 
protein turnover, the integrated effect of exercise and food consumption over a 24 h 
period should lead to elevated labeling of proteins in skeletal muscle. Our data suggest 
that a single bout of high intensity resistance exercise, without prior training in rats, may 
not be followed by a net anabolic effect. It is possible that our findings are a result of 
either the intense nature of the activity or that more time is necessary to observe the 
metabolic adaptations necessary to support the anabolic response to exercise.  
One could argue that our resistance exercise regimen was too intense to observe 
anabolic responses to exercise, as opposed to our prior work (56, 57) and work by others 
(50-52, 84) which used lower intensities. Consistent with that possibility, we previously 
demonstrated that rates of muscle protein synthesis are blunted following a single bout 
of high intensity, eccentric exercise; however, a second bout of exercise of the same 
magnitude one week later demonstrated elevated rates of synthesis in a fiber-specific 
manner (54). Therefore, while we cannot rule out that the higher intensity of the 
resistance exercise protocol in the present study potentially blunted post-exercise 
anabolic responses, it is more likely that a single bout without prior training leads to 
adaptations in skeletal muscle that are necessary before anabolic responses can be 
observed with subsequent bouts.  
We investigated muscle protein synthesis using two methodologies to account for  
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possible differences in the time of assessment. Reported fractional rates of mixed muscle 
protein synthesis typically range from ~ 0.05% per h post-absorptive to ~ 0.10% per h 
following feeding and RE in human vastus lateralis muscle (34, 41) and 0.2-0.9% per h 
under fasting-feeding conditions respectively in lower-limb rat muscle (63, 64, 133, 
151). Clearly, it is difficult to extrapolate measurements of protein synthesis made over 
minutes to a few hours and draw conclusions regarding the total amount of newly made 
protein over the course of an entire day. In support of this, had we extrapolated the 4h 
2H2O h and F flooding dose over 24, we would have over-estimated the % of newly 
made protein with the 4h 2H2O by 165% in the mixed gastrocnemius, 131% in the 
plantaris and 96% in the soleus (P<0.001) as well as underestimated FSR with the F 
flooding dose by 105% in the mixed gastrocnemius and 98% in the plantaris (P<0.01). 
However, when looking at the effect of time on the incorporation of label, it is clear that 
there is greater incorporation of 2H-labeled alanine into muscle protein after 24 h vs. 4 h 
exposure to the isotope and therefore, as expected more protein was synthesized over 24 
h (Tables 1 and 2, pages 53 and 54).  
 In addition to technical differences between the tracer methods, our seemingly 
discrepant differences in quantitative FSR extrapolated over time, particularly using the 
two deuterium oxide techniques, may be partly explained on the basis of food 
consumption. For example, although food was removed from all of the rats 4 hours prior 
to our assessment of muscle protein synthesis, it is possible that the rats consumed food 
up until the time of removal, allowing for labeling in the 4h group to be initiated in the 
postprandial state, ultimately enhancing FSR. While this happened in the other groups as  
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well, incorporation of label only occurred either minutes before the assessment of 
muscle protein synthesis 4 hours following food removal (F flooding), or over the entire 
24 h period (24h 2H2O). Thus, the impact of food consumption during this period of time 
would be minimized in the former (postabsorptive) and diluted with respect to the 24 h 
labeling period of the latter. Figure 11 (page 64) shows the consequences of sampling at 
different time intervals, such that if one were to measure FSR over 3 different periods of 
time, it is possible to obtain measurements that do not reflect the true values during each 
period. This simple example emphasizes the importance (or consequences) of 
understanding the metabolic state of the tissue (fed, fasted, pre or post-exercise, etc) 
during assessments of muscle protein synthesis.  
 
 
Fig. 11. Proposed scheme of measuring non-steady state protein synthesis in a 
homogeneous (purified protein) pool at different time points. Assuming that the time 
interval is the same (e.g. 1 h), if 1/5th of the available pool is newly synthesized protein, 
the percent per hour expression would be 20%. If in the next hour no new synthesis 
occurs, then 1/5th of the pool would be newly synthesized protein, however, the percent 
per hour expression would now only be 10%. If in the third hour of measurement 
another 1/5 of the pool is synthesized (2/5th total), the percent per hour expression would 
be ~13%, however, this fractional synthesis rate (FSR) does not represent the values  
obtained over either of the other intervals. 
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In summary, the present study demonstrates that a single bout of high intensity 
resistance exercise without prior training in rats does not stimulate muscle protein 
synthesis (mixed or myofibrillar) and that the phenylalanine flooding dose and 2H2O 
provide qualitatively similar results. Moreover, we conclude that one should consider the 
impact of extrapolating (regardless of methodology) vs. measuring FSR over different 
periods. Finally, 2H2O is an attractive stable isotope method for measuring protein 
synthesis due to the ease of administration and relative low cost, and most importantly 
because it can be effectively used during a variety of physiological perturbations.
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CHAPTER IV 
THE ASSESSMENT OF MUSCLE PROTEIN SYNTHESIS FOLLOWING 
CHRONIC RESISTANCE EXERCISE: A PLATEAU EFFECT? 
 
Introduction 
Resistance exercise training improves skeletal muscle function and in most, 
muscle mass. The observed muscle hypertrophy occurs as a result of an increase in 
muscle protein synthesis to a greater extent than muscle protein breakdown. This process 
has been well documented following acute resistance exercise in animals (50, 51, 55, 57, 
84) and humans (15, 35, 108, 109) and it is believed that these anabolic effects are 
cumulative and responsible for growth over time. However, when compared to acute 
resistance exercise, chronic resistance exercise training appears to result in an attenuated 
muscle protein synthesis response (50, 77, 107, 109). The reasoning for these 
observations could be due to an adaptation occurring within muscle serving to blunt 
growth beyond a mammalian organism‟s potential, which can only be surpassed with 
altered stimuli; or the timing of muscle protein synthesis has changed. 
The primary rate-limiting step in mRNA translation is initiation (116) and the 
rate limiting step in translation initiation is the binding of eukaryotic initiation factor 4E 
(eIF4E) to the transcript 5‟ cap structure, m7GpppN, where N is any nucleotide (22, 28, 
65, 95, 112, 123). A repressor binding protein (4E-BP1/PHAS1) modulates the activity 
of eIF4E by sharing the same binding site as the scaffolding protein eIF4G; however, 
this does not inhibit the cap interaction. The regulation of 4E-BP1 is via protein kinase B 
         
67 
(PKB) and the mammalian target of rapamycin (mTOR) protein kinase, which when 
activated by external stimuli (mechanical strain, growth factors and nutrients) result in 
phosphorylation of 4E-BP1 on Thr-37/46 (65). This phosphorylation serves as a priming 
event, which is required for subsequent phosphorylation of carboxy-terminal sites such 
as Thr-70 resulting in dissociation of eIF4E from 4E-BP1, thus allowing eIF4E to  
complex with eIF4G. Kubica et al. (84), using an exercise paradigm similar to that of the 
present study, demonstrated elevated mTOR-dependent (rapamycin-sensitive) 4E-BP1 
phosphorylation 16 h after resistance exercise at the onset of training. Thus, 4E-BP1may 
be a suitable marker for mTOR activation with chronic resistance exercise training. 
Although it is not completely understood whether or not cumulative hyper-
phosphorylation of 4E-BP1 is necessary for elevated rates of synthesis after acute 
resistance exercise, we felt that a reduced capacity to phosphorylate 4E-BP1 may limit 
the capacity of skeletal muscle to elevate rates of protein synthesis. Therefore, the 
purpose of this study was to determine if rates of protein synthesis were augmented in 
response to an acute exercise bout after 5 weeks of resistance exercise training. Our 
hypothesis was that muscle protein synthesis after exercise training would be similar to 
control levels, and this would be, in part, due to attenuated phosphorylation of 4E-BP1. 
 
Materials and Methods 
Chemicals and Supplies 
Unless specified, all chemicals and reagents were purchased from Fisher 
Scientific (Pittsburgh, PA). 2H2O (99.9 atom percent excess) and was purchased from 
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(Cambridge Isotopes, Andover, MA). L-[2,3,4,5,6-3H]phenylalanine (F) was purchased 
from GE Healthcare Life Science-Amersham (Buckinghamshire, England). Gas 
chromatography-mass spectrometry (GC-MS) supplies were purchased from Agilent 
Technologies (Wilmington, DE) and Alltech (Deerfield, IL). Antibodies, rabbit 
(polyclonal) anti-eIF4E (9742), anti-phospho-4E-BP1-Thr70 (9455), anti-4E-BP1 (9452), 
anti-rabbit IgG, HRP (7074) and kinase buffer (10X; 9802) were purchased from Cell 
Signaling Technologies (Danvers, MA). 
Animals and Operant Conditioning 
Forty-two male Sprague-Dawley rats (5-6 month old) were individually housed 
in a climate controlled small animal facility with a 12 hour light and dark cycle. Rats 
were fed ad libitum an experimental diet (Purina Test Diet, 5001) that was comprised of 
24% protein, 12% fat, 54% carbohydrate, 7% ash, 5% fiber, and vitamins. Cholesterol 
content was manipulated so that half of the animals received 180 ppm and the other half 
received 1800 ppm to determine if cholesterol influenced protein synthesis and growth. 
At this time there is inadequate data to support an interactive effect of cholesterol and 
exercise on anabolism, therefore, the data was pooled and the rats were randomized by 
body mass to resistance exercise (RE, n = 16), exercise control (EC, n = 15) or sedentary 
control (CC, n = 11) groups. Additional work (studies) is required to accurately assess if 
cholesterol is a potent mediator of skeletal muscle hypertrophy. All experimental 
procedures were approved by the Institutional Animal Care and Use Committee of Texas 
A&M University. 
The RE and EC animals were operantly conditioned to depress an illuminated  
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bar located high on a Plexiglas exercise cage (56). Negative reinforcement via a brief  
electrical foot shock (1 mA, 60Hz) was used to train the rats to perform the desired  
movements. After the animals were conditioned (4 sessions), a non-weighted Velcro vest 
was strapped over the scapulae and the rats were required to touch the illuminating bar 
50 times for two additional sessions. The CC animals were free from physical activity 
and remained single-housed over the course of the study. 
Experimental Protocol 
The RE and EC rats performed 15 training sessions (three sessions per week 
interspersed by at least 48 hours of rest) over a 5-wk period, modified from Westerlind 
et al. (139) and Farrell et al. (50). The RE group completed a progressive resistance 
training program with a starting weight of 80 g for 50 repetitions on session one and 
increasing to 410 g for 16 repetitions on session 15. The total volume was decreased 
(increased resistance and decreased repetitions) by 5% per week for a total of 25% over 
the 5-wk training period. The EC rats completed the same protocol following the 
resistance training sessions, performing the same number of repetitions and receiving the 
same number of electrical foot shocks, without resistance, to elicit a similar stress 
response experienced by the RE group (adrenal mass did not differ among groups, data 
not shown).  
Prior to and after 5-weeks of training, all rats were anesthetized with Ketamine 
(40-55 mg/kg) and Medetomidine (0.4 mg/kg) and dual x-ray absorptiometry (DEXA, 
GE Lunar Prodigy small animal program) scans were completed to assess changes in 
body composition. 
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Twenty hours prior to the final exercise bout (Fig. 12, page 70), all animals  
received an intraperitoneal injection (IP) of 1.5 ml of 2H2O and allowed free access to  
drinking water enriched to 4.0% 2H2O. Food was withdrawn 4 h prior to the animals  
being anesthetized as previously described, and the left carotid artery and right jugular 
vein were cannulated with sterile, heparinized polythene tubing (PE-50). Rats remained 
sedated after the insertion of  catheters and a flooding dose of tritiated L-[2,3,4,5,6-3H]F 
(~1 mCi/rat) in unlabeled F (150 mM, 1ml · 100 g body mass-1) was injected into the 
venous catheter over a 10- to 15-s period (63). Following injection, arterial blood 
samples (1 ml) were taken from the carotid cannula during a 12 min period (2, 6 and 12 
min) for the determination of F specific radioactivity. After arterial sampling; the fast 
glycolytic fiber plantaris (Plant) and  the slow oxidative fiber soleus (Sol) (3) were 
excised, wet weights recorded and immediately frozen between aluminum blocks and 
cooled in liquid nitrogen for later analysis. 
 
Fig. 12. Schematic display of study design used to measure the final 36 h following 5-
weeks of resistance exercise training. The first 14 resistance exercise sessions were 
conducted over 5 weeks and the final session was held on wk-6. At time 0, 1.5 ml of 
2H2O was provided (IP injection) to each rat and 4.0% 2H2O was added to the drinking 
water. The final resistance exercise session was completed at time + 20 h and at time + 
36 h the animals were cannulated and underwent flooding dose methodology, followed 
by muscle harvest to assess muscle protein synthesis. 
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Rates of Protein Synthesis (RPS) 
Approximately 0.150 g of muscle tissue was used to estimate the rate of 
incorporation of radioactive F into of the Plant and Sol mixed muscle proteins described 
by Vary et al. (133) (see Appendix A for detailed description). Briefly, the samples were 
pulverized under liquid nitrogen, homogenized in 2.0 ml of 10% trichloroacetic acid 
(TCA) and centrifuged at 3,800 rpm for 15 min at 4ºC. The supernatant (SPNT) was 
discarded and the protein precipitate was washed four additional times in 2.0 ml of 10% 
TCA, then freed from lipid with 2.0 ml of acetone, washed with 2.0 ml of distilled H2O 
and dissolved in 2.0 ml 0.25 N NaOH. A portion of the protein was used to quantify 
protein content using the bicinchoninic acid (BCA) method (121). Radioactivity was 
determined in both tissue and plasma samples (0.5 ml and 0.05 ml, respectively) via 
liquid-scintillation counting using appropriate correction for quench. The total 
concentration of plasma F was determined using high-performance liquid 
chromatography (HPLC) with a fluorescence detector after 1.5 mol/l HClO4 was added 
to deproteinize the sample according to Buentello and Gatlin (29). Rates of protein 
synthesis are reported as nmol F incorporated · g wet weight of muscle-1 · h-1 (133). 
 Fractional Protein Synthesis Rates (FSR) 
 2H Labeling of body water was assessed by exchange with acetone as described 
by Yang et al. (148) (see Appendix B for detailed description). We administered (i.p.) 
much less 2H2O (1.5 ml) than has been described previously (8, 10, 30, 44, 151), but 
were able to achieve adequate 2H labeling of body water (≥ 2.0%) by the addition of 
4.0% 2H2O to the drinking water. The reasoning for higher body water 2H2O in the CC 
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and EC animals could be due to the stressor of the final resistance exercise bout on the 
RE group, preventing them from drinking as much water. The reaction occurred with 20 
µl of a sample (or standard), 2 µl of 10N NaOH and 4 µl of a 5% (vol/vol) solution of 
acetone in acetonitrile for 24 h. Acetone was removed by the addition of 600 µl of 
chloroform and 0.5 g Na2SO4. The samples were mixed and 100 µl of the chloroform 
was transferred to a GC-MS vial. The sample was analyzed using an Agilent 5973N-
MSD equipped with an Agilent 6890 GC system, and a DB17-MS capillary column (30 
m × 0.25 mm × 0.25 µm). The following temperature program was used: 60ºC initial, 
increase by 20°C/min to 100ºC, increase by 50ºC/min to 220ºC, and hold for 1 min. The 
sample was injected at a spit ratio of 40:1 with a helium flow of 1 mL/min. Acetone 
eluted at ~ 1.7 min. The mass spectrometer was operated in electron impact mode 
(70eV). Selective ion monitoring of mass-to-charge ratios (m/z) 58 (M) and 59 (M + 1) 
was conducted using a dwell time of 10 ms per ion. 
  2H Labeling of protein-bound alanine was measured as previously described by 
Dufner et al. (44) (see Appendix B for detailed description). We chose to measure FSR 
in the plantaris and soleus due to the growth in the plantaris and the difference in fiber 
types (fast vs. slow). Briefly, ~ 0.030 g of Plant and Sol was homogenized on ice in 0.3 
ml of a 10% (wt/vol) TCA and centrifuged at 3,800 rpm at 4°C for 15 min. The SPNT 
was discarded and the protein pellet was washed 3 additional times with 10% TCA prior 
to dissolving in 6 N HCl (0.1 ml per 0.030 g tissue) and reacting at 100ºC for 18 h. An 
aliquot (0.100 ml) of the hydrolysate was freeze dried for 24 h. A 3:2:1 ratio (0.1 mL) of 
“Methyl-8” reagent (Pierce, Rockford, IL), methanol and acetonitrile was added to the 
         
73 
residue to determine the 2H labeling of alanine on its methyl-8 derivative. All samples 
were analyzed using an Agilent 5973N-MSD equipped with an Agilent 6890 GC system, 
and a DB17-MS capillary column (30 m × 0.25 mm × 0.25 µm) was used in all analyses. 
The following temperature program was used: 90ºC initial, hold for 5 min, increase by 
5°C/min to 130ºC, increase by 40ºC/min to 240ºC, and hold for 5 min. The sample was 
injected at a spit ratio of 20:1 with a helium flow of 1 mL/min. Alanine eluted at ~ 12 
min. The mass spectrometer was operated in electron impact mode. Selective ion 
monitoring of mass-to-charge ratios (m/z) 99 (M) and 100 (M + 1) was conducted using 
a dwell time of 10 ms per ion.  
We calculated fractional synthetic rate of mixed muscle proteins (FSR) by  
measuring the incorporation of 2H alanine into protein (EA) and using the precursor-
product model (see Appendix D for detailed description): 
FSR = EA/(EBW ∙ 3.7 · t) (eq 1)  
where EA represents amount of protein-bound 2H Ala (%), EBW is the quantity of 2H2O in 
body water (%), 3.7 represents the exchange of 2H between body water and alanine (44, 
111, 146) and t is time of label exposure (36 h). Additionally, an absolute rate of protein 
synthesis (ABS) was calculated using the product of FSR and protein concentration per g 
of wet weight (146, 147):  
APS = FSR/ (mg protein · g wet wt-1) (eq 2) 
Quantification of 4E-BP1, Phospho-4E-BP1 and 4E-BP1/eIF4E Association 
To determine eIF4E-BP1, phospho-eIF4E-BP1 (Thr 70) and eIF4E, 0.050 g of  
Plant was homogenized on ice in 400 µl of a 1 X kinase buffer (25 mM Tris-HCl, 5 mM  
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ß-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2) with 200 µM 
ATP, 0.01% Triton and protease inhibitors (Sigma-Aldrich, St. Louis, MO) added. 
Homogenates were centrifuged at 14,000 rpm at 4ºC for 30 min. After centrifugation, the 
supernatant containing the cytosolic and membrane portion was extracted, protein 
content in the SPNT was assayed using the bicinchoninic acid (BCA) method (121), and 
20 µg was added to a 10% discontinuous polyacrylamide gel. After electrophoresis, gels 
were transferred to a PVDF membrane using a semidry method (Immobilon-P; 
Millipore) and immunoblotted with the specific antibodies of interest mentioned above. 
Samples of mixed cardiac muscle from these animals were prepared identical and an 
equal quantity of protein was added to each gel to serve as a control. To determine if 4E-
BP1 was bound to eIF4E, eIF4E was precipitated out of 50 µg of protein with anit-
eIF4E, Super Block (Fisher Scientific, Pittsburgh, PA) and Protein A (Sigma-Aldrich, 
St. Louis, MO); modified from Kimball et al. (79). An equal amount (30 µl) was then 
added to a 10% discontinuous polyacrylamide gel as above, followed by electrophoresis, 
gel transfer and then immunoblotted with anti-4E-BP1. 
Statistical Analysis 
All data analysis was completed using SigmaStat version 3.5 and values are 
expressed as means ± S.E.M. Mean weekly body mass change comparisons were 
performed using a two way repeated measure analysis of variance (ANOVA) with the 
effects being physical activity and time. All other comparisons were made using a one 
way ANOVA with the effect being physical activity. Post hoc testing was performed 
using the Fisher LSD method when a main effect was observed. If a test of normality or 
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equal variance failed, then ANOVA on ranks followed by a Fisher LSD post hoc 
comparison test was performed. We accepted an analysis as statistically significant if P 
< 0.05. 
 
Results 
Effectiveness of  the RET Protocol 
There were no differences in pre-weights between RE (402 ± 2.5 g), EC (415 ± 
2.6 g) or CC (407 ± 3.0 g) groups (Fig. 13, page 76), however, there were significant 
differences in the main effect interaction (physical activity x time) between RE vs. EC 
and CC from week 3 to the end of the study (P < 0.001), such that the RE group gained 
less wt (2.1%) than the EC (9.3%) and CC (9.1%) groups. Total body fat percentage and 
total lean tissue were measured pre-and post training with DEXA (Fig. 14, page 77). 
There were significant differences in body fat percentages (Fig. 14A, page 77) between 
RE (-6.6 ± 5.6%) and EC (+6.0 ± 5.4%) vs. CC (+44.9 ± 5.8%) animals following the 
training protocol (P < 0.001); but no differences in lean tissue accretion (Fig. 14B, page 
77) among the groups. These data demonstrated a training effect in resistance exercised 
rats, as well as the efficacy of resistance exercise in the control of fat mass. 
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Fig. 13. Mean weekly weight gain in cage control (CC), exercise control (EC) and 
resistance exercised (RE) rats over 5 weeks. * = significant difference (P < 0.05) in RE 
vs. EC and CC rats. # = significant difference (p < 0.01) in RE vs. EC and CC rats. † = 
significant difference (P < 0.001) in RE vs. EC rats. Data are presented as means ± SE; 
(n = 11-16 per group). 
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Fig. 14. Total body fat percentage (A) and total lean tissue (B) assessed (DEXA) before 
and after 5 weeks of RE training. Cage control (CC), exercise control (EC) and 
resistance exercised (RE) rats. † = significant difference (P < 0.001) in RE and EC vs. 
CC rats. Data are expressed as % change (pre and post) and presented as means ± SE; (n 
= 11-16 per group).  
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Anabolic Response 
Plant wet weights were significantly greater in the RE vs. EC (5.7%, P < 0.05) 
and RE vs. CC (8.2%, P < 0.01) animals (Fig. 15, page 78), whereas, no differences 
among groups for soleus muscle mass were observed. In spite of an increased growth 
response in the Plant, rates of muscle protein synthesis (assessed in a subset of animals) 
did not differ among RE, EC or CC groups in the Plant and Sol muscles (Fig. 16, page 
79).  
 
 
Fig. 15. Wet weight of plantaris (Plant) and soleus (Sol) muscles following 5 weeks of 
RE training. Cage control (CC), exercise control (EC) and resistance exercised (RE) rats. 
* = significant difference (P < 0.05) in RE vs. EC rats. # = significant difference (P < 
0.01) in RE vs. CC rats. Data are presented as means ± SE; (n = 8-15 per group). 
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Fig. 16. Rates of mixed muscle protein synthesis (RPS) for plantaris (Plant) and soleus 
(Sol) assessed 16 h following the final bout of RE after 5 weeks of RE training. Cage 
control (CC), exercise control (EC) and resistance exercised (RE) rats. Data are 
presented as means ± SE; (n = 5 for CC and EC, n = 9 for RE). 
 
 
4E-BP1, Phospho-4E-BP1 and 4E-BP1/eIF4E Association  
In order to determine if similarities in muscle protein synthesis among groups 
were due to attenuated mTOR downstream signaling, we determined the total expression 
of 4E-BP1, the phosphorylation status of 4E-BP1 (Thr 70) and the bound 4E-BP1 to 
eIF4E in the Plant relative to control (heart standard) (Fig. 17, page 80). There were no 
differences between the RE, EC or CC groups in the expression of 4E-BP1 (Fig. 17A, 
page 80), phosphorylation of 4E-BP1 (Fig. 17B, page 80) or the 4E-BP1 and eIF4E  
complex (Fig. 17C, page 80). 
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Fig. 17. Downstream targets of mTOR assessed 16 h following the final bout of RE after 
5 weeks of RE training in the plantaris. Control, heart standards. Western blot analysis 
and graphical summaries of mean densitometry values are depicted. (A) eIF4E-4E-BP1 
complex in cage control (CC) (lane 1), exercise control (EC) (lane 2) and resistance 
exercised (RE) (lane 3). (B) 4E-BP1 phosphorylation in cage control (CC) (lane 1), 
exercise control (EC) (lane 2) and resistance exercised (RE) (lane 3). (C) Total 4E-BP1 
in cage control (CC) (lane 1), exercise control (EC) (lane 2) and resistance exercised 
(RE) (lane 3). Data are presented as means ± SE; (n = 7-10 per group).  
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Assessment of Protein Synthesis with 2H2O 
 The IP injection with1.5 ml of 2H2O and the 4.0% 2H2O added to the drinking 
water yielded at least 2.0% plasma 2H2O, with the CC and EC animals obtaining higher 
enrichment (Table 3, page 81). The only difference in protein labeling (2H-Ala) was in 
the Plant; with the RE group possessing much higher labeling (Table 3, page 81). The 
fractional synthesis rates (Fig. 18A, page 82) in the RE group were 142% higher than EC 
and 210% greater than the CC animals (P < 0.001). Due to the time of the labeling with 
2H2O (36 h) and the hypertrophy of the plantaris, we calculated absolute protein 
synthesis rates (mg of protein synthesized per gram of tissue) to account for any changes 
that may have occurred in the protein pool (Fig. 18B, page 82). The trend was similar 
with RE yielding a 139% greater absolute rate of protein synthesis than EC and 250% 
greater than CC (P < 0.001). No differences were observed for either fractional or 
absolute synthesis rates in the Sol muscle. 
 
Table 3. 2H-labeling of body water and skeletal muscle proteins 
 
   
Group      n  Plasma (MPE)     Plantaris (MPE)      Soleus (MPE)     
CC    7-8    2.92 ± 0.18     1.16 ± 0.12     1.00 ± 0.12 
EC       9-10       2.31 ± 0.11#        1.16 ± 0.10         1.08 ± 0.11 
RE    9-10       2.00 ± 0.06*†        2.53 ± 0.29†       0.89 ± 0.12 
Values are means ± SE. MPE, mole percent excess. Cage control, CC; exercise control, 
EC and resistance exercise, RE. * Significantly different (P<0.05) from EC group; # 
significantly different (P<0.01) from CC group; † significantly different (P<0.001) from 
CC group in plasma and from CC and EC groups in the plantaris.  
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Fig. 18. Mixed muscle protein fractional synthetic rate (FSR) and absolute rates of 
protein synthesis (ASR) assessed over 36 h following 5 weeks of RE training in the 
plantaris of cage control (CC), exercise control (EC) and resistance exercised (RE) rats; 
and soleus of CC, EC and RE muscles. † = significant difference (P < 0.001) in RE vs. 
EC and CC rats. Data are presented as means ± SE; (n = 7-10 per group). 
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Discussion 
Part of the significance of the present study is that it reports the absence of an 
acute anabolic response to resistance exercise training when rates of protein synthesis 
are examined in the pre-training anabolic window. Protein synthesis was even 
normalized in the plantaris, which hypertrophied with resistance exercise training. 
Consistent with our measurements in the traditional anabolic window, both the 
phosphorylation on 4E-BP1 (Thr 70) and the fraction of 4E-BP1 bound to eIF4E was 
similar in resistance exercise training and sedentary controls. Taken together, these 
results appear to indicate that chronic resistance exercise training, even that leading to 
the accumulation of muscle mass, may accomplish muscle hypertrophy with no 
sustained elevations of muscle protein synthesis. However, when the cumulative 
anabolic response was assessed over a 36 h period, the FSR with training was 
significantly greater than in the non-resistance trained muscle (at least in hypertrophied 
muscle), suggesting that evaluations of muscle protein synthesis in the traditional 
anabolic window prior to training may not accurately reflect the integrative anabolic 
potential that exercise training provides. 
The lack of an apparent anabolic effect of exercise with training is not novel. 
Farrell et al. (50) observed the lack of an anabolic response (rates of muscle protein 
synthesis) in selected hindlimb muscles following 8 wk of resistance exercise using a 
similar model in rats. In humans, Phillips et al. (109) observed an attenuation in mixed 
muscle FSR within 4 h following an acute bout of resistance exercise in individuals who 
had been undergoing resistance exercise training for more than 5 years (self-reported). 
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Additionally, Kim et al. (77) reported a decrease in mixed muscle FSR and no change in 
myofibrillar FSR when comparing a trained vs. untrained leg 12 h following an 8-week 
unilateral resistance exercise leg protocol. In the case of the human studies, it should be 
noted that both studies examined FSR in the fasted state, which may have influenced the 
lack of an anabolic response with training. However, another study by Phillips et al. 
(107), which examined the effects of an 8 wk resistance exercise training program on 
mixed muscle FSR in the fed state found that prolonged resistance exercise training may 
reduce the anabolic stimulus of resistance exercise. Thus the use of periodic assessments 
of muscle protein synthesis typically demonstrates a training-associated loss of the 
anabolic potential with chronic resistance exercise training, even when hypertrophy 
occurs.  
Consistent with our observations regarding rates of muscle protein synthesis, we 
found that phosphorylation of 4E-BP1 (Thr70), as well as 4E-BP1/eIF4E association 
was similar among groups. The lack of response in plantaris muscle, which underwent 
hypertrophy, may be an important contributor to the aforementioned „anabolic plateau‟ 
with resistance exercise training. Interestingly, we initially hypothesized that this plateau 
may be due to an over expression of 4E-BP1, which would serve to inhibit muscle 
protein synthesis even with adequate mTOR activation. However, since over expression 
of 4E-BP1 was not observed in the present study, we may alternatively conclude that the 
lack of hyperphosphorylation of this important anabolic suppressor, at least 16 h post 
exercise, may be due to attenuated mTOR activation after chronic resistance exercise 
training. More studies are necessary to elucidate this possibility.   
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Another possibility is that the anabolic response to exercise is still intact, but our  
ability to assess the effect of exercise in the traditional „anabolic window‟ may be  
diminished. To explore this possibility, we assessed FSR over the final 36 h period of  
resistance exercise training with 2H2O and found a significant, cumulative, anabolic 
response in plantaris muscle. To our knowledge, this study is the first to utilize this 
methodological approach in skeletal muscle with exercise. The use of 2H2O allows for 
2H to label body H2O and alanine, which may then be incorporated into proteins, 
including skeletal muscle, allowing measurements of protein synthesis in either an acute 
mode or during chronic exposure to the isotope (44, 111, 151). We chose to provide 
2H2O over the final 36 h to allow for a ‘cumulative’ assessment of FSR, thus allowing 
for food, sleep and exercise to influence the outcome (normal physiology), and 
ultimately, rule out the possibility that we may have missed the „anabolic window‟ with 
traditional flooding dose methodology. In addition, because the time of measurement 
was over 36 h, we determined the absolute rate of protein synthesis to account for any 
changes that may occur within the plantaris or soleus protein pool and observed a similar 
pattern as the FSR changes. Our data clearly show that FSR, when assessed for extended 
periods of time, are greater than 2-fold in plantaris muscle of resistance exercise trained 
rats, a finding not observed using flooding dose techniques. 
In support of a shift in the anabolic window comes from a recently published 
investigation by Tang et al. (124), whereby an 8-week unilateral resistance exercise leg 
protocol was followed, similar to Phillips et al. (107); the difference between those 
studies (107, 124) was that the relative work of the former load was changed following 
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training to represent the strength gains. They (124) reported significant increases in 
muscle protein synthesis in the trained leg 4 h post-exercise, but attenuation at 28 h. 
Thus, identification of this altered window becomes problematic when choosing which 
time points to examine. This issue can be resolved by utilizing 2H2O, which can be used 
for prolonged periods of time. 
In contrast to the plantaris muscle, the cumulative assessment of FSR in soleus 
muscle demonstrated no differences among groups, which was consistent with our 
findings using flooding dose techniques. Interestingly, unlike plantaris muscle, the 
soleus did not hypertrophy in response to chronic resistance exercise training, and 
therefore may not be responsive to this training paradigm. At the onset of training, the 
present work demonstrates that the soleus muscle is highly active during the exercise 
movements (unpublished observations) and responds with elevated rates of synthesis 
after exercise. However, it is possible that this highly active, postural/locomotor muscle 
is not responsive to chronic, voluntary training in intact hindlimbs.  
It is not clear why these muscle fibers responded so differently with exercise 
training; however, it is possible that anabolic responses to training may also depend on 
fiber composition, as plantaris is predominately composed of faster fibers (93%) and 
soleus is composed of slower fibers (89%) (3). Irrespective of fiber composition, 
findings of the present experiment reveal that cumulative absolute protein synthesis and 
FSR are almost identical, supporting the notion that skeletal muscle protein turnover is 
low, regardless of fiber composition. From the present work, it cannot be inferred if the 
enhanced cumulative anabolic response in plantaris muscle is due to a temporally 
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distinct anabolic window at another time-point(s), or a subtle, but persistent elevation of 
protein synthesis for greater periods of time. Therefore, more studies are necessary to 
explore these possibilities.   
In summary, this study highlights the importance of assessing total, cumulative  
anabolic responses to interpret anabolic potential of skeletal muscle with exercise 
training. When using shorter-term flooding dose procedures, there were no observable 
differences in mixed muscle rates of protein synthesis of exercised vs. sedentary muscle 
controls, 16 h following the final exercise session. This finding is consistent with the 
notion that chronic resistance exercise training leads to normalized muscle protein 
synthesis, even in hypertrophic muscle. However, when cumulative anabolic responses 
were assessed on hypertrophied muscle fibers over an extended period of time, the 
present work demonstrated that exercised muscle fibers display anabolic responses more 
than two-fold higher than those of the control muscles. Results from the present work do 
not support a „plateau‟ effect following chronic resistance exercise training, and further 
suggest that protein anabolism is still greater with training, although the precise 
mechanisms cannot be explained at this time. 
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CHAPTER V 
IMMEDIATE POST-RESISTANCE EXERCISE PROTEIN CONSUMPTION DOES 
NOT AUGMENT HUMAN CUMULATIVE MIXED MUSCLE PROTEIN 
SYNTHESIS 
 
Introduction 
There is little disagreement among muscle biologists that skeletal muscle protein 
synthesis must be, in some order magnitude, greater than protein breakdown for muscle 
growth to occur. Known stimuli of increasing protein synthesis are nutrient ingestion, 
physiological secretion of hormones/steroids and an adequate amount of overload 
produced from resistance exercise. Feeding alone increases human muscle protein 
synthesis and it is believed that the extracellular amino acid concentrations supplied by 
the diet mediate this response (20, 34, 58). Additionally, upon ingestion of nutrients, a 
pulsatory secretion of hormones (insulin) supports this process, mainly by inhibiting 
protein breakdown (33, 36, 66). Resistance exercise, in the post-absorptive state, has 
been reported to increase mixed muscle (15, 41, 50, 52, 57, 77, 84, 108, 109), 
myofibrillar (77, 94) and sarcoplasmic (94) protein synthesis in animals and humans 
from 1-72 h following the session; as well as increasing breakdown (41). The combined 
effect of resistance exercise and nutrients provide an interactive benefit in stimulating 
anabolism and attenuating catabolism in skeletal muscle (17, 40, 80, 114, 127, 128). The 
ideal timing for nutrient ingestion with resistance exercise training is, however, not well 
defined.       
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Long-term (12 weeks) studies by Esmarck et al. (47) and Andrews et al. (2) 
support the notion that protein consumption in the early period following resistance 
exercise is paramount for optimal muscle growth to occur in seniors. However, Rankin 
et al. (113) did not observe differences between post-exercise protein or carbohydrate 
consumption in 18-25 year old men who underwent 10-weeks of resistance exercise 
training. None of the investigations measured protein turnover; therefore, it is difficult to 
conclude whether post-exercise protein consumption truly influences the growth process.  
There have been several acute resistance exercise investigations that directly 
measured muscle protein metabolism with protein and/or carbohydrate before (59, 117, 
126, 128), during (9, 18) or after (25, 40, 80, 114, 126, 127) with mixed results. The 
discrepancy in the results can be attributed to differences in the methodological 
approach, such as the stable isotope ([13C] leucine, or ([13C], [15N], [2H]) phenylalanine) 
and the precursor pool used for calculation of muscle fractional rates of protein synthesis 
(FSR); as well as the intensity of the resistance exercise bout and the amount of nutrients 
provided at varying time points. In addition, the subjects are typically studied following 
an over-night fast due to the influence that feeding has on precursor enrichment (label 
dilution). This raises questions as to the applicability of the findings as humans eat, 
perform activities of daily living and sleep during a 24 h cycle.  
Cumulative assessments (over 24 h) of whole body protein synthesis have been 
made by using oral [1-13C]lysine (45) or intravenous [1-13C]leucine (24); however, no 
studies have examined skeletal muscle over 24 h. Thus, it is assumed that a measurement 
obtained over minutes to 6 h can be extrapolated to yield daily rates, which in human 
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skeletal muscle is believed to be 1.5-2% per day (62). However, we recently discovered 
that this is not the case when measuring skeletal muscle FSR in rats over 24 h with 2H2O 
compared to extrapolated values obtained with either flooding dose of L-[2,3,4,5,6-
3H]phenylalanine over 12 min or a 4 h 2H2O measurement (calculated values can under 
and/or over estimate FSR). The use of 2H2O allows for protein synthesis measurements 
to be made over short or extended periods of time. In addition, since 2H2O is not 
influenced by feeding, exercise, stress and sleep (normal biological processes); one can 
study perturbations that are typically difficult to account for with traditional tracer 
methodologies, thus providing a cumulative, real life picture.  
We, therefore, sought out to determine the effects of high intensity resistance 
exercise on cumulative FSR and whether the timing of post-exercise protein 
consumption (1 or 3 h) influences this response when energy and macronutrients are 
controlled. Our hypothesis was that FSR would be increased with an acute bout of high 
intensity exercise and that immediate post-exercise protein consumption would augment 
this anabolic response. We chose to examine both the mixed muscle and myofibrillar 
fraction to determine if differences in protein specific FSR responses occur over 24 h.  
 
Materials and Methods 
Chemicals and Supplies 
Unless specified, all chemicals and reagents were purchased from Fisher 
Scientific (Pittsburgh, PA). 2H2O (99.9 atom percent excess) was purchased from 
Cambridge Isotopes (Andover, MA). Gas chromatography-mass spectrometry supplies  
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were purchased from Agilent Technologies (Wilmington, DE) and Alltech (Deerfield, 
IL). Kinase buffer (10X) was purchased from Cell Signaling Technologies (Danvers, 
MA). 
Subjects 
Twelve healthy, recreationally active young males (Table 4) volunteered to 
participate in an acute bout of high intensity resistance exercise. All participants were  
Table 4. Subjects’ characteristics 
                                                       
                                                    PRO (n=6)                             CON (n=6)  
Age, yrs     22.33 ±  0.67               20.83 ±  0.31   
Ht, cm    179.00 ±  2.91           181.93 ±  1.91   
Wt, kg      81.14 ±  5.64               82.70 ±  3.57  
BMI, kg/m2     25.13 ±  1.23               25.00 ±  1.32 
Lean tissue, kg    65.75 ±  3.45               64.31 ±  0.82          
Body fat, %     15.35 ±  2.24               18.42 ±  3.58 
1RM LP, kg   244.09 ±16.55       201.29 ±23.52  
1RM LP/lean tissue      3.74 ±  0.25                      3.21 ±  0.35 
1RM KE, kg     99.24 ±  8.34                  96.21 ±  6.83 
1RM KE/lean tissue                    1.52 ±  0.11                            1.50 ±  0.11    
Values are expressed means ± SE. PRO, immediate post-exercise protein; CON, 
carbohydrate control; BMI, body mass index; 1RM, single repetition maximum (LP, leg 
press; KE, knee extension). No significant difference in any characteristics. 
 
informed of study purpose, procedures and risks associated with participation prior to 
providing informed consent. Subjects were randomized by lean tissue, in a double 
blinded manner, to either immediate post-exercise protein ingestion (PRO, n = 6) or an 
isocaloric carbohydrate control (CON, n = 6). Subjects completed a medical screening 
questionnaire to insure that they were healthy and free of chronic disease. Exclusion 
from participation included the following; a) collegiate athletes, b) regular resistance 
training in the previous 6 months, and c) consuming ergogenic aids. The Institutional  
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Review Board of Texas A&M University approved all experimental procedures. 
Diet and Post-Exercise Supplementation 
All subjects received 1 h of nutrition education by a registered dietitian (author) 
and were required to record 72 h (2 week days and 1 weekend day) of normal nutrient 
intake; as well as 24 h prior to the day of the study. Diets were analyzed for 
macronutrient composition using NutriBase 7.0 Clinical (Phoenix, AZ). The 72 h mean 
energy and macronutrient intake were 12,035 ± 988 kJ, 47 ± 2% carbohydrate, 20 ± 2%  
protein (1.7 ± 0.2 g protein ·kg -1 body mass) and 33 ± 2% lipid.                                                                                                         
In order to control diet for 24 h (study day), subjects were provided all meals in  
the form of liquid supplements (Boost Plus and Boost High Protein; Novartis Medical 
Nutrition, Fremont, IN). Each participant consumed 4 Boost Plus and 2 Boost High 
Protein during the 24 h period (Fig. 19, page 94) to provide a total of 8033 kJ with 56% 
being supplied by carbohydrates, 15% from protein (1.1 ± 0.04 g protein · kg-1body 
mass) and 29% from lipid. Additionally, subjects received a beverage immediately 
following resistance exercise and 3 h after. The PRO group received the protein 
beverage immediately following resistance exercise and the placebo 3 h later, whereas, 
the CON group consumed the placebo immediately after exercise and the protein 
beverage 3 h later. The volume of beverage supplied was based on the amount of protein 
relative to body mass (0.3 g protein ·kg-1) in both groups. This amount was chosen to 
provide an adequate precursor substrate for protein synthesis/anabolism and has been 
used previously (2, 81). The protein containing beverage (Gatorade Nutrition Shake; 
Chicago, IL) supplied 1959 ± 51 kJ, 0.8 g carbohydrate ·kg-1, 0.3 g protein ·kg -1 (milk 
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isolate, whey and casein) and 0.1 g fat ·kg-1; whereas the placebo (85% Waximaize Fruit 
Punch; Innovative Delivery Systems, Oviedo, FL and 15% Peanut Oil; commercially  
available) provided 1974 ± 52 kJ, 1.2 g carbohydrate ·kg-1, 0.0 g protein ·kg-1 and 0.1 g 
fat ·kg-1.    
In total, subjects consumed 12,217 ± 128 kJ, 56% carbohydrate, 15% protein (1.4 
± 0.2 g protein ·kg-1 body mass) and 29% lipid during the study day. Energy (kJ) and 
macronutrient composition (g) did not differ between the subjects 72 h, 24 h and study 
day intake; however, composition as a percentage was different (p < 0.05). We chose to 
increase the percentage of carbohydrates and reduce the percentage of protein and lipid 
to remain consistent with the dietary guidelines for Americans and athletes (1, 73). 
Acute Resistance Exercise 
Subjects performed an acute bout of dynamic resistance exercise (85 % of 1 
repetition maximum (1RM) until exhaustion) of leg-press (5 sets) and leg-extension (5 
sets) (Keiser, Fresno, CA) using one leg with the contralateral leg serving as a control. 
Subjects were allowed 2 min rest between sets and 5 min between the two exercises. A 
familiarization period and a 1 RM test were completed > 7 days prior to the study day, 
with at least 48 h separation between the two. Participants were instructed to maintain 
regular physical activity, but to refrain from any resistance activity 7 days prior to the 
day of the study. 
Body Water Enrichment of 2H2O 
All study participants reported to The Human Countermeasures Laboratory at 
0800 (Fig. 19, page 94) the morning of the study and consumed the first of four 75 mL 
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boluses of 70% 2H2O. This amount was chosen based on previous human investigations 
(30, 111) with the goal of obtaining ~ 0.04 atom percent excess of 2H labeling of body 
water. EDTA serum was collected at 4 time points over 24 h for measurements of body 
water 2H enrichment. No adverse affects occurred in any of the subjects. 
 
 
Fig. 19. Study Design. Blood and muscle sampling, 2H2O and beverage consumption are 
indicated by the arrows. The design of the study was identical for the immediate post-
exercise protein (PRO, n = 6) and carbohydrate control (CON, n = 6) groups except for 
the timing of protein supplement ingestion. See methods for detailed description of   
the study design. 
 
Plasma Sample Analysis 
Blood samples were collected in EDTA containing tubes and centrifuged at 
2,500 rpm at 4ºC for 20 min. Aliquots of plasma were immediately stored at -80 ºC. 
Glucose and lactate were measured with an YSI 2300 STAT Plus glucose and lactate 
analyzer (YSI Life Sciences, Yellow Springs, OH). Insulin was determined by an ELISA 
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kit (Alpha Diagnostic International, San Antonio, TX) with absorbance measurement 
completed on a DTX 880 Multimode Detetector (Beckman Coulter, Inc., Fullerton, CA). 
Plasma amino acids (isoleucine, leucine and valine) were determined by using high-
performance liquid chromatography (HPLC) as described by Buentello and Gatlin (29) 
(see Appendix C for detailed description). Briefly, samples were deproteinized on ice 
with 1.5 mol/l HCLO4 (1:1 vol), followed by neutralization with 2 mol/l K2CO3 (2:1 vol) 
and lipid removal with diethyl ether (1:3 vol). Upon filtering of samples (0.22-µm 
polycarbonate syringe filters), 1.0 ml of sample underwent precolumn derivatization 
with opthaldialdehyde (Sigma-Aldrich, St. Louis, MO). 
The 2H labeling of body water was determined by acetone exchange (148) (see  
Appendix B for detailed description). The reaction occurred with 0.02 ml of sample, 2 
µL of 10N NaOH and 4 µL of a 5% (vol/vol) solution of acetone in acetonitrile for 24 h. 
Acetone was removed by the addition of 0.6 ml of chloroform and 0.5 g Na2SO4. The 
samples were mixed and 0.1 ml of the chloroform was transferred to a GC-MS vial. The 
samples were analyzed using an Agilent 5975C-MSD equipped with an Agilent 7890 
GC system, and a HP-5ms capillary column (30 m × 0.25 mm × 0.25 µm). The 
following temperature program was used: 60ºC initial, increase by 20°C/min to 100ºC, 
increase by 50ºC/min to 220ºC, and hold for 1 min. The sample was injected at a spit 
ratio of 40:1 with a helium flow of 1 mL/min. Acetone eluted at ~ 1.7 min. The mass 
spectrometer was operated in electron impact mode (70eV). Selective ion monitoring of 
mass-to-charge ratios (m/z) 58 (M) and 59 (M + 1) was conducted using a dwell time of 
10 ms per ion.  
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Muscle Sample Analysis  
The following morning, 16 h after the acute bout of resistance exercise, subjects 
returned to laboratory at 0800 (+ 24 h) for muscle biopsies. Samples were obtained from 
both the exercised and control leg (vastus lateralis) with a 5 mm Bergström biopsy 
needle, under sterile procedure and local anesthesia (1% lidocaine). Fat, connective 
tissue and blood were removed from the samples, frozen in liquid N2 and stored at -80°C 
until further analysis. 
The 2H labeling of protein-bound alanine was measured as previously described 
by Dufner et al. (44) (see Appendix B for detailed description). Briefly, ~ 0.030 g of 
muscle was homogenized on ice in 0.3 ml of a 10% (wt/vol) TCA and centrifuged at 
3,750 rpm at 4°C for 15 min. This was repeated 3 additional times prior to dissolving the 
protein pellet in 6 N HCl (0.1 mL/0.030 g tissue) and reacting at 100ºC for 18 h. In order 
to determine if there was a difference in mixed muscle versus myofibrillar, ~ 0.040 g of 
muscle was homogenized on ice in 0.4 mL of a 1 X kinase buffer (25 mM Tris-HCl, 5 
mM ß-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4, 10 mM MgCl2) with 
200 µM ATP and 0.01% Triton. Homogenates were centrifuged at 14,000 rpm at 4ºC for 
30 min. After centrifugation, the supernatant containing the cytosolic and membrane 
portion was discarded and the precipitate representing the myofibrillar fraction was 
prepared similar to the mixed muscle. An aliquot (0.100 ml) of the hydrolysate was 
freeze dried for 24 h. A 3:2:1 ratio (0.1 mL) of “Methyl-8” reagent (Pierce, Rockford, 
IL), methanol and acetonitrile was added to the residue to determine the 2H-labeling of 
alanine on its methyl-8 derivative. All samples were analyzed using an Agilent 5973N-
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MSD equipped with an Agilent 6890 GC system, and a DB17-MS capillary column (30 
m × 0.25 mm × 0.25 µm) was used in all analyses. The following temperature program 
was used: 90ºC initial, hold for 5 min, increase by 5°C/min to 130ºC, increase by 
40ºC/min to 240ºC, and hold for 5 min. The sample was injected at a spit ratio of 5:1 
with a helium flow of 1 mL/min. Alanine eluted at ~12 min. The mass spectrometer was 
operated in electron impact mode. Selective ion monitoring of mass-to-charge ratios 
(m/z) 99 (M) and 100 (M + 1) was conducted using a dwell time of 10 ms per ion. 
 We calculated fractional synthetic rates of mixed muscle proteins (FSR) by  
measuring the incorporation of 2H alanine into protein (EA) and using the precursor-
product model (see Appendix D for detailed description): 
FSR = EA/(EBW ∙ 3.7 · t) (eq 1) 
where EA represents amount of protein-bound 2H Ala (%), EBW is the quantity of 2H2O in  
body water (%), 3.7 represents the exchange of 2H between body water and alanine (44, 
111, 146) and t is time of label exposure (36 h).      
Statistics 
All data analysis was completed using SigmaStat version 3.5 and values are 
expressed as means ± SE. Comparisons for glucose, lactate, insulin and amino acids 
were made using a two-factor repeated measures ANOVA with the main effects being 
diet and time. A one-factor repeated measure ANOVA for 2H labeling of plasma was 
used. A one-factor ANOVA was used to compare differences in 2H labeling of tissue 
alanine and the effect of exercise in the myofibrillar fraction. A two-factor ANOVA 
(diet and activity) was used to compare differences in mixed muscle FSR. Post hoc 
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testing was performed using the Fisher LSD method when a main effect was observed. If 
a test of normality or equal variance failed, a Kruskal-Wallis test was conducted, and the 
Fisher LSD Post hoc test was used when a main effect was observed. We accepted an 
analysis as statistically significant if P < 0.05. 
 
Results 
Exercise Session 
All subjects completed 5 sets of leg-press and 5 sets of knee-extension at 85% of 
their 1RM. There was no difference in the leg-press resistance used between the PRO 
(202 ± 10 kg) and CON (171 ± 20 kg) groups, nor was there any differences between the 
groups in the number of repetitions performed over the course of the 5 sets, PRO (11 ± 
2) vs. CON (13 ± 2). However, the CON group‟s powers output (854 ± 71 W) was 
significantly greater over the 5 sets of leg-press than the PRO group (730 ± 77 W) and 
thus, work (P < 0.01). In addition, there were no difference in the knee-extension 
resistance used (84 ± 7 vs. 79 ± 6 kg), the repetitions over 5 sets (2 ± 0.3 vs. 2 ± 0.2) or 
power output (136 ± 8 vs. 148 ± 5 W) between the PRO and CON groups respectively. 
Plasma Glucose, Lactate and Insulin 
Plasma glucose concentrations remained constant over the course of the 24 h 
period (Table 5, page 99) and did not differ at any time point between groups. In 
contrast, plasma lactate tended to increase (~ 2 fold over basal values, time 0 h) 1 h 
following the acute bout of resistance exercise in both groups and remained elevated at 3 
h following exercise in the PRO group (P < 0.05); whereas lactate decreased at 3 h post-
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exercise, but increased ~ 3 fold over pre-study concentrations 16 h after exercise in the 
CON group (P < 0.05) and was significantly different between treatments at this time (P 
< 0.05). Plasma insulin concentrations also increased 1 h following resistance exercise in 
both the CON (P < 0.05) and PRO (P < 0.01) groups vs. basal levels, but returned to 
normal concentrations the remainder of the time points. Additionally, there were no 
significant differences observed between treatments (P > 0.05). 
 
Table 5. Plasma glucose, lactate and insulin concentrations 
       
                                0              1 h Post-Ex                 3 h Post-Ex                  16 h Post-Ex                 
Glucose (mM) 
 
CON             4.9 ± 0.3  4.7 ± 0.3   5.0 ± 0.2    5.5 ± 0.5 
PRO             4.8 ± 0.3  4.1 ± 0.2   5.0 ± 0.3    5.0 ± 0.2 
 
     Lactate (mM) 
 
CON                1.0 ± 0.1  2.2 ± 0.8   1.0 ± 0.1    4.2 ± 1.3# 
PRO                 0.9 ± 0.1  2.7 ± 0.6   2.8 ± 0.9#    1.9 ± 0.6* 
 
Insulin (µU/mL)  
 
CON               7.7 ± 2.1 18.5 ± 5.0#   15.3 ± 3.5    9.0 ± 2.4  
PRO                8.1 ± 0.7          50.0 ±13.8†                     7.8 ± 1.9                     8.3 ± 2.1              
Immediate post-exercise protein (PRO, n = 4-6) and carbohydrate control (CON, n = 6) 
measured prior to the start of the study (0h), 1h post-exercise (+7.5h), 3h post-exercise 
(9.5h) and 16h post-exercise (+24h). Measurements are expressed means ± SE. #P<0.05 
vs. time 0 within same group; †P<0.01 vs. time 0 within same group. *P<0.05 vs. CON 
at same time point. 
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Plasma Amino Acids 
The branch chain amino acid concentrations over time are shown in Figure 20 
(page 101). Plasma isoleucine, leucine and valine all increased 1 h after resistance 
exercise over pre-exercise values in the PRO group (P < 0.001) and were significantly 
higher over the CON group (P < 0.001). In addition, plasma isoleucine and leucine 
responses were lower in the CON group 3 h following exercise vs. basal values (P < 
0.01) and treatment differences persisted at this time point with greater concentrations  
in the PRO group for isoleucine (P < 0.01), leucine and valine (P < 0.001). The amino 
acids returned to basal values 24-hours from the start of the study (16 h following 
resistance exercise) (P > 0.05). Although not shown, we observed a similar pattern  
for the majority of other amino acids, however, only chose to show the branched  
chain amino acids due to their proposed role in stimulating muscle protein  
synthesis (19).  
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Fig. 20. Plasma isoleucine, leucine and valine concentrations in immediate post- 
exercise protein (PRO, n = 6) and carbohydrate control (CON, n = 6) measured prior to  
the start of the study (0h), 1h post-exercise (+7.5h), 3h post-exercise (9.5h) and 16h 
post-exercise (+24h). Values are means ± SE. Data were analyzed with repeated-
measures ANOVA (treatment x time). Plasma isoleucine: *P < 0.001 vs. 0h in PRO 
group and P < 0.01 in CON group; †P < 0.01 vs. CON at same respective time point; ‡P 
< 0.001 vs. CON at same respective time point. Plasma leucine: *P < 0.001 vs. 0h in 
PRO group and P < 0.01 in CON group; ‡P < 0.001 vs. CON at same respective time 
point. Plasma valine: *P < 0.001 vs. 0h in PRO; #P < 0.05 vs. CON at same respective 
time point; ‡P < 0.001 vs. CON at same respective time point. 
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Muscle Protein Synthesis 
Body water 2H enrichment reached ~ 0.4 % excess (Table 6, page 103) over the 
course of the study and the 2H labeling of alanine did not differ between the exercised 
(Ex) and non-exercised (NoEx) legs. Both plasma and muscle 2H enrichments were 
adequate for FSR calculations. No differences in FSR (% · h-1) were observed between 
the PRO and CON groups, or between the Ex and NoEx legs (Fig. 21, page 104) in 
mixed muscle when assessed 16 h following the resistance exercise session (measured 
over 24 h). To determine whether there were differences in specific proteins being 
synthesized due to the length of FSR assessment, we examined the myofibrillar fraction 
in a subset of the muscle samples (insufficient amount of tissue to compare the main 
effect of protein) and observed a 20% increase in FSR in the Ex leg vs. the NoEx leg (P 
< 0.05), (Fig. 22, page 105). Thus, assessment of the myofibrillar fraction may be a 
preferred indicator of an anabolic response resulting from exercise in skeletal muscle. 
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Table 6.  2H-labeling of body water and skeletal muscle proteins 
 
  
                    Plasma (MPE)            Mixed SM (MPE) 
Subject             Pre          7.5 h          9.5 h          24 h               Ex Leg               NoEx Leg        
1  0     0.264         0.392         0.374     0.183        0.304 
2            -0.025     0.203         0.321         0.369               0.184        0.231 
3  0.030     0.188         0.303         0.386      0.235        0.169 
4            -0.009     0.198         0.341         0.368     0.152        0.153 
5  0.038     0.178         0.322         0.370     0.152        0.166 
6  0.026     0.212         0.310         0.362     0.177        0.316  
7            -0.007       0.199         0.318         0.376     0.259        0.178 
8            -0.015     0.145         0.229         0.340     0.085        0.244 
9  0.034     0.317         0.343         0.425     0.192        0.203 
10  0.056     0.233         0.306         0.356     0.179        0.178 
11  0.007     0.236         0.475         0.439     0.289        0.103  
12  0.023     0.151         0.231         0.341     0.254        0.298 
 
Mean  0.013     0.210*       0.324*        0.376*     0.195        0.212 
SEM                0.007       0.014        0.019          0.009               0.016                  0.019  
Plasma 2H labeling measured prior to the start of the study (0h), 1h post-exercise 
(+7.5h), 3h post-exercise (9.5h) and 16h post-exercise (+24h) in the plasma and 2H 
labeling of protein-bound alanine measured 16h post-exercise (+24h) in the exercised leg 
(Ex) and non-exercised leg (NoEx). MPE, mole percent excess. *Plasma 2H labeling was 
significantly higher at 7.5, 9.5 and 24 h than pre (time 0) values, P < 0.001.  
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Fig. 21. Mixed muscle protein fractional synthesis rates (FSR) assessed over 24 h in the 
carbohydrate non-exercised leg (CON NoEx, n = 6), carbohydrate trained leg (CON Ex, 
n = 6), immediate post-exercise protein non-exercised leg (PRO NoEx, n = 6) and 
immediate post-exercise protein exercised leg (PRO Ex, n = 6) groups. Data are 
presented as means ± SE.  
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Fig. 22. Myofibrillar protein fractional synthesis rates (FSR) assessed over 24 h in the 
non-exercised leg (NoEx, n = 8) and the exercised leg (Ex, n = 4). Data are presented as 
means ± SE. *P < 0.05.  
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Discussion 
To our knowledge, this is the first study to examine human skeletal muscle 
protein synthesis over 24 h to include feeding, resistance exercise, post-resistance 
exercise protein supplementation, hormonal stimulation/inhibition (biological patterns) 
and sleep; providing a cumulative assessment. Contrary to our hypotheses, we did not 
observe an exercise effect in stimulating mixed muscle FSR, nor did we find an 
augmentation in synthesis rates with the provision of a protein (0.3 g · kg body mass-1) 
containing beverage immediately following a bout of high intensity resistance exercise 
when total energy and macronutrients were controlled over a 24 h time frame in 20-24 
year old males. However, we did observe an exercise effect on myofibrillar protein FSR. 
We explain our findings by i) the potential for there being differences in protein pool 
turnover rates and ii) the dietary control over the experimental protocol, such that the 
timing may not be as critical as believed when sufficient energy and protein are provided 
throughout the day. 
The fact that we observed an exercise effect in the myofibrillar fraction (Fig. 22, 
page 105) but not in the mixed muscle (Fig. 21, page 104) is intriguing. Skeletal muscle 
is a mixture of proteins with very different renewal rates (131). However, mixed muscle 
protein has traditionally been measured to determine FSR as it represents an average of 
all muscle proteins. Myofibrillar protein (primarily actin and myosin filaments) 
constitutes the majority of the total muscle protein pool, > 70% (105), thus any changes 
in this fraction should (in theory) be observed with mixed muscle measurement. There 
are a limited number of human investigations that examine the synthesis of specific 
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fractions of muscle protein (myofibrillar, mitochondrial and sarcoplasmic). Studies by 
Cuthbertson et al. (37) and Miller (94) examined myofibrillar and sarcoplasmic FSR at 
3, 24 and 6 and 72 h, respectively, following an acute bout of resistance exercise 
(unilateral-leg kicking in the former and dynamic shortening or lengthening in the latter). 
They reported similar changes in both fractions; however, Miller (94) observed 
elevations in myofibrillar FSR at 72 h, but not sarcoplasmic. More recently, Wilkinson 
et al. (140) reported differences in mitochondrial and myofibrillar FSR following 
endurance and resistance exercise training (unilateral leg protocol). Although these 
studies (37, 94, 140) support the notion that different proteins within a heterogeneous 
pool turnover at dissimilar rates, it is not obvious as to why changes in the largest 
fraction (myofibrillar) were not apparent in the mixed muscle. Furthermore, had we not 
examined the myofibrillar fraction, we would have concluded that an acute bout of high 
intensity resistance exercise does not stimulate FSR when cumulative assessments are 
made. 
Our assessment of muscle protein synthesis was made over 24 h to include 
feeding, normal activities of daily living, an acute bout of dynamic high intensity 
resistance exercise, controlled feeding with adequate energy and macronutrients to 
support anabolism in this population, and sleep. We feel that our experimental design 
made it possible to observe increases in myofibrillar FSR with no changes in the total 
protein pool (Fig. 23, page 108). We provided 4 boluses of 2H2O with the first being at 
0800, thus 2H-labeled alanine would start to accumulate and be accelerated with the 
meals supplemented prior to the exercise protocol on both the Ex and NoEx legs. Upon 
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completion of the high intensity acute bout of unilateral-leg resistance exercise, there 
was possibly a decrease in the rate of 2H-labeled alanine incorporation due to the 
intensity (85% of 1RM until exhaustion, not fixed number of repetitions typically used) 
in the Ex leg compared to a constant rate in the NoEx leg. However, in the hours 
following with the provision of nutrients (protein) and rest, the rate of the 2H labeling of 
alanine in tissue was accelerated with the total accumulation of 2H-labeled alanine in the 
mixed muscle being similar over the 24 h time frame. Furthermore, the accelerated rate 
of 2H labeling of alanine in the myofibrillar fraction of the Ex leg, compared to similar 
changes in all fractions in the NoEx leg could explain the discrepancy between the 
mixed and myofibrillar protein fractions. Thus, our findings support the concept that 
resistance exercise increases FSR, however, when a cumulative assessment is made, the 
observed changes are within the fraction of muscle protein that is responsible for 
hypertrophy that occurs over time; myofibrillar protein. 
 
Fig. 23. Proposed scheme of measuring protein synthesis in a heterogeneous   
pool (mixed muscle). The consequences of assessing a mixed pool are that specific 
proteins with variable masses can have different synthesis rates. For example, if protein 
1 synthesizes 10% (1/10) of its structure and protein 2 makes 20% (4/20) over the same 
period of time, the percentage of newly made protein (17%, 5/30) does not reflect the 
average of each (15%, 30/2). Thus, mixed muscle assessment may not always be 
reflective of individual proteins (e.g. myofibrillar).  
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The fact that we did not find an effect of immediate post-exercise protein 
supplementation on mixed muscle FSR is not a novel finding, however, the context in 
which measurements were made is unique. More descriptively, many observe an 
augmentation in FSR with the consumption of protein and/or indispensible amino acids 
with or without carbohydrate following an acute bout of resistance exercise (15, 16, 37, 
40, 80, 82, 114, 127). However, in order to draw conclusions as to whether the timing 
following the early hours following resistance exercise is truly paramount, than a 
comparison to a different time point of ingestion should be included in the experimental 
design. In support of this, Rasmussen et al. (114) compared the provision of an essential 
amino acid-carbohydrate supplement either 1 h or 3 h following an acute bout of 
resistance exercise and reported elevations in FSR at both time points that were 
dependent upon the time of ingestion of the nutrients. Therefore, as a result of providing 
the protein immediately following (PRO) or 3 h after (CON) exercise, the timing was 
insignificant. Additionally, in this study, the participants started the acute bout of 
exercise ~ 1.75 h after the last meal and, therefore, consumed 4,017 kJ, 43 g protein (0.5 
± 0.02 g ·kg-1), 123 g carbohydrate and 34 g of lipid. This provided ~ 34% of energy, 
63% of protein, 35% of carbohydrate and 33% of lipid daily requirements for a 
moderately active 20-24 year old male (73). Thus, it would appear that subjects were, at 
least, in protein balance (although we did not directly measure this) prior to exercising 
and any additional protein could potentiate the protein synthetic response. In support of 
this, the PRO group displayed elevations in branched chain amino acids (BCAAs) up to 
3 h (Fig. 20, page 101) following the exercise session. Although it is believed that 
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indispensible amino acids, primarily leucine, promote anabolic signaling and muscle 
protein synthesis (26, 40, 127, 144), we chose to provide mixed beverages (protein was 
in the form of milk isolate) as people consume mixed meals, not just amino acid 
solutions. In addition, insulin also increased 1 h following exercise (Table 5, page 99), 
but the elevations were no different between groups (P < 0.09). Although the 
biochemical conditions appeared superior for the PRO group, at 24 h (16 h following 
resistance exercise) the BCAAs and insulin returned to pre-study values, the point at 
which muscle biopsies were extracted for measurement. It is possible that if we had 
measured FSR over the immediate time following exercise (up to 3 h) only, we would 
have observed elevations in the PRO group over the CON group. In contrast, had our 
measurements been made from 3-6 h post-exercise, we may have observed increases in 
the CON group over the PRO group; however, we wanted to examine „cumulative’ 
muscle protein synthesis to encompass perturbations (sleep, exercise, activities of daily 
living and rest) that occur daily in humans. Based on our observations, controlling the 
composition of diet over an extended period of time, negates the timing effect that post-
resistance exercise protein consumption has on augmenting muscle protein synthesis. 
However, we acknowledge that a limitation of this study was the inability to measure the 
main effect of the timing of protein on myofibrillar FSR, and thus an interaction 
(insufficient sample size). Therefore, we cannot discount the possibility that immediate 
post-exercise protein consumption was the reasoning for our observed increases in the 
Ex groups myofibrillar protein synthesis. Thus, more work in this area focusing on 
specific protein pools and proteins should be conducted.  
         
111 
Another finding that deserves mentioning is the calculated FSR values (% ·  h-1), 
which were ~ 5-10 fold higher than what is typically reported with feeding/exercise 
human investigations (~ 0.08 - 0.16%). We explain our results by our methodological 
approach for assessing muscle FSR and the limitations associated with tracer amino 
acids. First, 2H2O allows for long-term FSR assessment; however, our value does not 
make any description of protein degradation, thus although we are reporting an FSR of ~ 
0.8% · h-1, it is possible that breakdown occurred at a comparable rate. Second, in 
regards to tracer amino acid protocols, measurements are generally made (at least begin) 
in the post-absorptive state (following an overnight fast) with primed-continuous 
infusion protocols to insure that basal precursor and tissue enrichments are accurately 
determined. One concern with such designs becomes what physiological state is actually 
being examined as humans typically ingest nutrients upon awakening, which alters the 
hormonal state from catabolic to anabolic. If food is provided during the protocol, 
additional tracer should be added to insure that appropriate enrichment of the precursor 
is maintained to avoid a dilution effect. Another concern is the precursor pool that is 
used to calculate FSR. Due to the difficulty in obtaining the true precursor (aminoacyl-
tRNA), surrogates such as the intracellular (e.g. [2H]phenylalanine) or plasma (e.g. 
[13C]leucine, plasma α-KIC) are generally used. The concern with using plasma 
sampling is the site of collection relative to the tissue that is being collected, such that 
even if a femoral vein is used, consideration must be given to the influence of other 
muscle fibers and skin in the region. The use of 2H2O bypasses these limitations in that 
2H labeling of alanine occurs intracellularly via transamination reactions (30, 98) versus 
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the requirement of transmembrane transport with tracer amino acids. In addition to our 
methodological approach and short-comings of labeled amino acid study designs, one 
must consider that a calculated FSR is a „percentage‟ of the existing protein pool 
(assumed to be constant) synthesized over a period of time (146), however, does not 
describe changes in the absolute pool size (protein concentration). Thus, FSR  
comparisons between studies should be viewed „qualitatively‟. 
In conclusion, we report that an acute bout of high intensity resistance exercise  
stimulates cumulative myofibrillar protein synthesis in spite of detecting no change in 
mixed muscle. Additionally, the provision of protein immediately following high 
intensity resistance exercise does not appear to be advantageous than providing it 3 h 
later when energy and macronutrients are controlled. Future studies in the area of 
nutrition/exercise should focus more on specific protein fractions versus mixed muscle 
alone. Additionally, more long-term measurements of muscle protein synthesis are 
needed to fully comprehend real-time protein renewal; which can be accomplished with 
the use of 2H2O with relative ease.  
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CHAPTER VI 
CONCLUSIONS 
 
 These experiments were carried out to determine the effects of acute (rats and 
humans) and chronic resistance exercise (rats) on cumulative muscle protein synthesis. 
In order to conduct these studies, a validation study comparing 2H2O with the flooding 
dose was carried out. Five novel findings resulted from this reported research. First, 
2H2O provides qualitatively similar muscle protein synthesis results as the flooding dose 
when studying perturbations, such as exercise and feeding. Secondly, a single bout of 
resistance exercise does not appear to stimulate muscle protein synthesis in rats as it 
does in humans. This may either be due to the intensity or the necessity for subsequent 
sessions to promote skeletal muscle adaptation. Thirdly, chronic resistance exercise 
continues to be anabolic; however, the time by which this can be observed changes. 
Fourthly, immediate post-resistance exercise protein consumption does not augment 
human mixed muscle protein synthesis when a cumulative assessment (over 24 h) is 
made. Fifthly, an acute bout of resistance exercise stimulates human cumulative 
myofibrillar muscle protein synthesis. The fact that mixed muscle was apparently not 
increased further supports the notion that proteins within a heterogeneous pool undergo 
different turnover rates. Thus, measurement of specific proteins vs. the total pool may be 
more descriptive of what is actually occurring within a tissue of interest. 
 It was my (as well as my mentors and colleagues) intention to advance our  
understanding of the stimulatory effect of resistance exercise on skeletal muscle protein  
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anabolism. More specifically, we report that acute resistance exercise may not be 
anabolic in rats, there is a temporal shift in the timing of muscle protein synthesis 
following resistance exercise training in rats, immediate post-resistance exercise protein 
consumption does not augment human mixed muscle protein synthesis and there can be 
differences in specific proteins within the total pool (myofibrillar vs. mixed muscle). 
Future studies should be carried out to assess changes in cumulative muscle protein 
synthesis in specific disease states, such as debilitating and metabolic pathologies. 
Additionally, more emphasis should be placed on the assessment of specific proteins vs. 
a mixed sample. The data from this research could potentially serve as the foundation by 
which future comparisons in the area of muscle protein anabolism are made. 
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APPENDIX A 
 
MUSCLE PROTEIN SYNTHESIS PROCESSING (ASSESSED WITH L-[2,3,4,5,6-
3H]PHENYLALANINE)  
 
I.  Plasma Specific Radioactivity (HPLC-used for “The Assessment of   
Muscle Protein Synthesis Following Chronic Resistance Exercise: A Plateau 
Effect?”). 
 
Required Items      Catalog Number 
1.5 ml microcentrifuge tubes     Fisher, 02-681-284 
2.0 ml microcentrifuge tubes     Fisher, 02-681-291 
0.45 µm pore size membrane filter    Fisher, R04SP04700 
0.22 µm pore size membrane filter    Fisher, R02SP01300  
Amino acids: 
 L-Aspartic acid (C4H7NO4)    Sigma, A4534 
 L-Asparagine (C4H8N2O3)    Sigma, A8824 
 Taurine (C2H7NO3S)     Sigma, T0625 
 L-Phenylalanine (C9H11NO2)    Sigma, P8324 
 L-Ornithine (C5H12N2O2)    Sigma, O2375 
Borate (Na2B4O7)      Sigma, B9876 
Brij-35 (C2H4O)nC12H26O     Sigma, B4184 
Ethanolamine (NH2(CH2)2OH)    Sigma, E0135 
Hydrochloric acid (12N HCl)     EMD, HX0603-3 
Methanol (CH3OH-HPLC grade)    Fisher, MXO 475-1 
2-Mercaptoethanol (C2H6OS)     Sigma, 3148 
Perchloric acid (HClO4)     J.T. Baker, 9652-02  
Phthaldialdehyde (C8H6O2)     Sigma, P0657 
Potassium carbonate (K2CO3)    Sigma, P5833 
Shell vials for Waters autosampler    Fisher, 03-391-23 
Sodium acetate (C2H3O2Na)     Sigma, S7670  
Tetrahydrofuran (C4H8O)     Sigma, 34865 
Trichloroacetic acid (TCA-Cl3CCOOH)   EMD, TX1045-5 
Tuberculin slip tip (1ml)     BD, PK 100309602 
Water (H2O-HPLC grade)     Fisher, W5-4 
 
Procedure: 
 
A.  Plasma Phenylalanine Preparation: 
 
1. Centrifuge 1.0 ml of 2, 6 and 12 minute blood samples at 3,800 rpm at  
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2. 4ºC for 20 min.  
 
3. Extract plasma with 1.0 ml pipette and place into 1.5 ml microcentrifuge 
tubes, freeze at -80ºC. 
 
4. Weigh two 1.5 ml microcentrifuge tubes for each sample and  
record weights. Label tubes “A” and “B”, document. 
 
5. In tube A, place 0.25 ml plasma and 0.25 ml 10% TCA (Cl3CCOOH). 
 
6. Reweigh tube A, document weight. 
 
7. Centrifuge at 3,800 rpm at 4ºC for 5 min. 
 
8. Transfer supernatant with 1.0 ml pipette into tube B. 
 
9. Reweigh tubes A and B, record weights. 
 
10. Add 0.3 ml of 0.5 M Borate (Na2B4O7), which will yield a pH of 9.0 in 
each sample. 
 
11.  Reweigh tube B and record weights. 
 
12. Extract 0.05 ml of sample with 0.1 ml pipette and place into 1.5 ml 
microcentrifuge tubes. 
 
13. To 0.05 ml sample, add 0.45 ml HPLC grade H2O, cap and vortex. 
 
14. Remove 0.2 ml of sample, place into 1.5 ml microcentrifuge tubes and 
add 0.2 ml 1.5M perchloric acid (HClO4); cap and vortex. 
 
15. Add 0.1 ml 2.0 M potassium carbonate (K2CO3), cap and vortex. 
 
16. Centrifuge at 6,000 rpm at room temperature for 12 min. 
 
17. Remove 0.2 ml of supernatant and place in 2.0 ml microcentrifuge tubes. 
Add 1800 ml HPLC grade H2O, cap and vortex. 
 
18. Extract 1.0 ml of sample with tuberculin slip tip syringe and filter 1.0 ml 
of sample through a 0.22 µm membrane filter into 1.0 ml HPLC vials and 
place into refrigerator without caps overnight.  
 
19. Inject 1:1 (0.1 ml) of sample and OPA into Waters HPLC (phenylalanine 
elutes at 40 min). 
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B. High Performance Liquid Chromatography (HPLC): 
1. System:   
a.  HPLC Waters solvent delivery system (2 Waters 501 pumps, a 717 
Waters Autosampler, and Automated Gradient Controller [curve 6 
chosen] Waters 470 Scanning Fluorescence Detector [attenuation 350 
nm, gain 450 m]). 
 
b.  Column, Suelcosil  LC-18 (58985) 15 cm x 4.6 mm, 3 micron      
     beads. 
 
2. Gradient Solvent (A): 
a. Add 0.8 L of HPLC grade H2O into 1.0 L flask. 
b. Add 13.65 g sodium acetate (C2H3O2Na), 0.048 ml 6N HCl, 5.0 ml 
tetrahydrofuran (C4H8O) and 0.09 ml methanol (CH3OH-HPLC 
grade).  
c. Filter through 0.45 µm membrane filter into 1.0 L flask with side arm 
and q.s. to 1.0 L. 
3. Solvent B: 
a.  Filter 1.0 L methanol (CH3OH-HPLC grade) through 0.45 µm   
     membrane filter.  
 
4. Phthaldialdehyde (C8H6O2) (OPA) Reagent: 
a.  Add 0.05 g OPA to sterile 20.0 ml amber bottle. 
 
b.  Add 1.25 ml methanol (CH3OH-HPLC grade), 11.20 ml sodium    
     borate buffer, 0.05 ml 2-Mercaptoethanol (C2H6OS) and 0.4 ml   
     Brij-35 (C2H4O)nC12H26O, cap and store in the refrigerator.  
 
i. Sodium borate buffer: 
1.  Mix 15.22 g Borate (Na2B4O7) in 1.0 L HPLC   
     grade H2O; pH 9.2.   
 
5. HPLC Settings and Flow Rate: Linear gradient (1500 psi). 
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Time (min)         Flow (ml/min)             % Solvent A             %Solvent B          Curve 
         0    1.1           86            14               6 
       20    1.1          86            14               6 
       24    1.1           70            30               6 
       26   1.1           65            35               6 
       28    1.1           53            47               6 
       34    1.1           50            50               6 
       38    1.1           30            70               6 
       40    1.1                0   100               6 
       42    1.1                0   100               6 
48.1  1.1               86            14               6 
       48.5  1.1               86            14               6  
 
 
C.  Linear Standard Curve Preparation: 
 
1.  Stock Solution (250 nmol/ml): 
 
a.  To 0.6 ml of HPLC grade H2O, add the following: 
 
M.W. x M x Vol (L) 
 
L-Aspartic acid (C4H7NO4), M.W. = 133.10 (0.0020 g)   
L-Asparagine (C4H8N2O3), M.W. = 132.12 (0.0020 g)  
Taurine (C2H7NO3S), M.W. = 125.15 (0.0019 g)   
L-Phenylalanine (C9H11NO2), M.W. = 165.19 (0.0024 g)  
L-Ornithine (C5H12N2O2), M.W. = 168.62 (0.0025 g) 
b.  Add 0.6 ml ethanolamine (NH2(CH2)2OH) and 4.8 ml HPLC   
     grade H2O to the above; total volume 6.0 ml. 
 
nmol/ml ml of stock solution  ml HPLC H2O  total ml ratio 
 250.00  1.0            0         1.0   1:0 
 125.00  0.5            0.5     1.0   1:1 
   62.50  0.5            1.5     2.0   1:3 
   41.68  0.2            1.0     1.2   1:5 
   35.71  0.1667                     1.0                         1.1667           1:6 
   22.73  0.1            1.0     1.1   1:10 
   15.63  0.1            1.5     1.6   1:15 
   11.91  0.1            2.0     2.1   1:20 
     9.62  0.05            1.25     1.3   1:25 
     4.90  0.039            1.96     1.99   1:50
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c. Add 0.05 ml of each standard to 1.5 ml microcentrifuge tubes  
and add 0.45 ml HPLC grade H2O, cap and vortex. 
 
d. Remove 0.2 ml of sample, place into 1.5 ml microcentrifuge tubes 
and add 0.2 ml 1.5M perchloric acid (HClO4); cap and vortex. 
 
e. Add 0.1 ml 2.0M potassium carbonate (K2CO3), cap and vortex. 
 
f. Centrifuge at 6,000 rpm at room temperature for 12 min. 
 
g. Remove 0.2 ml of supernatant and place in 2.0 ml microcentrifuge 
tubes. Add 1800 ml HPLC grade H2O, cap and vortex. 
 
h. Extract 1.0 ml of sample with tuberculin slip tip syringe and filter 1.0 
ml of sample through a 0.22 µm membrane filter into 1.0 ml HPLC 
vials and place into refrigerator without caps overnight.  
 
i. Inject 1:1 (0.1 ml) sample and (0.1 ml) OPA into Waters HPLC 
(phenylalanine elutes at 40 min). 
 
 
II.  Plasma Phenylalanine (GC-MS used for “A Comparison of 2H2O and  
Phenylalanine Flooding Dose Methodologies to Investigate Muscle Protein 
Synthesis in Rats”). 
 
Required Items      Catalog Number 
1.5 ml microcentrifuge tubes     Fisher, 02-681-284 
2.0 ml microcentrifuge tubes     Fisher, 02-681-291 
Acetonitrile (CH3CN)      Fisher, A998-4 
GC-MS glass vials      Agilent, 5182-0714 
GC-MS vial inserts      Agilent, 5183-2085 
GC-MS vial screw top caps     Agilent, 5185-5820 
L-Phenylalanine (C9H11NO2)     Sigma, P2126 
L-[ring-13C6]phenylalanine (F-C313C6H11NO2)  Cambridge Isotopes, CLM-
1055 
MTBSTFA + 1% TBDMCS     Pierce, 48927 
Trichloroacetic acid (TCA-Cl3CCOOH)   EMD, TX1045-5 
Water (H2O-HPLC grade)     Fisher, W5-4 
 
Procedure: 
  
A. Plasma Phenylalanine Preparation: 
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1.  Centrifuge 1.0 ml of 2, 6 and 12 minute blood samples at 3,800 rpm at 4ºC 
for 20 min. 
 
2.  Extract plasma with 1.0 ml pipette and place into 1.5 ml microcentrifuge 
tubes, freeze at -80ºC. 
 
3.  Extract 0.3 ml of sample with 1.0 ml pipette and place into 1.5 ml  
microcentrifuge tubes. 
 
4.  Add 0.3 ml of 10% TCA (Cl3CCOOH) and 0.3 ml of 0.03 nmol/ml L-
[ring-13C6]phenylalanine (F-C313C6H11NO2) to each sample, cap and 
vortex. 
 
5.  Centrifuge at 3,000 rpm at 4ºC for 15 min. 
 
6.  Remove 0.05 ml of the supernatant with 0.1 ml pipette and add to 1.5 ml 
microcentrifuge tubes; leave tops open. 
 
7.  Dry under stream of N2 for 1h. 
 
8.  Add 0.05 ml of acetonitrile (CH3CN) and 0.05 ml of MTBSTFA + 1% 
TBDMCS (1:1, vol/vol); cap and vortex. 
 
9.  Allow to sit at room temperature for 20 min (capped), vortex and add 0.1 
ml of solution to the GC-MS vial inserts (in GC-MS vials) and cap. 
 
10. Inject sample into GC-MS at 1 µl/min; selective ion monitoring  
(m/z) 234 and 240. 
 
B.  Gas Chromatography Mass Spectrometry (GC-MS): 
 
 1.  System: 
 
  a.  Agilent 5975C-MSD equipped with an Agilent 7890 GC system. 
 
  b.  Column, HP-5ms capillary column (30 m × 0.25 mm × 0.25  
      µm). 
 
        2.  Settings: 
 
a. The following temperature program was used: 160ºC initial and hold 
for 5 min, increase by 15°C/min to 270ºC and hold for 8 min. The 
sample was injected at a spit ratio of 40:1 with a helium flow of 30 
mL/min. The mass spectrometer was operated in electron impact  
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  mode (70eV).  
 
b. Selective ion monitoring of mass-to-charge ratios (m/z) 234 (M) and  
240 (M + 6) was conducted using a dwell time of 30 ms per ion. 
Phenylalanine eluted at ~ 12 min. 
 
C.  Linear Standard Curve Preparation: 
 
 1.  Stock Solution of Phenylalanine (F) (10 µmol/ml): 
 
a. To 100 ml of HPLC grade H2O, add the following: 
 
M.W. x M x Vol (L) 
 
L-Phenylalanine (C9H11NO2), M.W. = 165.19 (0.165 g) 
 
      2.  Stock Solution of L-[ring-13C6]phenylalanine (0.06 µmol/ml): 
 
a. To 100 ml of HPLC grade H2O, add the following: 
     
L-[ring-13C6]phenylalanine (F-C313C6H11NO2), M.W. = 171.15 (0.0103 g) 
 
      3.  Preparation and Measurement: 
µmol/ml ml of stock F  ml HPLC H2O  total ml ratio 
   10.0                1.0           0      1.0   1:0 
       7.5                    0.750            0.250      1.0   3:1 
       5.0                0.500            0.500      1.0   1:1 
       2.5                0.250            0.750      1.0   1:3 
       1.225        0.1225            0.8775      1.0   1:7 
       0.625        0.0625            0.9375      1.0   1:15 
0.313                0.0313            0.9687      1.0   1:30 
0                  0             1.0      1.0   0:1 
 
a.   Add 0.3 ml of each standard (above), 0.3 ml of 10% TCA 
(Cl3CCOOH) and 0.3 ml of 0.06 µmol/ml L-[ring-13C6]phenylalanine 
(F-C313C6H11NO2) to 1.5 ml microcentrifuge   tubes, cap and vortex. 
 
b. Remove 0.05 ml of the standard with 0.1 ml pipette and add to      
 1.5 ml microcentrifuge tubes; leave tops open. 
 
c. Dry under stream of N2 for 1h. 
 
d. Add 0.05 ml of acetonitrile (CH3CN) and 0.05 ml of MTBSTFA +  
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1% TBDMCS (1:1, vol/vol); cap and vortex. 
 
e. Allow to sit at room temperature for 20 min (capped), vortex  
and add 0.1 ml of solution to the GC-MS vial inserts (in GC-MS 
vials) and cap. 
 
f. Inject sample into GC-MS at 1 µl/min; selective ion monitoring (m/z) 
234 and 240. 
 
 
III.  Plasma L-[2,3,4,5,6-
3
H]Phenylalanine Preparation: 
 
Required Items      Catalog Number 
1.5 ml microcentrifuge tubes     Fisher, 02-681-284 
6.0 ml scintillation vials     Fisher, 592928 
Complete counting cocktail  Research Products, Inc.,    
111167 
Trichloroacetic acid (TCA-Cl3CCOOH)   EMD, TX1045-5 
 
Procedure: 
 
1.  Centrifuge 1.0 ml of 2, 6 and 12 minute blood samples at 3,800 rpm at  
     4ºC for 20 min. 
 
2.  Extract plasma with 1.0 ml pipette and place into 1.5 ml  
     Microcentrifuge tubes, freeze at -80ºC. 
 
3.  Extract 0.3 ml of sample with 1.0 ml pipette and place into 1.5 ml  
     microcentrifuge tubes. 
 
4.  Add 0.3 ml of 10% TCA (Cl3CCOOH) to each sample, cap and vortex. 
 
5.  Centrifuge at 3,000 rpm at 4ºC for 15 min. 
 
6.  Remove 0.05 ml of the supernatant with 0.1 ml pipette and add to  
     6.0 ml scintillation vials. 
 
7.  Add 0.5 ml of ultrapure dH2O to each sample. 
 
8.  Add 5.0 ml of complete counting cocktail, cap and vortex. 
 
9.  Place in a scintillation counter (Beckman Coulter LS 6500 Multi-  
     Purpose Scintillation Counter) and allow to settle overnight. 
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10. Count 3H DPM (disintegrations per minute), each sample for 1h. Make  
      corrections for quench (subtract background from each sample). 
 
 
IV.  Tissue L-[2,3,4,5,6-
3
H]Phenylalanine and Total Phenylalanine: 
 
Required Items      Catalog Number 
1.5ml microcentrifuge tubes     Fisher, 02-681-284 
2.0ml microcentrifuge tubes     Fisher, 02-681-291 
2.0ml screwtop tubes      United Labs., UP 2031 
6.0ml scintillation vials     Fisher, 592928 
Acetone (CH3COCH3)     EMD, AX0120-8 
Bicinchoninic acid      Sigma, B9643 
Copper (II) sulfate      Sigma, C2284 
Culture test tubes (17x100mm)    Fisher, 14-956-1J 
GC-MS glass vials      Agilent, 5182-0714 
GC-MS vial inserts      Agilent, 5183-2085 
GC-MS vial screw top caps     Agilent, 5185-5820 
Hydrochloric acid (12N HCl)     EMD, 258148 
Kinase buffer (10X)      Cell Signaling, 9802 
L-Phenylalanine (C9H11NO2)     Sigma, P2126 
L-[ring-13C6]phenylalanine (F-C313C6H11NO2)  Cambridge Isotopes, CLM-
1055 
MTBSTFA + 1% TBDMCS     Pierce, 48927 
Protein Standards (BSA)     Sigma, P09M-5AMP 
Sodium hydroxide (NaOH)     Fisher, 5612-3 
Trichloroacetic acid (TCA-Cl3CCOOH)   EMD, TX1045-5 
Water (H2O-HPLC grade)     Fisher, W5-4 
 
Procedure: 
  
A. Tissue L-[2,3,4,5,6-3H]Phenylalanine:  
  Note: All steps must be done on ice. 
 
1. Weigh out between 0.1-0.2 g of powdered skeletal muscle in  
culture test tubes (17x100mm), record weights. 
 
2. Add 2.0 ml of 10% TCA (Cl3CCOOH), and homogenize using a 
polytron homogenizer at full speed. Take 0.025 ml of homogenate and 
place into 2.0 ml microcentrifuge tubes for BCA protein assay 
(refrigerate – do not freeze). Ideally, large orifice tips should be used  
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for transfer only on this step. 
a. The 0.025 mL aliquot should be diluted with Kinase buffer (1X), 
1:6 (i.e., add 0.125 ml of 1X Kinase buffer to vial and vortex). Note: 
May use Pilches buffer in place of 1X Kinase buffer. 
3. Centrifuge homogenate in super-speed at 3,750 rpm (using SM-24 
rotor) for 15 minutes at 4oC.   
4. Aspirate or carefully decant supernatant, and to the pellet add 2.0 ml 
10% TCA and vortex to resuspend. 
5. Centrifuge suspension in super-speed at 3,750 rpm (using SM-24 rotor) 
for 15 minutes at 4oC. 
6. Aspirate or carefully decant supernatant, and to the pellet add 2.0 ml 
10% TCA and vortex to resuspend. 
7. Centrifuge suspension in super-speed at 3750 rpm (using SM-24 rotor) 
for 15 minutes at 4oC. 
8. Aspirate or carefully decant supernatant, and to the pellet add 2.0 ml 
10% TCA and vortex to resuspend. 
9. Centrifuge suspension in super-speed at 3800 rpm (using SM-24 rotor) 
for 3 minutes at 4oC. 
10. Aspirate or carefully decant supernatant, and to the pellet add 2.0 ml 
ice-cold HPLC grade acetone (CH3Cl3) and vortex to resuspend. 
11. Centrifuge suspension in super-speed at 10,000 rpm (using SM-24 
rotor) for 5 minutes at 4oC. 
12. Aspirate or carefully decant supernatant, and to the pellet add 2.0 ml 
ice-cold water (ultrapure grade) and vortex to resuspend. 
13. Centrifuge suspension in super-speed at 10,000 rpm (using SM-24 
rotor) for 5 minutes at 4oC. 
14. Aspirate or carefully decant supernatant, and dissolve pellet in 2.0 ml of 
0.25 N NaOH. 
15. Incubate tubes (capped/sealed) at 60oC for 30 minutes or until protein is 
soluablized. Vortex often. If needed, use polytron homogenizer to 
break-up pellet. 
16. Remove 0.5 ml of protein solution and add to 6.0 ml scintillation vials 
containing 5.0 ml of complete counting cocktail and 0.5 ml ultrapure  
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water. Shake vigorously and allow settling overnight before counting. 
17. Take 0.025 ml of protein solution for post-assay protein analysis. Take 
remaining portion and place in 2.0 ml microcentrifuge tubes and freeze 
at -80oC. 
a.  Dilute protein solution with 0.075 ml (1:4) of 1X Kinase buffer   
     and run in triplicate (aliquot 0.010 ml per well). It is acceptable  
     to conduct both pre and post protein assays at the same time.  
     Must have standards on each plate. Label tubes numerically  
     with alphabetic designation “B” for post. 
 
b. Add 0.2 ml of BCA-Copper (II) sulfate (50:1, vol/vol) with repeat 
pipetter.  
c. Used a Beckman Coulter DTX 880 Multimode Detector 
(absorbance @ 595). 
B. Tissue Total Phenylalanine:  
1. Remove 1.0 ml of the NaOH protein solution (step 17 tissue L-[2,3,4,5,6-
3H]Phenylalanine preparation) and place in 2.0 ml microcentrifuge tubes. 
2. Add 1.0 ml of 6 N HCl to sample, cap and vortex. 
3. Place 1.0 ml of solution into 2.0 ml screwtop tubes. 
4. Add 0.1 ml of a 10 µmol/ml to sample (1 µmol/ml with 1.0 ml of 
sample). 
5. Incubate at 110ºC for 24h. 
6. Remove 0.05 ml of the sample with 0.1 ml pipette and add to 1.5 ml 
microcentrifuge tubes; leave tops open. 
 
7. Dry under stream of N2 for 1h. 
 
8. Add 0.05 ml of acetonitrile (CH3CN) and 0.05 ml of MTBSTFA + 1% 
TBDMCS (1:1, vol/vol); cap and vortex. 
 
9. Allow to sit at room temperature for 20 min (capped), vortex and add 0.1 
ml of solution to the GC-MS vial inserts (in GC-MS vials) and cap. 
 
10.  Inject sample into GC-MS at 1 µl/min; selective ion monitoring  
(m/z) 234 and 240. 
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C. Linear Standard Curve Preparation: 
 
 1.  Stock Solution of Phenylalanine (F) (10 µmol/ml): 
 
a. To 100 ml of HPLC grade H2O, add the following: 
 
M.W. x M x Vol (L) 
 
L-Phenylalanine (C9H11NO2), M.W. = 165.19 (0.165 g) 
 
       2.  Stock Solution of L-[ring-13C6]phenylalanine (10 µmol/ml): 
 
   a.   To 100 ml of HPLC grade H2O, add the following: 
     
 L-[ring-13C6]phenylalanine (F-C313C6H11NO2), M.W. = 171.15  
 (0.171 g) 
 
 3.  Preparation and Measurement: 
µmol/ml ml of stock F  ml HPLC H2O  total ml ratio 
   10.0                1.0           0           1.0   1:0 
       7.5                   0.750           0.250      1.0   3:1 
       5.0                0.500           0.500      1.0   1:1 
       2.5                0.250           0.750      1.0   1:3 
       1.225        0.1225           0.8775      1.0   1:7 
       0.625        0.0625           0.9375      1.0   1:15 
0.314                0.0313           0.9687      1.0   1:30 
0                  0            1.0      1.0   0:1 
 
a. Add 1.0 ml of each standard (above) and 1.0 ml of 6 N HCl. 
 
b. Take 1.0 ml of above sample and add 0.1 ml 10.0 µmol/ml L-[ring-
13C6]phenylalanine (F-C313C6H11NO2) to 1.5 ml microcentrifuge 
tubes, cap and vortex. 
 
c.  Remove 0.05 ml of each standard with 0.1 ml pipette and add to 1.5 ml 
microcentrifuge tubes; leave tops open. 
 
d.  Dry under stream of N2 for 1h. 
 
e.  Add 0.05 ml of acetonitrile (CH3CN) and 0.05 ml of MTBSTFA +  
 1% TBDMCS (1:1, vol/vol); cap and vortex. 
 
f.   Allow to sit at room temperature for 20 min (capped), vortex and  
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add 0.1 ml of solution to the GC-MS vial inserts (in GC-MS  
vials) and cap. 
 
g. Inject sample into GC-MS at 1 µl/min; selective ion monitoring (m/z) 
234 and 240 
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APPENDIX B 
MUSCLE PROTEIN SYNTHESIS PROCESSING (ASSESSED WITH 2H2O)  
 
I.  
2
H Labeling of Body Water. 
Required Items      Catalog Number 
1.5ml microcentrifuge tubes     Fisher, 02-681-284 
2.0ml microcentrifuge tubes     Fisher, 02-681-291 
2H2O     Cambridge Isotopes,  
DLM2259-1 
Acetone (CH3COCH3)     EMD, AX0120-8 
Acetonitrile (CH3CN)      Fisher, A998-4 
GC-MS glass vials      Agilent, 5182-0714 
GC-MS vial inserts      Agilent, 5183-2085 
GC-MS vial screw top caps     Agilent, 5185-5820 
Chloroform (CH3Cl3)      Fisher, C298 
Sodium hydroxide (NaOH)     Fisher, 5612-3 
Sodium Sulfate (Na2SO4)     Fisher, S414 
Trichloroacetic acid (TCA-Cl3CCOOH)   EMD, TX1045-5 
 
Procedure: 
 
A.  Preparation of Plasma Samples: 
 
1.  Centrifuge 1 ml of 2, 6 and 12 minute blood samples at 3,800 rpm at 4ºC 
for 20 min. 
 
2.  Extract plasma with 1.0 ml pipette and place into 1.5 ml microcentrifuge 
tubes, freeze at -80ºC. 
 
3.  Place 0.02 ml of plasma into 2.0 ml microcentrifuge tubes. 
 
4.  Add 2.0 µl of 10N NaOH to samples. 
 
5.  Add 4.0 µl of a 5% (vol/vol) acetone (CH3Cl3) in acetonitrile (CH3CN), 
cap and allow settling for a minimum of 24 h. 
 
6.  Add ~0.5 g sodium sulfate (Na2SO4) to samples. 
 
7.  Add 0.6 ml of chloroform (CH3Cl3) to each sample, cap and vortex 
vigorously. 
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8.  Inject sample into GC-MS at 1 µl/min; selective ion monitoring (m/z) 58 
and 59. 
 
B.  Gas Chromatography Mass Spectrometry (GC-MS): 
 
 1.  System: 
 
  a.  Agilent 5975C-MSD equipped with an Agilent 7890 GC system. 
 
b.  Column, HP-5ms capillary column (30 m × 0.25 mm × 0.25   
     µm). 
 
        2.  Settings: 
 
 a. The following temperature program was used: 60ºC initial,   
     increase by 20°C/min to 100ºC, increase by 50ºC/min to 220ºC,  
     and hold for 1 min. The sample was injected at a spit ratio of  
     40:1 with a helium flow of 1 mL/min. The mass spectrometer  
     was operated in electron impact mode (70eV).  
 
b. Selective ion monitoring of mass-to-charge ratios (m/z) 58 (M) and 59 
(M + 1) was conducted using a dwell time of 10 ms per ion. 2H 
acetone elutes at ~ 1.7 min. 
 
C. Linear Standard Curve Preparation 
1.  Stock Solution of 2H2O: 
 
a. 5% 2H2O (5.0 ml + 95 ml of ultrapure dH2O) 
 
     % labeled      ml of stock     ml of ultrapure dH2O      total ml 
5.0            1.0       0           1.0 
2.5            0.5       0.5           1.0 
1.25            0.25       0.75                   1.0 
1.0            0.20       0.8           1.0 
0.5            0.10       0.9           1.0 
0.25            0.05       0.95                      1.0 
0.125            0.025       0.975          1.0 
0            0                  1.0           1.0
     
b.  Place 0.02 ml of each standard into 2.0 ml microcentrifuge   
     tubes. 
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c.  Add 2.0 µl of 10N NaOH to samples. 
 
    d.  Add 4.0 µl of a 5% (vol/vol) acetone (CH3Cl3) in acetonitrile    
 (CH3CN), cap and allow settling for a minimum of 24 h. 
 
e.  Add ~0.5 g sodium sulfate (Na2SO4) to samples. 
 
f. Add 0.6 ml of chloroform (CH3Cl3) to each sample, cap and   
vortex vigorously. 
 
g. Inject sample into GC-MS at 1 µl/min; selective ion monitoring  
(m/z) 58  and 59. 
 
 
II.  
2
H Labeling of Protein-Bound Alanine. 
 
Required Items      Catalog Number 
2.0ml microcentrifuge tubes     Fisher, 02-681-291 
2.0ml screwtop tubes      United Labs., UP 2031 
Acetonitrile (CH3CN)      Fisher, A998-4 
ATP (C10H6N5O13P3)      Sigma, A9187 
GC-MS glass vials      Agilent, 5182-0714 
GC-MS vial inserts      Agilent, 5183-2085 
GC-MS vial screw top caps     Agilent, 5185-5820 
Hydrochloric acid (12N HCl)     EMD, 258148 
Kinase buffer (10X)      Cell Signaling, 9802 
L-Alanine (C3H7NO2)      Sigma, A7627 
L-Aalanine-2-d (CH3CD(NH2)CO2H)   Isotec, 485861 
Methanol (CH3OH-HPLC grade)    Fisher, MXO 475-1 
Methyl-8 reagent      Pierce, 49350 
Triton  X-100 (t-Oct-C6H4-(OCH2CH2)xOH, x= 9-10) Sigma, T8532 
Trichloroacetic acid (TCA-Cl3CCOOH)   EMD, TX1045-5 
 
Procedure: 
 
A. Preparation of Muscle Samples: 
 
1.  Weight out ~ 0.03 g of muscle (0.06 g if assessing myofibrillar fraction as 
it makes up 50% of the mixed muscle homogenate). 
 
2.  Place into 2.0 ml microcentrifuge tubes and add 0.03 ml of 10% TCA 
(Cl3CCOOH) on ice. 
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a. If want to separate myofibrillar from mixed muscle, place ~0.06 g of 
mixed muscle into a 10:1, vol:wt ratio of Kinase buffer (1X) with 200 
µM ATP (C10H6N5O13P3) and 0.01% Triton; keep on ice. 
 
b. Homogenize using a polytron homogenizer at full speed and allow 
settling on ice for a minimum of 1 h. 
 
c. Centrifuge at 14,000 rpm for 30 min at 4ºC. Decant supernatant and 
add 0.3 ml of 10% TCA on ice. The remainder of the steps are the 
same as the mixed muscle homogenate. 
 
 3.  Homogenize using a polytron at full speed, centrifuge at 3,800 rpm, 
decant supernatant and add 0.3 ml of 10%TCA on ice. 
 
 4.  Repeat step 3 three additional times. 
 
6. Add 0.3 ml of 6 N HCl, vortex and place into 2.0 ml screwtop tubes. 
 
7. Incubate at 100ºC for 24 h. 
 
8. Take 0.1 ml of hydrolysate and place into GC-MS glass vials and dry 
under a low stream of N2 (can place in heating block at heat at 100ºC with 
top off for 1 h). Freeze the remainder of the hydrolysate. 
 
9. Add a 3:2:1 solution of Methyl-8, methanol (CH3OH) and acetonitrile 
(CH3CN); cap and vortex vigorously. 
 
10. Place sample into GC-MS vial inserts and place into the GC-MS glass 
vials and cap. 
 
11. Inject sample into GC-MS at 1 µl/min; selective ion monitoring (m/z) 99 
and 100. 
 
12. NOTE: You may need to dilute you samples by 5, 10 or even 20. 
 
B. Gas Chromatography Mass Spectrometry (GC-MS): 
 
1.  System: 
 
 a.  Agilent 5973N-MSD equipped with an Agilent 6890 GC system. 
 
b. DB17-MS capillary column (30 m × 0.25 mm × 0.25 µm). 
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       2.  Settings: 
 
a.  The following temperature program was used: 90ºC initial, hold  
     for 5 min, increase by 5°C/min to 130ºC, increase by 40ºC/min   
     to 240ºC, and hold for 5 min. The sample was injected at a spit  
     ratio of 20:1 (5:1 for human tissue) with a helium flow of    
     1 ml/min. The mass spectrometer was operated in electron   
     impact mode (70eV).  
 
c. Selective ion monitoring of mass-to-charge ratios (m/z) 99 (M) and 
100 (M + 1) was conducted using a dwell time of 10 ms per ion. 2H 
alanine elutes at ~ 12 min (9 min on our system). 
 
C. Linear Standard Curve Preparation 
1.  Stock Solution of L-alanine (C3H7NO2):  
 
a.  Place 10 mg L-alanine into 1.0 ml of ultrapure dH2O (Solution  
     A). 
 
2.  Stock Solution of L-alanine-2-d (CH3CD(NH2)CO2H): 
 
a.  Place 1 mg of L-alanine-2-d into 1.0 ml of ultrapure dH2O   
     (Solution B). 
 
% labeled      Sol A (ml)      Sol B (ml)   H2O (ml)       total (ml) 
     2.0            1.0          0.2       0.8              2.0 
     1.0            1.0          0.1           0.9              2.0 
     0.75           1.0          0.075       0.925     2.0 
     0.5            1.0          0.050       0.950      2.0 
0.25                      1.0          0.025       0.975      2.0 
0            1.0          0        1.0       2.0 
 
b.   Take 0.1 ml of each standard and place into GC-MS glass vials  
      and dry under a low stream of N2 (can place in heating block at   
      heat at 100ºC with top off for 1 h). Freeze the remainder of the  
      hydrolysate. 
 
c.   Add a 3:2:1 solution of Methyl-8, methanol (CH3OH) and   
      acetonitrile (CH3CN); cap and vortex vigorously. 
 
d. Place sample into GC-MS vial inserts and place into the GC-MS glass 
vials and cap. 
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e. Inject sample into GC-MS at 1 µl/min; selective ion monitoring (m/z)  
99 and 100. 
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APPENDIX C 
PLASMA AMINO ACID ANALYSIS 
 
I.  Plasma Amino Acid (HPLC) 
Required Items      Catalog Number 
1.5 ml microcentrifuge tubes     Fisher, 02-681-284 
2.0 ml microcentrifuge tubes     Fisher, 02-681-291 
0.45 µm pore size membrane filter    Fisher, R04SP04700 
0.22 µm pore size membrane filter    Fisher, R02SP01300  
Amino acid standards      Sigma, AAS18 
Amino acids: 
B-Alanine (C3H7NO2)     Sigma, A7752 
L-Asparagine (C4H8N2O3)     Sigma, A8824 
L-Citrulline (C6H13N3O3)     Sigma, C7629 
L-Glutamine (C5H10N2O3)     Sigma, G3126 
Taurine (C2H7NO3S)      Sigma, T0625 
L-Tryptophan (C11H12N2O2)     Sigma, T8659 
L-Ornithine (C5H12N2O2)     Sigma, O2375 
Benzoic acid (C6H5COOH)     Sigma, 109479 
Borate (Na2B4O7)      Sigma, B9876 
Brij-35 (C2H4O)nC12H26O     Sigma, B4184 
Diethyl Ether (C4H10O)     EMD, EX0190-8 
Ethanolamine (NH2(CH2)2OH)    Sigma, E0135 
Methanol (CH3OH-HPLC grade)    Fisher, MXO 475-1 
2-Mercaptoethanol (C2H6OS)     Sigma, 3148 
Perchloric acid (HClO4)     J.T. Baker, 9652-02  
Phthaldialdehyde (C8H6O2)     Sigma, P0657 
Potassium carbonate (K2CO3)    Sigma, P5833 
Shell vials for Waters autosampler    Fisher, 03-391-23 
Sodium acetate (C2H3O2Na)     Sigma, S7670  
Tetrahydrofuran (C4H8O)     Sigma, 34865 
Tuberculin slip tip (1ml)     BD, PK 100309602 
Water (H2O-HPLC grade)     Fisher, W5-4 
 
Procedure: 
 
A. Plasma Amino Acid Preparation: 
 
1.  Centrifuge 1.0 ml of 2, 6 and 12 minute blood samples at 3,800  
rpm at 4ºC for 20 min.  
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2.  Extract plasma with 1.0 ml pipette and place into 1.5 ml   
     microcentrifuge tubes, freeze at -80ºC. 
 
3.  To 0.15 ml sample, add 0.15 ml HPLC grade H2O, cap and vortex. 
 
4.  Remove 0.2 ml of sample, place into 1.5 ml microcentrifuge tubes  
     and add 0.2 ml 1.5 M perchloric acid (HClO4); cap and vortex. 
 
5.  Add 0.1 ml 2.0 M potassium carbonate (K2CO3), cap and vortex,  
     then decap and allow settling for 5 min at room temp. 
 
6.  Centrifuge at 6,000 rpm at room temperature for 12 min. 
 
7.  Remove 0.3 ml of supernatant and place in 1.5 ml microcentrifuge  
     tubes. Add 0.9 ml of diethyl ether (C4H10O), cap and vortex. 
 
8.  Aspirate top layer (lipid, will see separation with a film).  
 
9.  Extract 0.2 ml of bottom layer and add 0.1 ml of 1.2% benzoic acid  
     (C6H5COOH) and 1.5 ml of HPLC grade H2O in 2.0 ml   
     microcentrifuge tubes; cap and vortex. 
 
11. Remove sample with tuberculin slip tip syringe and filter 1.0 ml of  
sample through a 0.22 µm membrane filter into 1.0 ml HPLC vials and 
place into refrigerator without caps overnight.  
 
12. Inject 1:1 (0.1 ml) of sample and OPA into Waters HPLC. 
 
B. High Performance Liquid Chromatography (HPLC): 
1.  System:   
 
a.  HPLC Waters solvent delivery system (2 Waters 501 pumps, a 717 
Waters Autosampler, and Automated Gradient Controller [curve 6 
chosen] Waters 470 Scanning Fluorescence Detector [attenuation 350 
nm, gain 450 m]). 
 
b.  Column, Suelcosil  LC-18 (58985) 15 cm x 4.6 mm, 3 micron   
     beads. 
 
2.  Gradient Solvent (A): 
 
a.  Add 0.8 L of HPLC grade H2O into 1.0 L flask. 
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b.  Add 13.65 g sodium acetate (C2H3O2Na), 0.048 ml 6 N HCl,         
     5.0 ml tetrahydrofuran (C4H8O) and 0.09 ml methanol (CH3OH- 
     HPLC grade).  
c.  Filter through 0.45 µm membrane filter into 1.0 L flask with side  
     arm and q.s. to 1.0 L. 
 
3.  Solvent B: 
 
a. Filter 1.0 L methanol (CH3OH-HPLC grade) through 0.45 µm 
membrane filter.  
 
4.  Phthaldialdehyde (C8H6O2) (OPA) Reagent: 
 
a.  Add 0.05 g OPA to sterile 20.0 ml amber bottle. 
 
b.  Add 1.25 ml methanol (CH3OH-HPLC grade), 11.20 ml sodium borate 
buffer, 0.05 ml 2-Mercaptoethanol (C2H6OS) and 0.4 ml Brij-35 
(C2H4O)nC12H26O, cap and store in the refrigerator.  
 
     i.  Sodium borate buffer: 
 
         1.  Mix 15.22 g Borate (Na2B4O7) in 1.0 L HPLC grade H2O;  
    pH 9.2.   
 
5.  HPLC Settings and Flow Rate: Linear gradient (1500 psi). 
 
Time (min)         Flow (ml/min)          % Solvent A          %Solvent B            Curve 
         0     1.1             86         14      6 
       20     1.1             86         14      6 
       24     1.1             70         30   6 
       26     1.1             65         35   6 
       28     1.1             53         47   6 
       34     1.1             50         50   6 
       38     1.1             30         70   6 
       40     1.1               0       100   6 
       42     1.1               0       100   6 
       42.1    1.1             86         14   6 
       48.5  1.1             86         14   6  
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C.  Linear Standard Curve Preparation: 
 
1.  Stock Solution (250 nmol/ml): 
 
a.  To 200 ml of HPLC grade H2O, add the following (GATCOTA): 
 
M.W. x M x Vol (L) 
 
B-Alanine (C3H7NO2), M.W. = 87.09 (0.0435 g)   
L-Asparagine (C4H8N2O3), M.W. = 132.12 (0.066 g)   
L-Citrulline (C6H13N3O3), M.W. = 175.2 (.0876 g) 
L-Glutamine (C5H10N2O3), M.W. = 146.1 (0.073 g) 
Taurine (C2H7NO3S), M.W. = 125.15 (0.0625 g)   
L-Tryptophan (C11H12N2O2), M.W. = 204.2 (0.102 g)  
L-Ornithine (C5H12N2O2), M.W. = 168.62 (0.0843 g) 
b.  Add 0.3 ml of amino acid standard, 0.3 ml of GATCOTA, 0.3 ml 
ethanolamine (NH2(CH2)2OH and 2.1 ml of HPLC grade H2O; total 
volume = 3.0 ml. 
 
nmol/ml ml of stock solution  ml HPLC H2O  total ml ratio 
 250.00  1.0            0         1.0   1:0 
 125.00  0.5            0.5     1.0   1:1 
   62.50             0.5            1.5     2.0   1:3 
   41.68             0.2            1.0     1.2   1:5 
   35.71             0.1667                     1.0                         1.1667           1:6 
   22.73  0.1            1.0     1.1   1:10 
   15.63  0.1            1.5     1.6   1:15 
   11.91  0.1            2.0     2.1   1:20 
     9.62  0.05            1.25     1.3   1:25 
4.90   0.039            1.96     1.999  1:50
  
c.  Add 0.15 ml of each standard to a 1.5 ml microcentrifuge tubes  
    and add 0.15 ml HPLC grade H2O, cap and vortex. 
 
d.  Remove 0.2 ml of sample, place into 1.5 ml microcentrifuge   tubes 
and add 0.2 ml 1.5 M perchloric acid (HClO4); cap and vortex. 
 
e.  Add 0.1 ml 2.0 M potassium carbonate (K2CO3), cap and vortex, than 
decap and allow settling for 5 min at room temp. 
 
f.  Centrifuge at 6,000 rpm at room temperature for 12 min. 
 
         
160 
g.  Remove 0.3 ml of supernatant and place in 1.5 ml  
microcentrifuge tubes. Add 0.9 ml of diethyl ether (C4H10O), cap and 
vortex. 
 
h.  Aspirate top layer (lipid, will see separation with a film).  
 
i.  Extract 0.2 ml of bottom layer and add 0.1 ml of 1.2% benzoic acid 
(C6H5COOH) and 1.5 ml of HPLC grade H2O in 2.0 ml 
microcentrifuge tubes; cap and vortex. 
 
j.  Remove sample with tuberculin slip tip syringe and filter 1.0 ml of 
sample through a 0.22 µm membrane filter into 1.0 ml HPLC vials and 
place into refrigerator without caps overnight.  
k.  Inject 1:1 (0.1 ml) of sample and OPA into Waters HPLC. 
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APPENDIX D 
CALCULATIONS 
 
Assessment With L-[2,3,4,5,6-
3
H]Phenylalanine 
I.  Determination of Plasma and Tissue Specific Radioactivity (SA): 
 
A.  Plasma SA with HPLC:  (DPM · ml -1) · (F · ml-1)-1 
 
1.  (DPM · ml -1) = DPM x 40 
 
2.  (F nmol · ml-1) = [(F) x B3] · [(B2 – B1) x ((A2 – A1) – (A3 – A1))]-1 
 
a. (F) = value of F in ml obtained from HPLC. 
 
b. A1 = weight of tube A empty. 
 
c. A2 = weight of tube A with 0.25 ml of plasma and 0.25 ml 10% TCA 
(Cl3CCOOH). 
 
d. A3 = weight of tube A with precipitate only (supernatant removed). 
 
e. B1 = weight of tube B empty. 
 
f. B2 = weight of tube B with supernatant. 
 
g. B3 = weight of tube B with supernatant and 0.3 ml of 0.5M Borate 
(Na2B4O7). 
 
B.  Plasma SA with GC-MS: (DPM · ml -1) · (F · ml-1)-1 
 
1.  (DPM · ml -1) = DPM x 40 
 
2.  (F nmol · ml-1) = (C x 60) · 0.3-1 
 
                      a.  C = Corrected ratio of 234/240 which is obtained by taking the  
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                           ratio, subtracting the intercept (measured standard 234/240   
                           ratios) and dividing by the slopes (expected 234/240 ratios   
                           obtained by taking standard values and dividing by the quantity   
                           of the internal standard (nmol/ml). 
 
                      b.  60 = internal standard quantity (nmol · ml-1). 
 
         c.   0.3 = quantity of sample used (ml). 
 
C.  Tissue SA with GC-MS:  (DPM · ml -1) · (F · ml-1)-1 
 
                 1.  (DPM · ml -1) = (DPM · 0.5-1) x 2 
 
                      a.  2 = volume that was originally used (2.0 ml). 
 
                 2.  (F nmol · ml-1) = ((C x 1000) · 1.0-1) x 2 
 
a.  C = Corrected ratio of 234/240 which is obtained by  
     taking the ratio, subtracting the intercept (measured  
     standard 234/240 ratios) and dividing by the slopes   
     (expected 234/240 ratios obtained by taking standard  
     values and dividing by the quantity of the internal  
     standard (nmol/ml). 
 
b. 1000 = internal standard quantity (nmol · ml-1). 
 
                        c. 1.0 = quantity of sample used (ml). 
 
      d. 2 = volume that was originally used (2.0 ml). 
 
II.  Calculation of Fractional Rates of Protein Synthesis (FSR): % · h-1 
 
           A.   FSR:  SP ∙ (SĀ x t)-1 x 100 (expressed as % · h-1) 
 
        1. SP = Specific radioactivity of tissue. 
 
             a. (DPM · ml-1) · (F · ml-1)-1 
 
         2.  SĀ = Mean specific radioactivity (2, 6, 12 min bloods) of plasma. 
 
a. (DPM · ml-1) · (F · ml -1)-1 
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                   3.  t = time from start of flooding to placement of tissue into liquid  
 N2 (h). 
 
          4.  100 = conversion to a % (expressed as % · h-1). 
 
III.  Calculation of Rates of Protein Synthesis (RPS): nmol F · g-1 · h -1 
 
A. RPS:  (DPM ∙ protein pool-1) ∙ (SĀ)-1∙ (t)-1     
  
                  1.  DPM = [(DPM · 0.5 -1) · post-protein-1] x [(2 x post-protein) ·  g  
                       tissue-1)] 
 
         a.  (DPM · 0.5 -1) = DPM is 0.5ml of NaOH. 
 
         b.  post protein = protein content in NaOH (mg · ml-1).   
   
        c.  (2 x post-protein) = quantity of protein (mg · ml -1) in   
                   2.0ml (original vol.). 
 
         2.  SĀ = Mean specific radioactivity (2, 6, 12 min bloods) of plasma. 
 
    b.  (DPM · ml -1) · (F · ml-1)-1 
 
                   3.  t = time from start of flooding to placement of tissue into liquid  
    N2 (h).                            
 
Assessment with 
2
H2O 
I.  Determination of Plasma and Tissue Enrichment: 
 
A.  Plasma Enrichment:  (59) · (58)-1 
 
     1.  (m/z) 59 = M+1 labeling of acetone (CH3COCH3). You could  
          potentially have up to 6 2H (6H in acetone), M+6, however, do not  
          need to measure the (m/z) 64. 
 
                2.  (m/z) 58 = M, meaning you have 0 labeling of acetone. 
 
.  Tissue Enrichment:  (100) · (99)-1 
 
      1.  (m/z) 100 = M+1 labeling of Methyl-8 fragment of alanine  
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             (C3H7NO2).   
 
                 2.  (m/z) 99 = M, meaning you have 0 labeling Methyl-8 fragment of  
                        alanine.  
 
II.  Calculation of Fractional Rates of Protein Synthesis (FSR):  
 
      A.  FSR:  2H-labeling of Ala in protein · [2H-labeling body water x 3.7 x  
                    time (h])-1   
            
        1.  Multiplying X 100 will convert to a % (% · h -1) 
 
        2.  3.7 represents exchange of 2H between body water and        
  alanine. 
 
                    3.  The assumption is that 2H labeled body water equilibrates with  
     free alanine more rapidly than 2H labeled alanine incorporates   
     into newly made protein and that proteins synthesis is linear over   
     time. 
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